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1 Summary
Cysteine proteases play a crucial role in medical chemistry concerning various fields
reaching from more common ailments like cancer and hepatitis to less noted tropical
diseases, namely the so called African Sleeping Sickness (Human Arfican Trypanoso-
miasis). Detailed knowledge about the catalytic function of these systems is highly
desirable for drug research in the respective areas. In this work, the inhibition mecha-
nisms of the two cysteine proteases cathepsin B and rhodesain with respectively one
low-molecular inhibitor class were investigated in detail, using computational meth-
ods. In order to sufficiently describe macromolecular systems, molecular mechanics
based methods (MM) and quantum mechanical based method (QM), as well as hy-
brid methods (QM/MM) combining those two approaches, were applied. Chapter 5
provides information about the theoretical background of the utilized methods. In
Chapter 7 and 8, the results of this work are presented and discussed. They are struc-
tured as follows: After a short introduction of the respective subject, a brief summary
of all relevant results will be given followed by detailed discussions.
Chapter 7 deals with the reaction behaviour of carbamate-based inhibitors in cathep-
sin B. The various reaction pathways of the inhibitor in the active site of the enzyme
were evaluated via thermodynamic calculations. In combination with docking studies
and consideration of experimental data concerning the inhibition potential of different
derivatives performed in the group of Prof. Guetschow in Bonn, [1] only one reaction
path remained feasible. The path contains an E1cB elimination reaction, followed by
a carbamylation of the active site amino acid Cys29 (see Firgue 1.1).
Figure 1.1: Proposed mechanism for the reaction of a carbamate-based inhibitor in cathepsin B.
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The two reaction steps were investigated separately. Concerning the first step (elim-
ination), different approaches at the QM/MM level of theory were applied in order
to find the energetically most favourable reaction path. Based on the computed re-
action profiles and potential energy surfaces, two conclusions were drawn. First, the
phenolate anion, formed during the reaction, has to be stabilized via a proton transfer
through Cys29 (see Firgue 1.1). Second, the results indicated that the mechanism is
a complex process involving a number of reaction coordinates. Therefore, “Nudged
Elastic Band” (NEB) calculations (QM/MM level) were performed, showing reaction
barriers of nearly 40 kcal/mol. As the inhibition is unlikely to occur under these con-
ditions, a new approach was applied. Based on a molecular mechanics simulation,
the active site of the enzyme holds enough space for the inhibitor and an additional
water molecule, placed in a favourable position for a water-bridged proton transfer.
Figure 1.2: Reaction scheme of the water-mediated mechanism for the inhibition of cathepsin B
using carbamate-based inhibitors.
The computed potential energy surfaces (QM/MM) predict reaction barriers of around
20 kcal/mol, whereas the NEB calculations (QM/MM) revealed barriers of only
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12 kcal/mol. Based on these results, a water-mediated E1cB elimination was assumed.
As the NEB calculations did not converge for the whole E1cB elimination (and also
for the carbamylation reaction) the mechanism was divided into four distinctive steps
shown in Figure 1.2. The second step of the investigated inhibition mechanism (car-
bamylation) was also calculated with help of several reaction profiles and NEB calcu-
lations at the QM/MM level of theory. The resulting path predicts a reaction barrier of
around 5 kcal/mol for the nucleophilic attack.
Figure 1.3: Computed NEB pathways of the reaction scheme shown in Figure 1.2. QM/MM
calculations with B3LYP/cc-pVDZ as QM method; for the utilized MM method, it
is referred to Chapter 6.
The calculations of the subsequent protonation of the inhibitor through His199 did
again indicate the participation of a water molecule in the mechanism. The inclusion
of this water molecule resulted in a nearly barrier free water-bridged proton transfer.
The resulting reaction path of the scheme in Figure 1.2 is depicted in Figure 1.3. In
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conclusion, the investigated mechanism seems to be a complex reaction that depends
on a number of coordinates and is partly concerted. Furthermore, the participation of
a water-bridged proton transfer reaction seems to be crucial for the reaction.
The second class of systems investigated in this work contain the cysteine protease
rhodesain as well as nitroalkene-based inhibitors. These are discussed in Chapter 8.
The computations entailed three derivatives of a nitroalkene-based inhibitor, differing
in one residue at the α position of the nitro alkene (see Figure 1.4). Nitroalkenes
represent a promising inhibitor class concerning the covalent-reversible inhibition of
rhodesain. Compared to the irreversible vinylsulfon inhibitor K11777, the inhibition
with nitroalkenes was shown to have higher binding affinities in combination with a
reversible reaction mechanism. [2]
Figure 1.4: Investigated nitroalkene inhibitors.
In Chapter 8.2, the inhibition behaviour of fluorinated and unfluorinated ni-
troalkenes is discussed. The fluorinated nitroalkenes showed an interesting be-
haviour in the experiment, performed by the group of Prof. Schirmeister. [3] While
for the unfluorinated systems a ”one-step” mechanism was measured, the experi-
ments showed a ”two-step” mechanism for the fluorinated compounds. The terms
”one-step”/”two-step” mechanism do, however, not refer to an actual mechanistic
course of the reaction, but to the scheme shown in Figure 1.5. The mechanism of a co-
valent inhibition contains the two reaction steps, depicted. Enzyme (E) and inhibitor
(I) form a non-covalent complex (E...I) in the first step, which subsequently reacts to a
covalent product (E I). The second step of this reaction may contain several sub-steps.
Figure 1.5: Scheme of a two step mechanism for a covalent reversible inhibition.
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For the reaction of the unfluorinated nitroalkenes, only one value quantifying the
inhibition potential was measured (Ki). This value thus contains information about
all mechanistic steps that occur during the reaction. Assuming the inhibition reaction
only includes the formation of the non-covalent complex E...I, Ki would exclusively
describe this single step. In case of a rapid reaction from E + I to E I, Ki contains
information about all steps. There are thus several possibilities for the inhibition by
the unfluorinated molecules: The reaction could stop at the non-covalent complex.
Alternatively, enzyme and inhibitor rapidly react to the covalent product or any
intermediate structure. For the fluorinated compounds, in contrast, two separated
steps were identified by experimental measurements, which renders the respective
inhibitors so called “slow-binders”. This implies that at some point of the mechanism,
the reaction is slowed down. In order to find the element that slows the reaction
of the fluorinated systems down, the two systems were compared via various com-
putational methods. Thermodynamic calculations within a model system on a QM
level of theory with a number of (un)fluorinated nitroalkene and vinylsulfone deriva-
tives did not provide an explanation for the measured phenomenon. Within the NEB
calculations of the systems, based on preceding MD simulations of the non-covalent
enzyme-inhibitor complexes, no differences were found either. Both inhibitors showed
a similar behaviour during the MD simulation of the non-covalent enzyme-inhibitor
complex and the respective reaction barriers for the formation of the covalent product
(step A and step B in Figure 1.6) were also in a similar range. The results would speak
for a rapid reaction of the unfluorinated compound to the covalent product, as both
reaction barriers are in a similar range and the reaction enthalpy is in a range around
-10 kcal/mol. The reactants would thus react so rapidly that the measurement could
only “resolve” one reaction step.
Figure 1.6: Reaction scheme for the investigation of the barriers and the performance of MD
simulations.
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In order to gain insight in a potential influence of the environment on the reaction, MD
simulations were performed with the intermediate structures (11 Int and FGA124 Int)
of both systems. The unfluorinated nitroalkene inhibitor stayed in a stable position
inside the active site during the simulation with no significant structural changes.
For the system with the fluorinated compound, the active site amino acid histidine
(His), which normally stabilizes the NO2 group and protonates the double bond in
the second reaction step, rotates out of the active site, away from the electrophilic
part of the inhibitor (also known as warhead). The reason for the rotation could
be connected to the reduced electron density in the warhead, with respect to the
unfluorinated molecule. This movement could cause a longer residence time inside the
active site for the fluorinated intermediate, as either histidine has to rotate back, or the
protonation would have to take place from the unfavourable orientation. The extended
residence time of the fluorinated compounds would be a plausible explanation for the
measurement of a two-step mechanism, as the reaction would rapidly proceed to the
covalent intermediate FGA124’ INT (see Figure 1.6) and then slow down due to the
rearrangement of the system. In order to quantify the influence of this rearrangement,
reaction profiles for the second step of the mechanism (protonation through histidine,
see Figure 1.6) were compared for the unfluorinated system and both orientations (His
rotated and His unrotated) of the fluorinated systems. The unfluorinated system has a
reaction barrier of +8.3 kcal/mol (QM/MM NEB calculations). For the rotated histidine
ring, the barrier exceeded 30 kcal/mol (QM/MM reaction profile calculations) due to
the unfavourable orientation. The fluorinated nitroalkene intermediate FGA124’ INT
(see Figure 1.6) with the histidine ring in its original orientation has a barrier of
+6.8 kcal/mol for the second step of the reaction. In conclusion, the decreased electron
density of the fluorinated nitroalkenes is likely to cause weaker interactions between
enzyme and inhibitor inside the active site. The resulting rotation of histidine out of
the active site causes a longer residence time of the fluorinated derivatives, which can
be used to explain the “slow-binder” mechanism of the compounds.
Chapter 8.3 discusses the different behaviour of compound 11 and 15 (see Figure 1.4).
Experiments performed by the Schirmeister group showed that compound 11 (R = H)
has a significantly lower Ki value for the formation of the non-covalent bond com-
pared to compound 15 (R = CH3). Thermodynamic calculations and docking studies
of the systems did not show crucial differences in the behaviour of the two inhibitors.
However, MD simulations of the non-covalent enzyme-inhibitor complexes revealed
that due to steric hindrance, the methyl residue of inhibitor 15 changes its orienta-
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tion, which leads to a rotation of the warhead out of the active site. Inhibitor 11, in
contrast, stays in a relatively stable position in favour of a reaction with the active site
amino acids. The simulations could thus explain the different behaviour of the two
compounds. In conclusion, the worse inhibition potential of inhibitor 15 compared to
inhibitor 11 can be traced back to sterical hinderance due to the methyl substituent.
For inhibitor 15, no “two-step” mechanism was measured and previous experiments
showed that without the presence of the warhead, no inhibition takes place at all. It
can thus be assumed, that the inhibition mechanism with the methylated nitroalkene
only contains the reversible formation of the non-covalent enzyme-inhibitor complex,
whereas the unmethylated inhibitor forms a covalent bond with the enzyme.
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2 Zusammenfassung
Cysteinproteasen spielen eine wichtige Rolle in der medizinischen Chemie. Nicht
nur im Bereich bekannterer Krankheiten wie Krebs oder Hepatitis, sondern auch
bezu¨glich weniger verbreiteter, tropischer Krankheiten wie der sogenannten afrika-
nischen Schlafkrankheit (Afrikanische Trypanosomiasis) haben diese Enzyme eine
große Bedeutung. Im Bereich der Wirkstofffindung ist ein detailliertes Wissen u¨ber
die katalytische Funktion der an einer Krankheit beteiligten Enzyme unabdingbar. In
der vorliegenden Arbeit wurden die Inhibitionsmechanismen der beiden Cysteinpro-
teasen Cathepsin B und Rhodesain in Verbindung mit zwei niedermolekularen Inhibi-
torklassen anhand theoretischer Berechnungen untersucht. Um die makromolekula-
ren Systeme ausreichend genau beschreiben zu ko¨nnen, wurden neben molekularme-
chanischen (MM) und quantenmechanischen (QM) Ansa¨tzen auch Hybridmethoden
verwendet, welche beide Ansa¨tze (QM/MM) verbinden. Der genaue mathematische
Hintergrund dieser Methoden ist Gegenstand von Kapitel 5. In den Kapiteln 7 und 8
werden die Ergebnisse der Arbeit vorgestellt und diskutiert. Die Kapitel sind dabei
wie folgt aufgebaut: Nach einer kurzen Einleitung zu den jeweiligen Themen folgt
eine Zusammenfassung aller relevanten Ergebnisse. Danach werden die einzelnen
Ergebnisse detailliert diskutiert.
Kapitel 7 befasst sich mit dem Reaktionsverhalten Carbamat-basierter Inhibitoren in
Cathepsin B. Mithilfe thermodynamischer Berechnungen wurden die verschiedenen
Reaktionsmechanismen des Inhibitors in der aktiven Tasche des Enzyms evaluiert.
Die Erkenntnisse dieser Rechnungen in Kombination mit Dockingstudien und expe-
rimentellen Daten bezu¨glich des Inhibitionspotentials, welche im Arbeitskreis von
Prof. Guetschow in Bonn [1] durchgefu¨hrt wurden, erlauben nur einen mo¨glichen
Reaktionsweg. Dieser beinhaltet eine E1cB Eliminierung als ersten Schritt, gefolgt
von einer Carbamylierung der Aminosa¨ure Cys29 (siehe Abbildung 2.1). Bezu¨glich
des ersten Reaktionsschrittes (der Eliminierung) wurden Berechnungen mittels der
QM/MM Methode durchgefu¨hrt, um den energetisch gu¨nstigsten Reaktionspfad zu
finden.
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Abbildung 2.1: Vorgeschlagener Mechanismus fu¨r die Hemmung von Cathepsin B mit
carbamat-basierten Inhibitoren.
Aufgrund der resultierenden Reaktionsprofile und Potentialfla¨chen konnten zwei
wichtige Schlussfolgerungen gezogen werden. Erstens muss das Phenolat-Anion,
welches wa¨hrend der Reaktion gebildet wird, durch eine Protonierung von Cys29
stabilisiert werden (siehe Abbildung 2.2). Zweitens deuten die theoretischen Ergeb-
nisse darauf hin, dass es sich bei dem vorliegenden Mechanismus um einen kom-
plexen Vorgang handelt, der von einer Vielzahl an Reaktionskoordinaten abha¨ngt.
Daher wurden “Nudged Elastic Band”(NEB) Rechnungen (mit der QM/MM Metho-
de) angefertigt, welche eine Reaktionsbarriere von nahezu 40 kcal/mol vorhersagen.
Da die Reaktion unter diesen Bedingungen nicht real ablaufen wu¨rde, wurde ein
weiterer Ansatz der theoretischen Modellierung getestet. Aufgrund einer vorange-
gangenen MD-Simulation des Systems stellte sich heraus, dass in der aktiven Tasche
genug Platz fu¨r den Inhibitor und ein zusa¨tzliches Wassermoleku¨l ist. Dieses Was-
sermoleku¨l diffundierte wa¨hrend einer Simulation in die aktive Tasche und lag in
einer gu¨nstigen Position fu¨r einen wasser-verbru¨ckten Protonentrasfer (siehe Abbil-
dung 2.2). Die berechneten Potentialfla¨chen fu¨r dieses neue System (QM/MM) sagen
Reaktionsbarrieren von circa 20 kcal/mol voraus, wohingegen die NEB Rechnungen
sogar die ho¨chste Barriere bei nur 12 kcal/mol ansetzt. Basierend auf diesen Ergebnis-
sen wird ein wasser-verbru¨ckter Mechanismus angenommen. Die NEB-Rechnungen
des gesamten E1cB Mechanismus als auch der gesamten Carbamylierung konver-
gieren nicht, wodurch keine validen Ergebnisse erhalten wurden. Daher wurden die
Reaktionen in vier Schritte, wie sie in Abbildung 2.2 gezeigt sind, unterteilt. Der zweite
Reaktionsschritt (Cabamylierung) wurde ebenfalls mithilfe mehrerer Potentialfla¨chen
und NEB-Pfade auf QM/MM Niveau berechnet.
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Abbildung 2.2: Reaktionsschema des Wasser-verbru¨ckten Mechanismus.
Der energetisch gu¨nstigste Reaktionspfad hat eine Barriere von 5 kcal/mol fu¨r den
nukleophilen Angriff von Cys29 an den Inhibitor (siehe Abbildung 2.3). Die Be-
rechnungen des nachfolgenden Protonentransfers von His199 zum Inhibitor deu-
teten erneut auf einen wasser-verbru¨ckten Mechanismus hin. Unter Einbezug des
zusa¨tzlichen Wassermoleku¨ls resultierte ein nahezu barrierefreier Protonentransfer
als letzter Schritt der Reaktion (siehe Abbildung 2.3). Der NEB Reaktionspfad des
in Abbildung 2.2 gezeigten Schemas ist in Abbildung 2.3 dargestellt. Zusammen-
fassend handelt es sich bei dem untersuchten Mechanismus um eine komplexe Re-
aktion, deren Reaktionsschritte zum Teil konzertiert ablaufen. Außerdem scheinen
wasser-verbru¨ckte Protonentransferreaktionen entscheidend zum Reaktionsverlauf
beizutragen.
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Abbildung 2.3: Berechneter NEB-Pfad (QM/MM mit B3LYP/cc-pVDZ als QM Methode) des
Reaktionsschemas aus Abbilung 2.2.
Das zweite System, welches im Rahmen dieser Arbeit untersucht wurde, beinhal-
tet die Cysteinprotease Rhodesain zusammen mit Nitroalken-basierten Inhibitoren
und wird in Kapitel 8 diskutiert. Es wurden drei Derivate eines Inhibitors unter-
sucht, die sich jeweils in einer Modifikation am α-Kohlenstoff des Nitroalkens un-
terscheiden (siehe Abbildung 2.4). Nitroalkene stellen eine vielversprechende Inhi-
bitorklasse bezu¨glich kovalent-reversibler Hemmung von Rhodesain dar. [2] Im Ver-
gleich zum bereits bekannten, irreversibel bindenden Vinylsulfoninhibitor K11777
haben Nitroalkene ho¨here Bindungsaffinita¨ten in Kombination mit einem reversi-
blen Inhibitionsmechanismus. In Kapitel 8.2 wird das Inhibitionsverhalten fluorier-
ter und nicht-fluorierter Nitroalkene in Rhodesain untersucht. In den Experimen-
ten der Arbeitsgruppe von Prof. Schirmeister [3] zeigten die fluorierten Nitroalkene
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ein interessantes Verhalten. Wa¨hrend fu¨r die unfluorierten Systeme ein “Ein-Schritt-
Mechanismus”gemessen wurde, konnte bei den fluorierten Derivaten ein “Zwei-
Schritt-Mechanismus“ festgestellt werden. Die Begriffe beziehen sich hier allerdings
nicht auf den tatsa¨chlichen mechanistischen Ablauf, sondern auf das Reaktionschema,
welches in Abbildung 2.5 gezeigt ist. Der Mechanismus einer kovalenten Inhibitions-
reaktion beinhaltet die zwei in der eben erwa¨hnten Abbildung gezeigten Schritte.
Abbildung 2.4: Untersuchte Nitroalken-Inhibitoren.
Enzym (E) und Inhibitor (I) bilden im ersten Schritt einen nicht-kovalenten Komplex
(E...I), der dann im zweiten Schritt zu einem kovalenten Produkt (E I) weiter reagiert.
Dieser zweite Schritt kann je nach Reaktionsmechanismus selbst wieder aus mehreren
Unterschritten bestehen.
Abbildung 2.5: Reaktionsschema fu¨r einen zweischrittigen Inhibitionsmechanismus einer ko-
valent reversiblen Inhibition.
Fu¨r die Reaktion der unfluorierten Nitroalkene in Rhodesain wurde lediglich ein
Wert gemessen, der das Inhibitionspotential quantifiziert (Ki). Dieser Wert entha¨lt
folglich Informationen u¨ber alle beteiligten Schritte. Wu¨rde die Hemmung nur aus
der Bildung des nicht-kovalenten Komplexes E...I bestehen, wu¨rde Ki ausschließlich
diesen Schritt beinhalten und quantifizieren. Im Fall einer schnellen Reaktion von E + I
zu E I, entha¨lt Ki hingehen Informationen zu allen beteiligten Schritten. Es gibt daher
mehrere Mo¨glichkeiten, den Wert fu¨r die unfluorierten Nitroalkene zu interpretieren:
Die Reaktion ko¨nnte nach der Bildung des nicht-kovalenten Komplexes stoppen oder
Enzym und Inhibitor ko¨nnten so schnell zu dem kovalenten Produkt (oder jedem
stabilen Intermediat) reagieren, dass experimentell nur ein Wert gemessen werden
kann.
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Fu¨r die fluorinierten Verbindungen wurden im Gegensatz dazu zwei separate Schrit-
te gemessen, weshalb die entsprechenden Inhibitoren als “slow-binders”(sinngema¨ß
“langsame Binder”) bezeichnet werden. Diese Messungen implizieren, dass die Reak-
tion an irgendeinem Punkt verlangsamt wird. Um den Ursprung der Verlangsamung
zu finden wurden die beiden Systeme (fluoriert: FGA124’; unfluoriert: 11, siehe Ab-
bildung 2.6) anhand diverser theoretischer Modell-Rechnungen untersucht und ver-
glichen. Thermodynamik-Rechnungen mit Modellsystemen auf QM Niveau lieferten
keine Erkla¨rung fu¨r die gemessenen Werte. Auch NEB Rechnungen der Systeme auf
QM/MM Niveau in relaxierter Umgebung (im Anschluss an eine MD Simulation des
nicht-kovalent gebundenen Komplexes) konnten das unterschiedliche Verhalten nicht
erkla¨ren. Beide Verbindungen zeigten ein a¨hnliches Verhalten im nicht-kovalenten
Enzym-Inhibitor Komplex wa¨hrend der MD Simulation, sowie bei der Reaktion zu
den Intermediaten (11 Int und FGA124’ Int in Abbildung 2.6) und den Produkten
(11 P und FGA124’ P in Abbildung 2.6). Die Ergebnisse sprechen fu¨r eine schnelle
Reaktion der unfluorierten Nitroalkene hin zum kovalent gebunden Produkt, da beide
Reaktionsbarrieren in einem energetisch a¨hnlichen Bereich sind und die Reaktions-
enthalpie bei -10 kcal/mol liegt. Die Reaktanden wu¨rden daher so schnell miteinander
reagieren, dass bei der Messung nur ein Schritt aufgelo¨st werden kann.
Abbildung 2.6: Reaktionsschema der (un)fluorierten Nitroalkene in Rhodesain fu¨r die Unter-
suchung der Reaktionsbarrieren und MD-Simulationen.
Um einen potentiellen Einfluss der Umgebung auf den Reaktionsversverlauf zu unter-
suchen, wurden ausgehend von Intermediat-Strukturen erneut MD-Simulationen von
beiden Systeme angefertigt. Das unfluorierte Nitroalken blieb dabei stabil in der ak-
tiven Tasche des Enzyms, ohne signifikante strukturelle Vera¨nderungen des Systems.
Bei der Simulation des fluorierten Intermediates dagegen drehte sich das Histidin
des aktiven Zentrums, welches normalerweise die NO2-Gruppe stabilisiert und im
zweiten Reaktionsschritt die Doppelbindung protoniert, aus der Enzymtasche heraus.
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Der Grund fu¨r die Drehung kann durch eine schwa¨chere Wechselwirkung zwischen
Histidin und der NO2-Gruppe des Inhibitors erkla¨rt werden, die wiederum durch
eine verringerte Elektronendichte im “warhead”(electrophiler Bereich des inhibitors)
der Verbindung, aufgrund des Fluorsubstituenten, zuru¨ckgefu¨hrt werden kann. Die
daraus folgende, ungu¨nstige Orientierung des Inhibitor-Intermediates zum Histidin
wu¨rde eine verla¨ngerte Residenzzeit des Inhibitors in der aktiven Tasche nach sich
ziehen, da die Protonierung entweder aus der ungu¨nstigen Orientierung statt finden
mu¨sste oder eine erneute Rotation des Histidin-Rings erforderlich wa¨re. Durch diese
verla¨ngerte Residenzzeit kann auch die Messung des Zwei-Schritt-Mechanismus im
Experiment erkla¨rt werden, wenn man annimmt, dass die Reaktion bis zum kovalen-
ten Intermediat FGA124′ INT schnell durchla¨uft und dann aufgrund der Umorientie-
rung des Histidin verlangsamt. Um den Einfluss der Drehung des Histidins zu quan-
tifizieren, wurden Reaktionsprofile des zweiten Schrittes der Reaktion (Protonierung
durch Histidin, siehe Abbildung 2.6) fu¨r beide Systeme (das fluorierte System in bei-
den Orientierungen des Histidins) berechnet. Das unfluorierte System zeigte bei den
NEB-Rechnungen auf QM/MM Niveau eine Reaktionsbarriere von +8.3 kcal/mol auf.
Die Barriere fu¨r das fluorierte System mit dem gedrehten Histidin-Ring war aufgrund
der ungu¨nstigen Orientierung u¨ber 30 kcal/mol hoch (Berechnung u¨ber Reaktions-
profil). Fu¨r die gu¨nstigere Orientierung des Histidins mit dem fluorierten Intermediat
wurde anhand eines Reaktionsprofils eine Barriere von +6.8 kcal/mol berechnet. Zu-
sammenfassend scheint aufgrund der verringerten Elektronendichte der fluorierten
Nitroalkene eine schwa¨chere Wechselwirkung zwischen Inihibitor und Enzym im ak-
tiven Zentrum stattzufinden. Die darin begru¨ndete Drehung des Histidin-Rings weg
vom “warhead”des Inhibitors zieht eine verla¨ngerte Residenzzeit des fluorierten Ni-
troalkens nach sich, was wiederum den “slow-binder“-Mechanismus der fluorierten
Systeme erkla¨rt.
Kapitel 8.3 bescha¨ftigt sich mit der theoretischen Modellierung von in der Arbeits-
gruppe von Prof. Schirmeister durchgefu¨hrten Experimenten zu den Inhibitoren 11
und 15. [2] Inhibitor 11 (R = H in Abbildung 2.4) zeigt ein signifikant ho¨heres In-
hibitionspotential in Rhodesain im Vergleich zu Verbindung 15 (R = CH3 in Ab-
bildung 2.4). Da sich bei thermodynamischen Berechnungen als auch in Docking-
studien keine Unterschiede zwischen den beiden Systemen zeigten, wurden MD-
Simulationen der nicht-kovalenten Enzym-Inhibitor-Komplexe durchgefu¨hrt. Im
Rahmen dieser Simulationen bewegte sich die Methylgruppe von Inhibitor 15 auf-
grund sterischer Hinderung in eine andere Orientierung, wodurch der “warheada¨us
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dem aktiven Zentrum herausgedreht wurde. Da bei Inhibitor 11 keine solche ste-
rische Komponente vorliegt, blieb dieser Inhibitor in einer relativ stabilen Position,
von der aus er gut mit dem aktiven Zentrum des Enzyms reagieren ko¨nnte. Den Un-
tersuchungen zufolge kann das bessere Inhibitionspotential von Verbindung 11 im
Verlgeich zu Verbindung 15 also auf einen ho¨heren sterischen Anspruch des methy-
lierten Inhibitors 15 zuru¨ckgefu¨hrt werden. Da fu¨r Inhibitor 15 kein “Zwei-Schritt-
Mechanismus”gemessen wurde und vorhergegangene Experimente zeigten, dass oh-
ne “warhead”keine inhibition stattfindet, kann davon ausgegangen werden, dass der
Inhibitionsmechanismus ausschließlich aus der Bildung des nicht-kovalenten Kom-
plexes besteht, wohingegen der unmethylierte Inhibitor bis zum kovalenten Produkt
durchreagiert.
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3 Introduction
3.1 Cysteine Proteases
3.1.1 Cysteine Proteases in Medicine and Research
The human body contains over 500 proteolytic enzymes, also known as proteases.
Their main task is to catalyze the cleavage of peptide bonds, which leads to the de-
gradation of proteins. Roughly 2% of the human genome encodes proteases, whereas
for bacteria and viruses it is up to 5%. [4,5] The role of proteases in pharmaceutical
research has dramatically changed in the last decades. In the beginning, they were
primary considered to be important for processes like digestion and intracellular tur-
nover. [6] In the 1950s, Davie et al. (together with a number of others) discovered that
limited proteolysis also takes place in protein activation of blood clotting. [7,8] Since
then, proteases have also been considered as regulative proteins, making them an
interesting target for drug research. Today, they are known to participate in physiolo-
gical key processes like DNA replication, cell death or immune responses. [9] Cysteine
proteases in particular make up a big part of all known proteolytic enzymes. They
can be found in mammals, plants, fungi, protozoa viruses and bacteria. Their diverse
occurrence in different organisms has made them an interesting target for medical
research. The involvement of cysteine proteases in many different physiological and
pathogenic processes offers a great number of opportunities for the development of
pharmaceutical compounds. Regarding the human organism, cathepsins, which be-
long to the papain-like cysteine protease family, play a crucial role. Diseases related
to cathepsins include Alzheimer’s disease, [10] Osteoporosis [11] and cancer. [12,13] They
occur from a breakdown in the control of protease activity which leads to undesired
and unregulated proteolysis. [14] Parasitic cysteine proteases are most often associated
with tropical diseases. They participate in a number of physiological key steps of the
parasite and are essential for their survival. [11,15,16] Diseases like Malaria, Chagas or
African Trypanosomiasis originate from parasites. In 2017, 216 million people were
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infected with Malaria, from which 445.000 have died. [17] Viral infections connected
with cysteine proteases are Hepatitis A or SARS. [11] In viruses, there is often only one
essential cysteine protease for the replication of the virus and there are no structural
related human enzymes, making them a much easier target than for example parasitic
cysteine proteases. [18] Table 3.1 gives examples for different cysteine-protease related
diseases and the involved enzymes. [9,11]
Tabelle 3.1: A number of pharmaceutical relevant cysteine proteases and their function in
living organisms.
Occurrence Protease Function Disease
Human
Homo sapiens Cathepsin B Cell Degradation of
Pathogens
Cancer, Rheumatoid
Arthritis
Homo sapiens Cathepsin K Tumor Spreading Breast Cancer
Parasites
T. b. rhodesiense Rhodesain Cell Replication of
the Parasite
African
Trypanosomiasis
P. falcilarum Falcipain-2 Hemoglobin
Degradation in
Trophozoites
Malaria
Viruses
Hepatitis A Virus Picormaine 3C Viral Replication
and Transcription
Hepatitis A
SARS Coronavirus SARS-CoV Mpro Viral Replication
and Transcription
SARS
T. b.: Trypanosoma brucei; P. falcilarum: Plasmodium falciparum; SARS: Severe Acute Respi-
ratory Syndrom.
Due to structural similarities of many cysteine proteases, the design of specific inhi-
bitors is a real challenge. Proteases were once described as “Mother Nature′s Swiss
Army Knife. They have many different functions, even though they often have nearly
identical structures.” [19] Concerning cysteine proteases, there are many evolutionary
relations between the different clans and families, making it a very challenging task
to address one specific enzyme.
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3.1.2 Classification, Structure and Catalytic Mechanism
While all proteases cleave peptide bonds via hydrolysis, they differ in a number of
aspects, for example regarding their catalytic mechanism, structure and recognition
patterns. A number of models arose from different attempts to classify proteases.
One of these models parts the proteases in two categories, namely endo- and exopep-
tidases. Endopeptidases cleave peptide bonds of non-terminal amino acids, whereas
exopeptidases cleave terminal peptide bonds. There is a further categorization of exo-
peptidases into amino and carboxy-peptidases, depending on whether the peptide
bond is cleaved from the carboxy or amino end.
In 1999, N.D. Rawlings and A.J Barrett developed a database for the categorization of
proteases, called MEROPS. [20] Their classification is based on the structural relations
between the proteases and includes evolutionary information.
Abbildung 3.1: Schematic categorization of cysteine proteases on the basis of the MEROPS
database with selected examples.
MEROPS includes six main categories: The Cysteine-, Serine-, Aspartic-, Threonine-,
Glutamine- and Metalloproteases, based on the active-site amino acid or additional
compounds. Furthermore, there is a seventh category for unknown proteases that
are mixtures of the above mentioned. The proteases inside a category are further
divided into clans and families. All proteolytic enzymes inside a clan have the same
evolutionary origin. They show similarities in their tertiary structures or amino acid
18
3.1. CYSTEINE PROTEASES
sequences around the active site. [20] A clan can include one or more families, whereas
a family is assigned via similarities of amino acid sequences.
Cysteine proteases are divided into a number of clans. The three biggest are the
papain-like (CA), the caspase-like (CD) and the adenain-like clan (CE). Furthermore,
there are cymotrypsin-like cysteine proteases (PA), which also include serine
proteases. [20,21] The majority of cysteine proteases are members of the papain-like
clan, rendering this category the subject of intensive research. The clan includes over
40 families from which the papain-like family C1 and the calpain-like family C2 play
a crucial role in parasitic proteases. [20,22] The human cathepsin B and the parasitic
rhodesain, which are both subjects of this work, belong to the subfamily C1A of
family C1. Figure 3.1 shows a schematic categorization of cysteine proteases with
selected examples on the basis of the MEROPS data base. [20] As the investigated
systems of this work are papain-like cysteine proteases, the following sections will
focus on this subject.
All papain-like proteases share similar features in their structure. They consist of two
domains, the L-domain (left side) and the R-domain (right side). In between them lies
the active site cleft with a cysteine and a histidine residue as active site amino acids. [23]
The histidine is located in the R-domain, which also includes a short α-helical passage
and larger passages of β-sheets (orange in Figure 3.2). The domain has a shape similar
to a vessel. The active site cysteine is part of the L-domain, which is dominated by a
large α-helix (green in Figure 3.2). [9,23,24] Figure 3.2 illustrates the structures of three
papain-like cysteine proteases with the characteristics described above.
Abbildung 3.2: Crystal structures from the RCSB data-base [25] of cathepsin B (1HUC), [26] pa-
pain (1PPN) [27] and rhodesain (2P7U). [28] Active site amino acids are depicted
as ball and stick.
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Even though the tertiary structures and a number of amino acid sequences are similar
inside a family, the different enzymes can be highly selective. The structure and
orientation of the binding site has a strong influence on this selectivity. The binding
site of proteases can be described via subsites or bonding pockets, depending on
the orientation of the ligand in the catalytic center. Berger and Schechter introduced
this scheme in 1967. [29] The binding site is divided into several binding pockets (see
Figure 3.3). In the center of the binding site lies the cleavage site. The non-primed side
is located towards the amino-end of the ligand (N-terminus). The binding pockets of
the enzyme on this side are numbered as Sn with n = 1,2,3, ... starting with the smallest
number in the center of the binding site. The respective positions of the substrate are
named Pn, where P1 and S1 can interact. Regarding the carboxy-end of the ligand
(C-terminus), the same principle is used, whereas the side is called primed side with
binding pockets S‘n of the enzyme and areas P‘n of the ligand.
Abbildung 3.3: Berger-Schechter Scheme of the binding site of a protease with a substrate.
The highly conserved active site of the papain-like cysteine proteases lies, as men-
tioned above, in the cleft between L- and R-domain. It contains the two amino acids
Cys25 and His159 (papain-numbering) and additionally holds an asparagine residue
Asn175, which stabilizes the His159 via hydrogen bonding. The glutamine residue
Gln19 is part of the oxyanion-hole, an area which contains a number of amino acids
that form hydrogen bonds with the negative charged oxygen-atom of the substrate-
intermediate (see Figure 3.4).
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Abbildung 3.4: Active site amino acids of an exemplary cysteine protease (rhodesain). The
underlying structure is taken from the RCSB data base. [28]
Cysteine proteases use covalent catalysis for the cleavage of peptide bonds. The cystei-
ne residue acts as a nucleophile, when it is in a deprotonated form. The protonation
states of the cysteine and histidine residue inside the active site differs for the parti-
cular enzymes. The protonation state may furthermore be pH-dependent and is still a
controversial and debated issue for some species. [30,31,32,33] In the zwitter-ionic form
of the catalytic dyade, the cysteine attacks the peptide bond at the carbonyl carbon
atom, forming a tertiary intermediate. The negative charge at the oxygen atom is
stabilized through Gln19 inside the oxyanion hole of the enzyme. As typical for a
nucleophilic substitution, the carboxylic double bond is rebuilt, releasing the amino
group of the substrate, which is then protonated through His159. The primed side
of the substrate exits the reaction and the starting point of the catalysis is reached
again with the hydrolysis of the thioester and the release of the non-primed side of
the substrate. This mechanism is shown schematically in Figure 3.5.
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Abbildung 3.5: Mechanism of peptide bond cleaving in the active site of cysteine proteases.
3.2 Covalent Reversible Inhibition
Covalent inhibition of enzymatic reactions has not been a focus of pharmaceutical
research throughout the last years, even though well known covalent inhibitors like
penicilins or acetylsalicylic acid exist. [34] The reasons for the seeming unpopularity
of these agents are the possible severe side effects that may occur due to the strong
covalent bonding. [35,36,37] A promising research area addressing this issue is covalent
reversible inhibition. [2,34,38,39,40] Covalent reversible inhibitors hold the advantages of
covalent inhibition, namely higher binding affinities, longer drug target residence time
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or lower sensitivity against pharmacokinetic aspects, while the reversibility reduces
the risk of undesired side effects. [38]
Abbildung 3.6: Energy diagram of a covalent inhibition mechanism. ∆GB is the enthalpy for
the formation of the non-covalent complex and ∆GR is the enthalpy of reaction
for the formation of the covalent bond. [38]
Figure 3.6 illustrates the mechanism′s underlying covalent inhibition. Due to the
second step of the reaction mechanism, covalent inhibition is a more complex task
compared to non-covalent inhibition. As a result, the development of covalently re-
versible binding compounds is much more challenging. A covalent inhibitor can bind
irreversibly to an enzyme or form a reversible bond. In case of a reversible bond
formation, an additional rate constant (k4 in Figure 3.6) for the dissociation of the
reaction product E I is introduced. For both, a reversible and irreversible covalent
inhibition, the inhibitor enters the active site of the enzyme in the first step and
forms a non-covalent enzyme-inhibitor complex E...I. The stability of the complex E...I
(∆GB in Figure 3.6) depends on the arrangement of the inhibitor in the active site and
the resulting interactions. The corresponding dissociation constant Ki can be obtained
experimentally and is often used as a representative value for the inhibition potential
of a component. As the constant only holds information about the first, non-covalent
step of the mechanism, it is a common quantity for not only covalent reversible, but al-
so irreversible and non-covalent reversible inhibition. In the following step, a covalent
bond is formed between the enzyme and the inhibitor, resulting in the product E I.
The size of the exothermicity of this step is crucial for the reversibility of the reaction.
In Figure 3.7 a scheme of the reaction steps is depicted, where kn are the respective ra-
te constants for the formation and dissociation of the non-covalent enzyme-inhibitor
complex E...I and the covalent product E I.
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Abbildung 3.7: Scheme of a two step mechanism for a covalent reversible inhibition.
Ki is the dissociation constant of the first step of the mechanism and K∗i corresponds
to the entire two-step mechanism. The energetic profile of the second step can be
controlled by the choice of the inhibitor warhead.
A popular example in this area is the inhibition of rhodesain with the peptidyl vinyl-
sulfon compound K11777 (see chapter 3.4). The original inhibitor binds to the enzyme
in a covalent irreversible reaction. [28] The halogenation of the inhibitor at the alpha
position of the double bond with bromine, however, leads to the reversibility of the
inhibition. [38] This example shows that rational design of covalent inhibitors opens
manifold possibilities in drug-research, combining the advantages of covalent and re-
versible inhibition. In the following section, the two papain-like proteases cathepsin B
(human) and rhodesain will be discussed in detail.
The dissociation constants can be obtained by
Ki =
k2
k1
(3.1)
and
K∗i = Ki
k4
k3 + k4
. (3.2)
In the first step of the mechanism, the non-covalent inhibitor-enzyme complex E...I
is formed. If k3 is by far larger than k4, or the rate constant of the reverse reaction is
nearly zero, the second step, and with it the whole mechanism, becomes irreversible.
For the quantization of inhibitor potentials, the Ki and IC50 value are typically used
for competitive inhibition. [41] The latter gives the concentration of the inhibitor that
is needed to halve the enzyme activity. For irreversible inhibition, it depends on
the substrate concentration and the residence time of the inhibitor in the active site
compared to the substrate. [42] The Ki value is connected with the law of mass action
of the dissociation of the non-covalent inhibitor-enzyme complex E...I. The smaller the
Ki value, the stronger the inhibition.
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3.3 Cathepsin B
Human cathepsin B contains around 250 amino acids and has a molecular weight
of 30 kDa. [26] It is ubiquitously expressed in the human organism and is involved
in a number of physiological processes, such as apoptosis (programmed cell death),
wound healing or remodelling of extracellular matrices . [43,44,45] Due to a special
structural feature (the occluding loop), cathepsin B can act both as an endo- and
an exopeptidase. [43] The 18-residue-long loop contains two histidine residues and
has a crucial impact on the enzyme activity. [43,46,47,48,49] It is located on the primed
side of the enzyme and can cover the active site cleft (see Figure 3.8). As the loop is
flexible, it controls the enzymatic activity as endo- or exopeptidase. [43] Montcourrier
et al. identified a pH dependency of the loop formation. [50] When the loop covers
the active site cleft, the two histidine residues can interact with the C-terminal of
the substrate. The histidines are responsible for the carboxy peptidase activity of the
enzyme. The catalytic dyade in the active site, Cys29 and His199, form an ion pair
due to the conserving environment. [43]
Abbildung 3.8: Structure of human cathepsin B (1HUC [26] from RCSB data base [25]) with the
active site dyade Cys29 and His199 as well as the two histidine residues His110
and His111 of the occluding loop (cathepsin B numbering) highlighted.
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Role in Pathogenic Processes
Cathepsin B is associated with a number of diseases, including invasive and me-
tastatic cancer, Alzheimers Disease and rheumathiod arthritis. [11,51,52] The origin
and symptoms of these pathogenic disorders do not have a systematical connecti-
on, which shows the variety of physiological impact of cathepsin B on the human
organism. A severe symptom of rheumatoid arthritis is the erosion of articular carti-
lage. [11,53] Cathepsins, including cathepsin B, were found to be expressed in cartilage
tissue. [54,55,56,57] The destruction of this tissue is caused by excessive proteolytic de-
gradation. [53] It has been shown that cysteine protease inhibitors such as peptidyl
vinyl sulfones or fluoromethyl ketones reduce this degradation. [58,59,60]
Another pathogenic field, on which cathepsin B has an impact, is cancer. The term
cancer sums up a number of different disorders with a variety of origins. Tumor pro-
gression and metastasis depend on proteolysis in the respecting areas. [11] There is a
number of complex cascades, responsible for the pathogenic process. The overexpres-
sion of cathepsin B is connected with prostate, bladder or colon carcinomas. [61,62,63,64]
A third intensive research area in medicine concerns the Alzheimer’s Disease, a brain
degrading disorder. Infected patients suffer, among other symptoms, from memory
loss and speech disorder. In a diseased brain, amyloid plaques deposit between neuron
cells. [65] Amyloid is a protein that is cleaved and degraded in a healthy brain. In
Alzheimer’s Disease, the precursor protein of amyloid, APP, is altered, leading to a
defect in the degradation of amyloid. As a consequence, the protein agglutinates in the
brain. [65] Cathepsin B is known to be involved in the processing of APP and therefore
presents a potential target for a regulation of the pathogenic progression. [43,65]
Potential Inhibitors
Finding potent inhibitors for cathepsin B is a challenging task, as it requires selectivity
and efficiency. Besides the endogenous protein inhibitors from the cystatin superfa-
mily, recent drug-related research concentrates on the development of low-molecular
compounds based on information gained from crystal-structures. [43,46] Those molecu-
les consist of an electrophilic part, the warhead, which interacts with the Cys29 anion,
and a peptidyl backbone to fit inside the active site pockets. [43] Examples include
peptidyl-aldehydes, -vinylsulfones, -disulfides and -halomethyl ketones. [66]
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3.4 Rhodesain
The parasitic cysteine protease rhodesain represents an important target in the field
of tropical diseases. It contains around 219 amino acids and has a molecular weight of
40 kDa. [28] The name rhodesain origins from the protozoan parasite trypanosoma brucei
rhodesiense (t.b. rhodesiense). [41] This parasite causes the human african trypanosomiasis
(HAT), also known as african sleeping sickness. [15,41,67] HAT is transmitted by the bite
of an infected tsetse fly. The parasite lives in the blood stream and tissue fluids of
infected mammalian hosts. [67]
Human Arfican Trypanosomiasis
According to the WHO, over 70% of the reported cases of HAT over the last ten
years occurred in the Democratic Republic of Congo. [68] Two forms of the disease
exist, whereas the acute, rapid-onset variant transmitted from t.b. rhodesiense is widely
spread in southern and eastern Africa. [69,70] This form represents the minority of the
reported cases, but develops rapidly and is a lethal disease, if it is not treated. [41,68]
The disease is characterized by two main symptomatic stages. In the first (haemoly-
phatic) stage, the parasite lives mainly in the bloodstream of the mammalian host, but
can migrate to further areas like the lymphatic system, spinal fluids and spleen. [41,71]
The symptoms in this stage are fever, muscle aches, itching or rash. [68,72] The second,
neurological stage, is indicated by confusion, mental deterioration, extreme lethargy
in combination with sleep disturbance (the origin of the disease’s eponym) and even-
tually ends in death. In this stage, the parasite has crossed the blood brain barrier of
the host and causes damage in the nervous system. [68,71,72,73]
The papain-like cysteine protease rhodesain appears in all life-cycle stages of t.b. rhode-
siense, and thus plays a crucial role in a number of essential processes. [15,74] It is requi-
red for the nutrition of the parasite and is involved in the invasion of the host. [75,76,77]
Furthermore, rhodesain is implicated in the crossing of the blood-brain barrier, which
leads to the second stage of the disease. [78] The inhibition of this essential protease
would thus cause the parasite’s death. [15,74]
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Inhibition of Rhodesain
There are several problems regarding the inhibition of rhodesain, and therefore the
treatment of HAT. The parasite′s ability to invade the host′s immune system makes it
a challenging task to find an effective treatment. There is no effective vaccine on the
market and the drugs currently available are in some cases extremely toxic. [41,67,79,80]
There are only four drugs against HAT on the market, from which three were develo-
ped more than 60 years ago and exhibit severe side effects. One even has a mortality
rate of 1-5%, making the development of new drugs an urgent task. [41]
Abbildung 3.9: Structure of the peptidyl-based vinylsulfon inhibitor K11777. [28]
There are different kinds of potential inhibitors, like peptidyl-based inhibitors with
warheads, similar to the cathepsin B inhibitors, and non-peptidyl agents. [41] Peptidyl
vinyl-sulfones turned out to be a very promising molecule class regarding the inhibi-
tion of rhodesain. The compound K11777 [28] (see Figure 3.9), in particular, was shown
to perform covalent irreversible inhibition of the protease. [28]
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4 Aim of this work
The development of new, effective drugs with little side effects is the desired goal
in all areas of pharmaceutical research. In the case of disease-related enzymes, a de-
tailed understanding of the inhibition mechanism is mandatory for the development
of new selective drugs. Experimental data in this field provides information about the
efficiency of different pharmaceutical components and allows for conclusions concer-
ning the inhibition mechanism. However, the possibilities of such experiments have
their limitations and can reach a point where further insights are required. Theoretical
investigations can provide additional information by computer simulations of the re-
spective systems. The combination of experiment and theory is therefore a promising
connection, especially with regards to the examination of the exact reaction mecha-
nism between inhibitor and enzyme.
In this work, two biochemical systems have been investigated via computational me-
thods. In both cases, the examinations are based on preceding experiments and are
aimed at the elucidation of the inhibition mechanism between different low-molecular
components and the respective enzyme. The first topic concerns nitroalkene-based in-
hibitors in rhodesain, an enzyme that is connected with the African sleeping sickness.
Experimental results showed that small structural changes like a methylation or ha-
logenation of the inhibitor warhead leads to changes in the corresponding inhibition
potentials and the mechanistic course. The inhibition potentials of the components
are represented by their Ki and K∗i values (depicted in Figure 4.1).
Abbildung 4.1: Ki and K∗i values in [nM] for the evaluated nitroalkenes.
[2,3]
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A smaller value implies increased inhibition.For a detailed explanation and discus-
sion, it is referred to the chapters 3.2 and 8.1. The aim of this work is thus to find the
origin of this unexplained behaviour in order to provide information for the develop-
ment of new and more effective compounds.
The second topic concerns the inhibition of cathepsin B with carbamate-based com-
ponents. Until now, the mechanism of this inhibition has not been determined. Ex-
perimental data indicates that a reaction including an elimination and carbamylation
could take place. However, there is no evidence for this. To investigate whether this
interpretation is sound, the corresponding reaction courses are computed. All other
possible reaction pathways are analyzed using thermodynamic considerations.
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5 The Treatment of Biosystems in
Computational Chemistry
5.1 Quantum Mechanical / Molecular Mechanical
Hybrid Methods
The treatment of biomolecules in theoretical chemistry has always been a challenge,
due to the size of the systems. In 1976, A. Warshel and M. Levitt published their idea of
treating only small parts of a large system on a quantum mechanical (QM) level, while
the rest is computed based on molecular mechanical (MM) methods. For those hybrid
schemes, the phrase “QM/MM”has prevailed. [81] Taking enzymes as an example, the
“important”part, where the catalysis takes place, is limited to the active site and
its adjacent amino acids in most cases. Before QM/MM was established, molecular
modeling on a QM basis was actually not possible, as the computational methods
were restricted to a few hundred atoms. [82] By now, the areas of application not only
include biosystems, but also solid-state [83,84] as well as inorganic and organometallic
systems [85,86]. Figure 5.1 illustrates the concept of QM/MM hybrid methods.
For the successful performance of a QM/MM calculation, several decisions concerning
the calculation setup have to be made. First of all, there are different possibilities to
compute the total energy of a system. As the QM and MM regions interact, the
energy cannot simply be computed by adding up the energies of the two isolated
subsystems, especially when bond breaking is involved. Another challenging task is
the computation of the covalent and non-covalent interactions between the regions,
which also bears different possibilities.
Calculation of the Total Energy
As mentioned above, the calculation of the total energy of a system on a QM/MM level
requires some thought. For this task, two main models have emerged, the additive and
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Abbildung 5.1: Scheme of a system with a QM/MM setup with an inner region I and an outer
region II.
the subtractive scheme. [82,87] For the latter, an MM calculation of the whole system
(EMM(I + II)) and the inner region (EMM(I)) is needed. Additionally, a QM calculation
of the inner subsystem (EQM(I)) is required. The total energy is then given by
EQM/MM(I + II)sub = EMM(I + II)−EMM(I) + EQM(I). (5.1)
The biggest advantage of this method is its simplicity. No explicit QM/MM coupling
terms are needed and the different calculations can be performed independently. This
means there is no need for special implementation. Secondly, there are no artifacts
from link-atoms (see section 5.1), as long as the parametrization of the QM part is done
carefully. However, there are some severe drawbacks of the method. Most important-
ly, the coupling between the QM and MM region is purely carried out on an MM
level. This is especially problematic for the calculation of non-bonded electrostatical
interactions between the two regions. [82]
The second way to calculate the total energy of the system is the additive scheme.
Here, the outer system (II) is calculated at the MM level of theory(EMM(II)), while a QM
calculation is performed on the inner system (EQM(I)). Additionally, a QM/MM coup-
ling term Ecoupling(I, II) is introduced. This term contains van der Waals, electrostatic
and covalent interactions in the form of an explicit QM/MM method:
EQM/MM(I + II)sub = EQM(I) + EMM(II) + Ecoupling(I, II). (5.2)
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The drawback of this, compared to the subtractive scheme, is the additional effort in
computation and implementation. Nevertheless, it has become the model of choice in
most QM/MM schemes. [88] In recent years, new methods have been developed that go
beyond the classification of the standard definition of subtractive or additive schemes.
Those multilayer methods introduce additional areas around the QM region into the
system. A popular example for this is the substractive multilayer scheme ONIOM, a
model where MM charges are included into the QM Hamiltonian. [87,89]
The coupling term Ecoupling(I, II) contains the bonded and non-bonded interactions,
such as van der Waals and electrostatics. There are different embedding schemes to
manage this task.
Embedding Schemes
The coupling between the QM charge density and the MM point charges requires
accurate evaluation using a sophisticated method. Concerning electrostatic interac-
tion, three main models have been developed, which differ in the level of mutual
polarization. [88]
In mechanical embedding, the non-covalent interactions are treated solely at the MM
level of theory (see section 5.4). This means that the MM part accounts for the QM
part only as a region of rigid point charges. This scheme does not require additional
effort during the computation and can be implemented easily into existing software.
Those advantages, however, entail drawbacks in the quality of the calculations. If all
interaction between the two subsystems is based on MM, the logic consequence is
that the outer MM region cannot interact with the QM density, as the latter is only
represented by rigid point charges. The MM region is thus not polarized by the QM
density.
The more common electrostatical embedding includes the MM point charges into the
QM Hamiltonian via one-electron terms. In this model, the QM subsystem is polarized
by the MM area. The major drawback of this model is an overpolarization, which is
obtained for atoms in close proximity to the QM charge distribution. [82] Additionally,
the inclusion of an MM point charge into the Hamiltonian poses difficulties, as the
parametrization of a force field is not automatically suitable for the representation of
a QM charge. [82] Still, electrostatic embedding is one of the most popular embedding
schemes in use today, especially for biomolecular applications.
The computationally most demanding, and for that matter also the most realistic em-
bedding scheme, is called polarizable embedding. It includes a flexible MM charge
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distribution that can react to the QM density and is thus polarized by it. Polarizable
embedding is further divided into two models. In the first one, only the MM part is
polarizable, whereas in the second one, a mutual polarization between the two sub-
systems takes place. In principle, the latter one would be the method of choice for a
QM/MM calculation, but besides the higher effort in computation, there is only a small
number of biomolecular force fields with these capabilities available today. However,
the promising idea of the model causes progression in this research area. [90,91,92,93,94]
Van der Waals interactions are most commonly treated solely on the MM level of
theory, using the Lennard-Jones potential (equation 5.58). [82,95] An improvement in
this area would be for example an optimization of parameters for B3LYP/AMBER. [96]
Treatment of Covalent Bonds
In some cases, the QM/MM border cuts through a covalent bond. This situation
requires a certain theoretical treatment. The cleaved bond must in some way be
capped, as an unsaturated bond would not describe the electronic character of the
system properly. There are three common schemes available to deal with this problem,
the link-atom scheme, boundary atoms and frozen localized orbitals. [82] This work
will concentrate on the most widely used link-atom scheme. The cleaved bonds are
saturated with the help of an additional atomic center, most commonly a hydrogen
atom. These link-atoms are not part of the real system (see Figure 5.2). They are used
for the computation of the inner QM subsystem, in order to correctly describe the
capped atom Q1, but are not considered in the actual calculation of the total system
energy.
Abbildung 5.2: QM/MM boundary area with atom names according to the relative position.
L is the linker atom and QM or MM designates atoms in the QM or MM area.
As previously mentioned, the main problem within this scheme is the overpolariza-
tion. Since the two adjacent atoms M1 and Q1 are extremely close, their non-bonded
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interaction will be overestimated. A widely used approach for this issue is the shif-
ting scheme. [88] Here, the point charge of the adjacent M1 atom is distributed to its
neighbouring atoms M2 (see Figure 5.2).
QM/MM has become the method of choice for the calculation of large systems, espe-
cially in biochemistry. The number of possibilities for the setup of such a calculation
requires a lot of thought and experience in order to obtain reproducible results and
make realistic predictions. Of course, apart from the various embedding schemes,
the QM and MM methods themselves are crucial for the performance of the hybrid
calculation. The following sections will give an overview of QM and MM methods,
as well as the technique of MD simulations.
5.2 Quantum Mechanical Methods
Parts of this section have already been published in the master thesis of the author. [97]
5.2.1 Hartree-Fock
The Hartree-Fock (HF) method provides the foundation of all wave function-based
computational methods. It is an iterative approach using a single determinant as a
wave function (equation 5.3): [98,99]
|Ψ0〉 = |χ1χ2...χN〉. (5.3)
The general idea behind the method is to minimize the energy of a system as a function
of its spin orbitals {χa}: [99]
∂
∂χa
〈Ψ0|Hˆel|Ψ0〉 = 0. (5.4)
Solving this equation by the utilization of Lagrangian multipliers leads to the Fock
equation
fˆ |χa〉 = a|χa〉, (5.5)
where a is the energy of spin orbital a in the mean field of all other electrons of the
system and fˆ is the effective one-electron Fock operator: [98,99]
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fˆ = h(1) +
∑
b,a
Jb(1)−
∑
b,a
Kb(1). (5.6)
In this equation, h(1) is the core hamiltonian operator, which contains the kinetic
energy and core interaction of one electron
h(1) = −1
2
∇21−
∑
A
ZA
r1A
. (5.7)
Jb and Kb are the Coulomb- and Exchange operators:
Jb(1)χa(1) =
[∫
dx2χ∗b(2)
1
r12
χb(2)
]
χa(1) (5.8)
Kb(1)χa(1) =
[∫
dx2χ∗b(2)
1
r12
χa(2)
]
χb(1) (5.9)
For the computational description of molecules, the molecular orbitals ψi are often
written as a linear combination of N atomic orbitals φmu (LCAO approach):
ψi =
N∑
µ
cµiφµ (5.10)
Applying this approximation and converting the differential equations into the matrix
formulation, the Fock equation becomes the Roothaan-Hall matrix equation: [100,101]
FC = SCE, (5.11)
where C is the N x N matrix of the coefficients cµi, E is a N x N diagonal matrix
containing all orbital energies i and S is the overlap matrix between two atomic
orbitals φµ and φν
Sµν = 〈µ,ν〉 =
∫
φ∗mu(1)φnu(1)dτ1. (5.12)
The nontrivial solution of this eigenvalue problem provides a set of optimal spin
orbitals. The HF energy is obtained as the expectation value of the Slater determinant
built from these optimized spin orbitals.
However, the HF approach is problematic, because of the lack of electron correlation.
The term correlation energy is defined by the difference between the Hartree-Fock
energy and the actual energy of a system. Therefore, fundamental processes like
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homolytic dissociation can not be described accurately by the HF approach. [99] To
overcome this lack in description, post-Hartree-Fock methods (electron correlation
methods) were developed. All post Hartree Fock methods build upon a Hartree Fock
calculation, providing optimized spin orbitals. The wave function is then improved
by taking more than one Slater determinant into account:
Ψtot = c0Φ0 +
∑
i,a
ci,aΦai +
∑
i j,ab
ci j,abΦabi j + .... (5.13)
In this equation, the letters i and j represent indices for occupied orbitals, whereas a
and b stand for virtual orbitals. Φai and Φ
ab
i j are excited state determinants including
single and double excitations. There are various post HF methods that differentiate in
their manner of determining the coefficients ci. [99]
5.2.2 Møller-Plesset Perturbation Theory
Many Body Perturbation Theory
Many-Body Perturbation theory generally assumes that the problem to be solved
(perturbed problem) only slightly differs from a solvable (unperturbed) problem. [99]
This approach is applied to the Hamilton operator:
H = H0 +λH
′
, (5.14)
where H is the exact Hamilton operator, H0 is the unperturbed operator and H
′
is the
perturbation operator. λ is a parameter defining the strength of the perturbation. The
perturbed Schro¨dinger equation is
HΨ = WΨ. (5.15)
The wave function Ψ and energy W can be written in a taylor expansion in powers of
the perturbation strength:
W = λ0W0 +λ1W1 +λ2W2 + ...+λnWn, (5.16)
Ψ = λ0Ψ0 +λ
1Ψ1 +λ
2Ψ2 +λ
3Ψ3 + ...+λ
nΨn. (5.17)
After substituting Ψ and W in equation 5.15 with the taylor expansion and sorting the
terms by the power of λ, n perturbation equations of the nth order result.
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Zeroth order (λ0 = 0): H0Ψ0 = W0Ψ0.
First order (λ1): H0Ψ1 + H
′
Ψ0 = W0Ψ1 + W1Ψ0
Second order (λ2): H0Ψ2 + H
′
Ψ1 = W0Ψ2 + W1Ψ1 + W2Ψ0
nth order (λn): H0Ψn + H
′
Ψn−1 =
∑n
i=0 WiΨn−i
The resulting energies (up to the second order) are:
W0 = 〈Φ0|H0|Φ0〉 (5.18)
W1 = 〈Φ0|H′ |Φ0〉 (5.19)
W2 =
∑
i
ci〈Φ0|H′ |Φi〉 =
∑
i,0
〈Φ0|H′ |Φi〉〈Φi|H′ |Φ0〉
E0−Ei (5.20)
Møller-Plesset Perturbation Theory
In Møller-Plesset perturbation theory (MP), the unperturbed Hamilton operator is the
sum of the Fock operators of all occupied electrons: [102]
H0 =
occ∑
i=1
fi (5.21)
As the perturbation is defined as H
′
= H−H0, H′ contains the difference between the
two-electron operator gi j of H and the averaged two-electron operator 〈gi j〉 of the Fock
operator:
H
′
= H−H0 = Vee−〈Vee〉. (5.22)
The unperturbed energy (MP0) then equals the sum of the occupied spin orbital
energies i:
W0 =
∑
i
i, (5.23)
This is a worse approximation than the Hartree-Fock energy. The energy correction of
first order W1 is
W1 = 〈Φ0|H′ |Φ0〉 = −〈Vee〉. (5.24)
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As a result, the MP1 energy equals the Hartree-Fock energy:
E(MP1) = W0 + W1 = E(HF) (5.25)
The most common method in this field is MP2. Here, the energy correction is
W2 =
occ∑
i< j
vir∑
a<b
〈Φ0|H′ |Φabi j 〉〈Φabi j |H
′ |Φ0〉
E0−Eabi j
, (5.26)
which gives the MP2 energy
E(MP2) =
occ∑
i< j
vir∑
a<b
〈φiφ j|φaφb〉− 〈φiφ j|φbφa〉
i + j−a−b . (5.27)
The numerator of the term contains two-electron integrals of the coulomb and ex-
change interaction between the occupied orbitals φi, j and the virtual orbitals φa,b. The
denominator of equation 5.27 contains the orbital energies of the HOMO and the
LUMO. As a consequence, the method fails for systems with a small HOMO-LUMO
gap.
Spin Component Scaling (SCS)
Spin-Component-Scaled MP2 was proposed in 2003. [103] The idea of spin component
scaling focuses on the fact that the correlation energy EC between electron pairs with
the same (SS) and opposite spin (OS) differ systematically. Physically speaking, the
correlation of an SS electron pair refers to the Fermi hole (which results from the Pauli
principle [104]), whereas the behaviour of OS pairs is connected with the Coulomb hole.
EC = ESSC + E
OS
C . (5.28)
The theoretical background of the method is based on the fact that in Hartree-Fock
calculations, the correlation of SS pairs is already included through the anti-symmetric
wave function and the resulting exchange terms. For OS pairs, no correlation is inclu-
ded yet. As a post-HF method, MP2 introduces OS correlation, but due to an original
imbalance from HF, this contribution is still underestimated. [105] SCS-MP2 introduces
empirical factors c to the correlation energy of a system, upscaling the OS correlation
while the SS correlation is scaled down (cOS = 6/5 and cSS = 1/3).
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EC[SCS−MP2] = cSSESSC [MP2] + cOSEOSC [MP2]. (5.29)
In the original MP2 method, these factors are both equal to 1. There is no extra cost
to the calculation, as the energy-contributions are simply scaled via the empirical
factor. The performance of SCS-MP2 in reaction energy calculations was shown to be
comparable to QCISD(T). [103] It is a trustworthy method for the computation of barrier
heights [106] and geometries. [30,107,108] It is a very reliable method that corrects for many
of the drawbacks from MP2, especially for ground state properties of most biologically
relevant molecules. Regarding processes like the dissociation of molecules or spin
contamination, the underlying weakness of HF gains influence on the performance of
the method. [105] There is a number of variants, namely SOS-MP2, where cSS is set to
zero [109], MOS-MP2 [110], that uses a long range correction in the correlation energy, or
SCS-CC2 and SCS-CIS(D), which focus on excited state calculations [105]. As always in
computational chemistry, the key step is to use the right method for the right system,
which also accounts for the parametric scaling factors.
5.2.3 Density Functional Theory
Other than wave function-based methods, the density functional theory (DFT) descri-
bes a system by means of its electron density. This approach implies that the density
contains all relevant information about a system, namely the number of electrons,
the geometry and the nuclear charges. These quantities define the Hamilton operator
of any system. [111,112] The number of electrons N can be obtained by integrating the
density over all coordinates: ∫
ρ(~r)d~r = N (5.30)
The poles of the electron density contain information about the geometry, as they
correspond to the position of the nuclei. The charge of a nucleus is indicated by the
mean density at its position. [112] Within DFT, several advantages arise, compared to
wave function-based methods. The electron density is a property that can be measured
experimentally. In addition, the dimension of the calculations decreases drastically,
from a 4N dimensional problem for wave function-based methods (one spin and three
spacial coordinates per electron) to a three-dimensional problem within DFT. This is
the main reason why DFT is widely used for systems with a large number of elec-
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trons. The application of DFT for quantum chemical problems arose in the 1990s. [111]
Since then, the size of the investigated systems grew drastically and therefore had a
great impact to computational research, especially in a biochemical context. Another
remarkable aspect about DFT is that within this method, it is (theoretically) possible
to get an exact solution for any many-electron system. However, so far this remains
unfeasible. The following sections give an overview about basic ideas, theorems and
variants of DFT.
Thomas-Fermi Model
The idea to use electron density as a descriptive representative of a system origina-
ted from Thomas in 1927. [113] He made the assumption that an electronic state of a
homogeneous electron gas (HEG) is a solution of the Schro¨dinger equation (in its
corresponding form). The Schro¨dinger equation was introduced one year before, in
1926. [114] Thomas also assumed that the nuclear-electron interaction depends exclu-
sively on the position and charge of the nuclei. Based on that, he formulated the first
kinetic energy functional together with Fermi: [113,115]
TTF = CF
∫
d3~rρ5/3(~r), (5.31)
where ρ is the electron density and the expression CF corresponds to
CF =
3
10
(3pi2)2/3. (5.32)
Within the Thomas-Fermi model, the nuclear-electron and electron-electron contribu-
tions were treated in a classical way, leading to the following energy expression:
ETF[ρ(~r)] =
3
10
(3pi2)2/3
∫
ρ5/3(~r)d~r−Z
∫
ρ(~r)
r
d~r +
1
2
∫ ∫
ρ(~r1)ρ(~r2)
r12
d~r1d~r2. (5.33)
This made it possible to calculate the energy of a system exclusively by means of its
electron density. Nevertheless, the procedure had some severe drawbacks and did not
yield reliable quantitative results.
In 1930, Dirac addressed this problem by introducing the first exchange functional
(equation 5.34). [116] The phenomenon of exchange energy was formulated earlier in
the same year by Fock. [117]
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ELDAx = −34(
3
pi
)1/3
∫
d3~rρ4/3(~r) (5.34)
Even though this step was an improvement, it was still not possible to describe
fundamental properties like chemical bonding with it.
Hohenberg-Kohn Theorem
In 1964 the Hohenberg-Kohn theorem was formulated by Pierre Hohenberg and
Walter Kohn. [118] The theorem provides the basis for density functional theory, as it
addresses the question whether it is reasonable to take the electron density of a system
as the uniquely defining quantity.
The first theorem states, that “the external potential Vext(~r) is (to within a constant) a
unique functional of ρ(~r); since, in turn Vext(~r) fixes Hˆ we see that the full many particle
ground state is an unique functional of ρ(~r)”. [118] In other words, the external potential
Vext(~r) has an unique dependence on both the electron density and the wave function.
This allows to take the electron density of a system as the system representative.
The two functionals for the electron-electron interaction and the kinetic energy of the
electrons are system-independent.
The theorem can be proven by reductio ad absurdum, thus considering that the ground
state electron density is not an unique functional of the ground state wave function
and the Hamiltonian. This assumption leads to a mathematical contradiction and
therefore shows the unique connection between ground state density, wave function
and Hamiltonian. Since the density also contains all information about the system,
namely the number of electrons N, the charges and the position of the nuclei ZA and
RA, the first Hohenberg-Kohn theorem can be formulated as [111]
ρ0→ {N,ZA,RA} → Hˆ→Ψ0→ E0. (5.35)
Equation 5.35 shows that the ground state energy E0 is a functional of the ground state
electron density with E0 being defined as
E0[ρ0] = T[ρ0] + Eee[ρ0] + ENe[ρ0]. (5.36)
As stated above, the external potential Vext(~r) (represented through the functional
ENe[ρ0] in equation 5.36) is the only system-dependent component of equation 5.36.
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It is called external potential or electron nuclei potential. T[ρ] and Eee[ρ] are universal
functionals and can be combined in the Hohenberg-Kohn functional:
FHK[ρ] = T[ρ] + Eee[ρ]. (5.37)
If this functional would be known exactly, it would yield the exact energy and due
to its system independence, molecules from a very small size up to vast biomolecules
could be computed with absolute accuracy.
The second theorem addresses the question whether the observed density really is the
ground state density. To achieve this, it has to have the lowest energy for the system.
Hohenberg and Kohn showed that the variational principle is also a valid approach
concerning the electron density.
E0 ≤ E[ρ˜] = T[ρ˜] + ENe[ρ˜] + Eee[ρ˜]. (5.38)
In this equation, ρ˜ stands for any trial density that represents a system. This means
any density other than the ground state density will result in higher energies. Using
the unique connection between the density and the Hamiltonian and thus the wave
function, the second Hohenberg-Khon theorem can also be written as
〈Ψ˜|Hˆ|Ψ˜〉 = T[ρ˜] + Vee[ρ˜] +
∫
ρ˜(~r)Vextd~r = E[ρ˜] ≥ E0[ρ0] = 〈Ψ0|Hˆ|Ψ0〉. (5.39)
Kohn-Sham Approach
In 1965, Kohn and Sham published a paper that revolutionized DFT. This even-
tually established a way for density functional theory to correctly describe molecu-
les. [111,112,119] The problem older DFT approaches had regarding the proper descrip-
tion of covalent bonds occurs particularly due to the bad description of the kinetic
energy functional of electrons. It is known that wave function-based methods, such as
Hartree-Fock, describe the kinetic energy accurately. Kohn and Sham thus suggested
to exactly calculate all known contributions and then put the remaining unknown
parts into one approximate functional, known as the exchange-correlation functio-
nal. [111] The connection between a density-based and a wave function-based descrip-
tion was established via the so-called Kohn-Sham orbitals. For this purpose, Kohn
and Sham constructed a non-interacting reference system, built from one-electron
functions (i.e. the Kohn-Sham orbitals φi), which are moving in an effective potential
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Vs. This system of non-interacting electrons is exactly described by one Slater deter-
minant. For this system, the operator of the kinetic energy is known from HF-theory
as
THF = −12
N∑
i
〈φi|∇2|φi〉, (5.40)
which yields the exact kinetic energy.
Thus in Khon-Sham theory Vs is chosen in a way that the density of this non-interacting
reference system ρs(~r) equals the density of the real system ρo(~r):
ρs(~r) =
N∑
i
∑
s
|φi(~r,s)|2 = ρo(~r). (5.41)
Within the Kohn-Sham approach, the respective functionals may furthermore be in-
terpreted in a new way.
The functional for the kinetic energy T[ρ] becomes Ts[ρ], which gives the exact solution
for the kinetic energy for a system of non-interacting electrons. Analogous, the exact
functional for the electron-electron interaction Eee[ρ] becomes J[ρ], which contains
the Coulomb interaction for the electrons. As a result, the energy of a system can be
described as
E[ρ] = Ts[ρ] + J[ρ] + ENe[ρ] + Exc[ρ] (5.42)
with
Exc[ρ] = (T[ρ]−Ts[ρ]) + (Eee[ρ]− J[ρ]). (5.43)
As stated above, the exact solution for the correlation-exchange functional would yield
the exact energy for every system, regardless of its size. As the exact functional is being
unknown, this created room for countless different approaches for this functional.
These approaches have no hierarchy, so a systematical improvement is not possible.
Nevertheless, they are often categorized with the Jacob′s ladder of DFT. [120] The
different rungs of the ladder are defined by the dependency of Exc on the electron
density.
In the first rung (LDA) the functional exclusively depends on the electron density. In
the second rung, the derivative of the density is additionally considered (Generalized
Gradient Approximation-GGA). The third rung (meta-GGA) additionally depends on
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Abbildung 5.3: Jacobs ladder of DFT. [121]
the kinetic energy density of the system. The fourth rung has an additional depen-
dence on occupied orbitals, whereas the fifth rung depends on occupied and virtual
orbitals. This means, that in both cases (fourth and fifth rung), a certain amount of HF
exchange is added, whereas the fifth rung contains contributions derived from per-
turbation theory (double hybrid). The functionals often also contain (semi-)empirical
parameters which were often optimized for certain kind of systems or properties. As
a result, the different functionals have to be adapted to the system and specific target
properties of a calculation.
In this work, the functional B3LYP, [122] named after Becke, Lee, Yang and Parr, was
widely used as the QM method in QM/MM calculations. Being a hybrid GGA functio-
nal, it is assigned to the third rung of the Jacob′s ladder. It also contains semi-empirical
parameterization and is a functional that is routinely used for many different kind of
systems and calculations. There are more modern functionals like the Minnesota fa-
mily (M06L, [123] M11, [124]...) or double hybrids such as B2PLYP [125] or PBE0-DH. [126]
Especially for the fifth rung, the computation time increases drastically, but gives very
reliable results if applied to the right kinds of system. Although DFT still has some
drawbacks regarding its accuracy and is strongly dependent on which functional is
used for which kind of system, it is widely employed in computational chemistry. The
scaling factor O(N3−4) is remarkable for this level of accuracy, which makes DFT the
method of choice, especially for large systems. [112]
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5.3 Semi-Empirical Approaches
The main problem with ab initio methods is their computational cost and basis set
dependency. Semi-empirical methods try to conquer this problem by introducing a
number of approximations. First of all, valence electrons are only explicitly treated
with a minimal atomic orbital basis, while the core electrons are considered as a re-
duced nuclear charge. Additionally, some of the two-electron integrals of the Fock
matrix (equation 5.11) are neglected. To compensate for these simplifications, the re-
maining integrals are modified by parametrization, based on empirical measurements
or highly accurate ab initio calculations. [127]
In order to decide which integrals can be excluded from the calculation, it is necessary
to consider the Fock matrix (equation 5.11) more closely. The matrix consists of a
sum of the one-electron matrix H (core Hamiltonian) and two-electron matrix G. The
matrix elements are
Fµν = Hµν+ Gµν. (5.44)
Hµν contains the kinetic energy of the electrons and the nuclei-electron attraction for
the atomic orbitals µ and ν:
Hµν = 〈µ| − 12∇
2|ν〉−
∑
A
〈µ|ZA
riA
|ν〉. (5.45)
The two-electron matrix Gµν describes the electron-electron pair interactions. It con-
tains the orbital coefficients in the form of the density matrix Pλσ and all two-electron
integrals of the system.
Gµν =
∑
λ
∑
σ
Pλσ[(µν|λσ)− 12(µλ|νσ)] (5.46)
The density matrix is defined as:
Pλσ = 2
Nocc/2∑
i=1
cλicσi. (5.47)
It is important to consider the two-electron integrals in order to decide which of the
interaction terms are to be neglected. Equation 5.48 and 5.49 show the interaction
terms in the basis of spacial orbitals.
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They consist of a Coulomb term
(µν|λσ) =
∫
dr1dr2µ∗(1)ν(1)
1
r12
λ∗(2)σ(2) (5.48)
and an exchange term
(µσ|λν) =
∫
dr1dr2µ∗(1)σ(1)
1
r12
λ∗(2)ν(2). (5.49)
Zero Differential Overlap
The Zero Differential Overlap (ZDO) approximation is a central quantity for semi-
empirical calculations. The differential overlap (DO) is defined as
DO(µν) = µ(1)ν(1)dτ, (5.50)
thus it contains information about the position of an electron, depending on the
relative position of the orbitals µ and ν. Inserting this definition into the equations
5.48 and 5.49 yields
(µν|λσ) =
∫
DO(µν)DO(λσ)
1
r12
(5.51)
and
(µσ|λν) =
∫
DO(µσ)DO(λν)
1
r12
. (5.52)
Considierung all two-electron integrals, the computational cost of a calculation for
a system with N atomic orbitals would have a scaling factor of N4. [128] Taking the
position of the atomic centers into account, the integrals can be separated into one-,
two-, three- and four-center terms. The idea of semi-empirical methods is to reduce
the scaling factor by neglecting some of those integrals, depending on how many
different atom centers are involved.
The Zero Differential Overlap (ZDO) approximation was introduced in the late
1950s. [129,130] According to the ZDO, the differential overlap DO(µν) of two atomic
orbitals µ, ν is set to zero if they are located on different atomic centers µA and νB. This
approximation zeros all three- and four center integrals. On the basis of this, three
different models were developed: CNDO (Complete Neglect of Differential Overlap),
INDO (Intermediate Neglect of Differential Overlap) and NDDO (Neglect of Diatomic
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Differential Overlap), the latter being the most widely used model nowadays. [131] De-
pending on the model, the remaining one- and two-center integrals are further sorted
out. The well known methods MNDO [132], AM1 [133] and PM3 [132,134] all belong to the
family of NDDO. The difference between them lies in their parameterization.
5.4 Molecular Mechanics
In molecular mechanics (MM), molecules are described classically using a ball-and-
spring model. [135] Atoms are represented by dots without expansion with a certain
mass m and charge q. Bonds between the atoms are described as springs. Depen-
ding on the strength of the bond, the spring stiffness can be harder or softer. The
biggest difference between molecular and quantum mechanics is the treatment of
the electrons. [136] In quantum mechanical approaches, the electrons are treated expli-
citly in a three-dimensional distribution, whereas in molecular mechanics, they are
not considered explicitly. Information about the geometry of a molecule is included
using the angles Φ and dihedrals θ between the atoms. Non-covalent interactions
like Coulomb- or van der Waals interactions are included with classical electrostatic
interaction terms.
Abbildung 5.4: Parameters for molecular mechanics calculations.
In this model, the different energy contributions are assigned to classic mechanical
energy terms. The terms are functions of the parameters given by the atom types and
geometry of the system (see Figure 5.4). The energy of a system is described as a sum
of different energy contributions. [99]
E = Estrech + Ebend + Etors + EvdW + Ecoulomb + Ecross. (5.53)
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The energy E represents a snapshot of the system in one certain conformation. As
soon as one bond or angle changes, the energy changes simultaneously.
The first three energy terms contribute to the bonded interactions, whereas EvdW and
Ecoulomb describe the non-bonded intermolecular forces. The last term Ecross contains
possible couplings between the other terms, which depends on the respective force
field.
Estrech describes the bond between two atoms A and B. It therefore contains a force
constant kAB as well as the distance of the atoms relative to their equilibrium distance
rAB0 and is summed up over the number of bonds in the system N:
[99,137]
Estrech =
N∑
i=1
kAB
2
(rAB− rAB0 )2 (5.54)
The second term Ebend contains information about the angle-dependent energy contri-
butions. This sum is running over M, the number of directly bonded angles. Equally
to Estrech, the term depends on a force constant kABC and the difference between an
angle Φ and the equilibrium angle Φ0. [99,137]
Ebend =
M∑
i=1
kABC
2
(ΦABC−ΦABC0 )2 (5.55)
Both of these energy expressions can be interpreted as a taylor series that is terminated
at the second order. This implies the use of a harmonic potential. The last of the bonded
energy contributions is Etors. Here, the rotation around a bond is described with the
spherical angleθ between four adjacent atoms. Unlike Estrech and Ebend, a Fourier series
underlies this expression containing information about the rotational barrier VABCD
as well as a parameter n, that describes the periodicity. [99]
EABDCtors = V
ABCDcos(nABCDθ) (5.56)
For n = 1, the rotation is periodic by 360◦, for n=2 it is periodic by 360◦/2 and so on. The
remaining non-bonding terms are EvdW and Ecoulomb. The latter describes the classic
coulomb interaction between the partial charges q1 and q2 of a system. The potential
depends on the inter-atomic distance rAB and contains the dielectric constant . [99]
EABcoulomb =
q1q2
|rAB| (5.57)
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The last contribution includes all weak non-bonded interactions in the term EvdW. The
van der Waals energy expression contains dispersion and dipole-dipole interactions.
The most common potential that is used for its description is the Lennard-Jones
potential [95]:
EABvdW =
c1
(rAB)12
− c2
(rAB)6
. (5.58)
The repulsive first term dominates the energy for short distances and represents
the Pauli-repulsion. For medium distances, the second term outweighs the first one,
leading to an attractive force. The Lennard-Jones potential is sometimes also referred
to as the “12-6-potentiala¨nd is widely used. Force field methods can be applied to large
systems that cannot be computed with high level ab initio methods, due to their size.
Especially for the description of biological systems, they provide the possibility for
theoretical investigations. Nevertheless, it has to be kept in mind that these methods
are highly dependent on the force field parameters used and that only ground-state
properties can be calculated. Additionally, it is not possible to evaluate bond breaking
with MM methods.
Molecular Dynamics
Molecular Dynamics (MD) simulations are an important tool in theoretical chemistry.
They were first introduced in the late 1950s by B.J. Alder and T. W. Wainwright. [138,139]
Regarding proteins, they can provide insight to inhibition mechanisms or protein
folding. To perform a MD simulation, the energy expression E from equation 5.53 is
needed. Additionally, an equation that introduces motion to the examined system is
introduced. For the classic description of a system with low velocities (relative to the
speed of light), Newton′s equation of motion can be used. [140]
dV
dr
= F(r) = m
dv
dt
= m
d2r
dt2
. (5.59)
The equations provide information about how a particle with the constant mass m
reacts to a force F. The “reactiono¨f the particle is described by the right side of the
equation. It is expressed through the derivative of the velocity with respect to the
time, which equals the second derivative of its position with respect to the time. In
other words, the position changes with the time. In the left part of equation 5.59,
the connection between the potential V and the force is defined, the latter being the
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derivative of V with respect to the position. While performing a MD simulation, the
computer solves the differential equations above with numerical integration as a series
of a finite number of small steps. There are different logarithms for this calculation, a
very common one being the Verlet algorithm. [141]
v(t +∆t) = v
(
t +
1
2∆t
)
+
f (t +∆t)
2m
∆t. (5.60)
The first step of each MD is the assignment of initial velocities for example with the
help of the Maxwell-Boltzmann distribution for a given temperature. The initial coor-
dinates are normally taken from the input data file. In the second step, the resulting
force is calculated with a method of choice. In most cases, fore field methods are used,
as the usage of ab initio methods would be extremely time-consuming. Although MD
simulations are often performed on a low level of theory, they play an important
role in computational analysis. In order to yield reliable results, sufficient sampling is
required.
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6 Computational Methods
MD Simulations
All MD simulations were performed using the AMBER program package. [142,143]
The applied force fields were ff99SB [144] and ff14SB, [145] whereas GAFF [146,147] in
combination with the program antechamber [147,148] was used for the parametrization
of the ligands. An octahedral TIP3P [149] water shell with a radius of 30 Å was added
around the parameterized system with help of the module AMBERTOOLS 1.4. [142,143]
Spherical boundary conditions were applied to the system and the net charge was
neutralized by the addition of sodium ions. A procedure containing three distinct
calculation steps was applied to all systems in preparation for the actual MD run.
First, a geometry optimization of only the water shell was performed, followed by
an optimization of the whole system. After that, a short MD simulation, running
over 400 ps with time steps of 1 fs was performed. The protein was kept within weak
constraints during the simulation and the temperature was gradually increased from
0 K to 300 K. The simulation times of the subsequent MD calculations were adapted
to the respective problem. The specific data is given in the respective sections. For
temperature controlling, a Langevin thermostat was used. The SHAKE algorithm
was applied to bonds that involved a hydrogen atom.
The simulation (QM/MM MD) discussed in chapter 7.3.2 was performed using the
ChemShell 3.6 program. [150,151] The QM area was represented by an electrostatic po-
tential, calculated with the semi-empirical method AM1. For the embedding scheme,
the same settings as described below (see “QM/MM”) were applied. The simulation
ran over a time of 2 ns with fs time steps at 300 K, using a Bendersen thermostat. The
applied force field was ff14SB.
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QM Calculations
All quantum mechanical ab-initio calculations were performed, using the Turbomole
program package (version 6.6 and 7.1 [152,153,154]). For the simulation of a solvent
surrounding, the implicit solvation model COSMO [155] was used. Semi-empirical
calculations were performed using the MNDO 7.0 program package. [156]
QM/MM Calculations
The program ChemShell 3.6 was used as an interface within the performed
QM/MM calculations. All systems calculated on a QM/MM level were taken from
preceding MD calculations and therefore included the TIP3P water shell and the
neutralizing sodium ions. The applied boundary treatment included electrostatic
embedding in combination with the charge shift method and the link atom approach.
All QM/MM optimizations were performed using the DL-FIND module [157] of
ChemShell with an active area of 10 Å around the reaction center of the enzyme.
The rest of the system was kept fixed during the calculations. For all QM/MM
calculations, the MM part was calculated with the AMBER program package
and the ff14SB force field. Therefore, the MM method is not explicitly mentioned
in the respective chapters for every QM/MM calculation. The QM calculations
were performed with the Turbomole 6.6 and 7.1 program package. For the NEB
calculations, the same boundary treatment as described above was utilized. The
calculations were performed with different counts of frames, reaching from 7 up to 17.
The programs used for the analysis and visualization of the results were OriginPro
2016, [158] VMD 1.9.1, [159] ChemDraw and CorelDraw 2018.
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7 Inhibition Mechanisms of
Carbamates in Cathepsin B
In this chapter, carbamate-based inhibitors for cathepsin B are discussed. The follow-
ing sections are structured as follows: First, after a short introduction to the topic,
a summary is provided. The detailed discussion of the various computational steps
investigated is given subsequently. In addition to the Nudged Elastic Band (NEB) cal-
culations performed for the analysis of certain mechanisms, potential energy surfaces
and reaction profiles were computed. This proceeding is based on the fact that while
NEB calculations can provide reliable results concerning the mechanistic process, they
are computationally extremely demanding and their interative scheme does not con-
verge in many cases. In order to gain maximal insight into the mechanism, both types
of calculations were performed.
7.1 Background and Previous Experimental Results
Carbamates are known to be potent inhibitors for choline esterases. A popular ex-
ample thereof is the inhibition of acetylcholine esterase (AChE). [160,161,162] AChE is
responsible for the hydrolysis of the neurotransmitter Acetylcholin (ACh) in the ner-
vous system. [161] The inhibition of the enzyme has been found to play a potential role
in the treatment of Alzheimer′s Disease. [163] Carbamate-based inhibitors carbamylate
the active site amino acid of choline esterases (e.g. serine) to interfere their catalytic
activity. [163] The carbamylation can occur with help of an isocyanate intermediate,
formed in an elimination reaction of the carbamate according to an E1CB mecha-
nism. [163,164,165,166] Alternatively, a covalent adduct can be formed through a direct
nucleophilic attack at the carbamate carbon. [166,167,168,169] Experimental data regar-
ding cathepsin B and carbamate-based inhibitors from the group of Prof. Guetschow
in Bonn showed, that an acidic hydrogen atom at the carbamate nitrogen leads to a
better inhibition potential (a detailed discussoin is given below). These results indi-
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cate an E1cB elimination as the inhibition mechanism, as for such a reaction, an acidic
hydrogen and a poor leaving group (LG), linked to two adjacent atoms, are necessary
(see Figure 7.1). [170] The mechanism is initiated by the abstraction of the proton, for-
ming an anion. The double bond is subsequently formed trough the expulsion of the
LG.
Abbildung 7.1: E1cB reaction mechanism.
Figure 7.2 schematically shows the elimination of carbamates by the degradation of
the carbamate-based insecticide ethiofencarb, a pesticide used for the control of aphids
on vegetables, corn and fruit. [171,172] Concerning carbamates, the acidic proton (red
in Figure 7.2) is bound to the nitrogen atom. The alcohol, formed during the reaction
(blue in Figure 7.2), is known to be a poor leaving group.
Abbildung 7.2: Degradation of ehtiofencarb in an alkaline medium.
The nitrogen atom is deprotonated in the first step of the reaction and forms an anion,
which dissociates into an isocyanate and a phenolate derivative. The phenolate is
protonated to an alcohol. In the subsequent step, a carbamic acid anion is formed
through the nucleophilic attack of hydroxide. The unstable compound dissociates
into carbon dioxide and a primary amine after the protonation of the nitrogen. The
carbamate-based pesitcide ethiofenarb (popularly known as Croneton), undergoes
this degradation mechanism when exposed to rough weather conditions or during
storage periods. [165,171,172] In its function as an insecticide, ethiofencarb carbamylates
the active site of AChE. [171,173]
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Carbamates in Cysteine Proteases
Carbamate derivatives have been shown to be potential inhibitors of esterases and
a number of cathepsins. [167,168,169,174,175] In the group of Prof. Guetschow, the four
peptidylic carbamates displayed in Figure 7.3 are investigated (among others) as po-
tential inhibitors for cathepsin B. Only two of the compounds (1 and 2) have an acidic
hydrogen atom, making an E1cB mechanism possible. The other two compounds (3
and 4) are the respective derivatives with an α methyl group.
Abbildung 7.3: Investigated compounds from the group of Prof. Guetschow.
Based on the reaction behavior of carbamates reported in the literature, the initial
step of the inhibition is assumed to be an elimination, according to an E1cB mecha-
nism. [161,163,164,165,171] The measurements of the four compounds revealed an enzyma-
tic rest activity of 2% and 4% for compound 1 and 2 inside cathepsin B. [1] In contrast,
the activity of the inhibited enzyme with the compounds 3 and 4 were 85% and 98%,
which indicates that the acidic α hydrogen is required for the inhibition. [1] All mea-
sured values refer to an inhibitor concentration of 20 µM. More detailed information
can be found in the appendix of this work. Docking calculations of the carbamate-
based inhibitor and its respective isocyanate shown in Figure 7.4 were performed
by the group of Prof. Guetschow. The compounds were docked into the active site
of cathepsin B (crystal structure 1HUC [26]). The resulting structures are taken as a
basis for theoretical investigations of the proceeding of the proposed mechanism (see
Figure 7.5).
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Abbildung 7.4: Investigated inhibitor and its respective isocyanate.
Abbildung 7.5: Reactant, intermediate and product structures of the proposed mechanism for
a carbamate-based inhibitor in cathepsin B.
7.2 Summary
As already mentioned in the beginning of this chapter, a summary of all relevant
results is given, before a detailed discussion of the respective topics follows. The
reaction mechanisms of the system were investigated using different computational
approaches including NEB calculations as well as reaction profiles and potential
energy surfaces (PES). Even though NEB calculations provide more information
compared to reaction profiles and PES, their iterative scheme hardly converge for
complex reaction mechanisms. Therefore, other types of calculations were addi-
tionally performed. Figure 7.6 shows an overview of possible reaction mechanisms
between carbamate-based inhibitors and the active site of cathepsin B.
Possible Reaction Mechanisms
In a first step, the various reaction pathways of the carbamate-based inhibitor
in the active site of cathepsin B were evaluated via thermodynamic calculations
(SCS-MP2/aug-cc-pVDZ with COSMO; =78.93). More detailed information about
the applied methods is given in Chapter 6. For this purpose, a small model system
was set up, containing only the side chains of histidine and cysteine (the backbone
was replaced by a methyl residue) as well as the warhead of the inhibitor.
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Abbildung 7.6: Possible reaction mechanisms for cathepsin B with a carbamate warhead. All
structures are optimized using SCS-MP2/aug-cc-pVDZ including implicit sol-
vation (COSMO; = 78.93). Energies are given in kcal/mol; n.c.: not converged.
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Calculations for the structures B3, B4 and B5 did not converge, which is in agree-
ment with chemical intuition, as both of the protonated carbamate oxygen atoms are
extremely weak bases. The reaction from A to B1 is most exothermic compared to
all other initiating steps. This mechanism describes a proton transfer from His199 to
Cys29. However, as cathepsin B is known to have a zwitterionic active site that is
conserved through the enzymatic environment, this pathway would be energetically
unfavourable, when the whole enzyme is considered in the calculations. [43] Addi-
tionally, the reaction enthalpies of the subsequent steps exceed 50 kcal/mol, which
excludes these pathways from further investigations.
For the remaining reactions, two main pathways arose that primarily differ in the
function of Cys29 in the first step of the mechanism. For the mechanisms staring with
A→ D1 (see Figure 7.6), cysteine initiates the reaction by a nucleophilic attack at the
carbamate carbon. However, all pathways starting with A→ B2 (see Figure 7.6) con-
tain an isocyanate intermediate, formed through the dissociation of the inhibitor. In
these cases, the Cys29 acts as a base and deprotonates the carbamate group in the first
step of the reaction. The subsequent dissociation of the inhibitor completes the E1cB
elimination reaction, initiated by the deprotonation through Cys29. As the experimen-
tal data indicated an E1cB elimination reaction being the first step (see Chapter 7), all
pathways leading over D1 were also excluded from further investigations. Based on
these considerations, the pathways containing A→ B2→ C1 (see Figure 7.6) remain.
Commencing from C1, there are seven possible reaction pathways, which all describe
a proton transfer reaction. In three of them (C2, C3 and C4) the isocyanate nitrogen
is protonated forming a cation. All of those reactions have reaction enthalpies larger
than 30 kcal/mol and are therefore not further investigated. The reactions from C1
to C5 (deprotonation of Cys29) and to C7 (protonation of phenolate) include exter-
nal buffer molecules. Thus, these pathways were also not further studied. Although
a model system containing an acetate buffer is investigated in Chapter 7.4.1, at the
QM level of theory, the buffer was removed for the computations using the QM/MM
hybrid approach.
The remaining two reactions both entail a protonation of phenolate, either through
His199 (C6) or Cys29 (C11). Histidine is a more potent proton donor, which
is reflected in the lower reaction enthalpy compared to Cys29 as proton donor
(around 4 kcal/mol). However, during MD simulations of the system, the arrangement
of the active site amino acids and the inhibitor in cathepsin B showed a constantly
smaller distance between Cys29 and the carbamate oxygen (around 2 - 4 Å) compared
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to the distance between His199 and the oxygen atom O (5-8 Å) . Figure 7.7 shows a
representative structure of the system, which was taken from a MD simulation and
subsequently optimized (QM/MM with B3LYP/aug-cc-pVDZ as QM method).
Abbildung 7.7: Structure of the inhibitor inside the active site of cathepsin B. The distance is
given in Å.
After these preliminary investigations, the remaining feasible mechanism describes
an elimination reaction according to an E1cB mechanism (A→B2→C1) with a proton
transfer from cysteine to phenolate (C1 → C11) and a subsequent carbamylation of
cysteine (C11→ E2→ F1)(see emphasized scheme in Figure 7.8).
As this pathway fulfills all criteria and is therefore the only one the be reasonable, it
alone will be investigated further. Therefore, the model system was enlarged to the
whole enzyme including a docked inhibitor structure.
E1cB - Reaction Path
For the examination of the reaction with the real system, the reaction was parted
into the two steps as shown in Figure 7.17. Starting with the elimination reaction, a
potential energy surface was calculated on QM/MM level (PM3 [132,134] as QM method).
The geometries of the resulting reaction path were used for single point calculations
on a higher level of theory (B3LYP/aug-cc-pVDZ) [122,176] for the QM part. The energy
barrier calculated using PM3 was 40.8 kcal/mol, whereas B3LYP predicted a barrier
of only 22.0 kcal/mol. Additionally, the energetic course of the path calculated with
B3LYP had abrupt changes in the energetic course of 5-8 kcal/mol between very similar
structures. This indicates an insufficient description of the system by a pure treatment
of the QM area with PM3. As a consequence, PM3 was henceforth only used for
pre-optimizations and for qualitative estimations.
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Step One: E1cB Elimination - Stabilization of Phenolate
Before further calculations concerning the mechanism were performed, the stabili-
zation of the phenolate anion formed during the dissociation of the inhibitor was
examined. The aim of these investigations was to find a path with a lower reaction
barrier by stabilizing phenolate either through non-covalent interactions or protona-
tion. A MD simulation with a frozen QM area containing the dissociated inhibitor
(represented by its charge-density) was performed in order to see if any stabilizing
interactions are formed with the negative charged phenolate. The enzymatic environ-
ment did not undergo significant changes, whereas a small water shell surrounded
the anion. One water molecule was observed to diffuse into the active side. However,
a quantification of the stabilizing effect was not possible, as the structural changes
of the environment around the active site dominated the energy of the compared
systems. A fixation of the surrounding amino acids lead to a destabilization of the
structure with the water inside the active site by 10.8 kcal/mol, as the adjacent fixed
molecules could not adapt to the water molecule. The promising structure with the
water molecule inside the active site is examined further in a later part of this work
(see “E1cB - Water-Mediated Proton Transfer“or Chapter 7.3.4).
Next, the protonation of the formed phenolate through Cys29 was investigated using
DFT methods (no hybrid methods were applied). The deprotonation of the inhibitor
was assumed to be the first step of the reaction with the subsequent dissociation and
protonation of phenolate. The deprotonation was computed using a reaction profile
(B3LYP/aug-cc-pVDZ with COSMO; =78.93). The dissociation of the inhibitor and
protonation of phenolate were investigated with the help of a potential energy sur-
face (B3LYP/aug-cc-pVDZ with COSMO; =78.93) in order to cover the possibility of a
concerted mechanism. The resulting pathway has an energy barrier of 28.8 kcal/mol.
In an attempt to investigate if a reaction path with a lower barrier exists, the possi-
bility of the three steps (deprotonation, dissociation and protonation of phenolate)
occurring simultaneously was investigated via multiple potential energy surfaces
(B3LYP/aug-cc-pVDZ with COSMO; =78.93). However, the resulting reaction barrier
still remained at 32.9 kcal/mol.
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Abbildung 7.8: Possible reaction mechanisms for cathepsin B with a carbamate warhead. All
structures are optimized using SCS-MP2/aug-cc-pVDZ including implicit sol-
vation (COSMO; = 78.93). Energies are given in kcal/mol; n.c.: not converged.
The examined mechanism is indicated in bold.
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Step One: E1cB Elimination - Nudged Elastic Band
The gained results indicate that the reaction depends on a number of variables and
can therefore only be poorly described by reaction profiles and potential energy
surfaces. As a solution, Nudged Elastic Band (NEB) calculations on QM/MM level
(B3LYP/cc-pVDZ as QM method) were performed in order to find a reaction path
between the structures. Two computations were performed, describing an E1cB eli-
mination with and without protonation of the formed phenolate anion.
Abbildung 7.9: Reactant and product structures of the performed NEB calculations.
For the deprotonated phenolate (NEB1 in Figure 7.9), the reaction barrier as well as
the product structure had an energy of 40.1 kcal/mol (see Figure 7.10a). This strongly
indicates that a reaction is only possible if the alcoholate ion is protonated e.g. through
cysteine. In the reaction pathway resulting from NEB2 (see Figure 7.9 and 7.10b), the
product structure was energetically decreased compared to the highest point of the
barrier. However, the predicted activation energy was still approximately 40 kcal/mol,
which indicates that the reaction cannot take place.
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Abbildung 7.10: a) NEB pathway on QM/MM level (B3LYP/cc-pVDZ as QM method) of NEB1.
b) NEB pathway on QM/MM level (B3LYP/cc-pVDZ as QM method) of NEB2.
Step One: E1cB Elimination - Reaction Path Water-Mediated Proton Transfer
Based on a recent publication on water-catalyzed proton transfer reactions in enzymes
of the group of Prof. Engels in Wu¨rzburg, a water molecule was included in the system
in order to simulate a water-bridged proton transfer reaction (see Figure 7.11). [177,178]
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According to a MD simulation performed with the dissociated inhibitor structure, a
water molecule can diffuse inside the active site of the enzyme (see “E1cB - Stabiliza-
tion of Phenolate“or Chapter 7.3.2).
Abbildung 7.11: Reaction scheme of water-mediated E1cB reaction.
Therefore, a system with an additional water molecule was manually prepared for
QM/MM calculations and optimized using B3LYP/cc-pVDZ as the QM method. As
the number of relevant system variables increases by the inclusion of the water mo-
lecule, several PES (PM3 as QM method) were performed in order to gain qualita-
tive insights. The most promising surfaces were combined in a reaction profile with
subsequent single point calculations using QM/MM hybrid schemes with the QM
methods B3LYP/aug-cc-pVDZ and SCS-MP2/aug-cc-pVDZ. The reaction barrier was
significantly lower compared to the reaction without an additional water molecule
(22.2 kcal/mol for SCS-MP2/aug-cc-pDVZ; Figure 7.12a). The structure W12 TS′ is
obtained from the calculation of a PES describing the deprotonation and dissociation
of the inhibitor. It holds an isolated oxonium ion. This structure, however, does not
appear in the NEB reaction path. In a final step, NEB calculations on the QM/MM
level of theory (B3LYP/cc-pVDZ as QM method) were performed to examine whether
a reaction path with an even lower barrier can be found. As the NEB calculation from
structure W1 wat to W3 wat did not converge, the two NEB profiles fromW1 wat to
W2 wat and from W2 wat to W3 wat were combined in one reaction coordinate (see
Figure 7.12b). The x-axis therefore contains equidistant marks, one for each frame of
the calculation. The reaction barrier of this path is therefore the lowest one for the re-
action (15.3 kcal/mol) with a reaction enthalpy of -8.1 kcal/mol. Based on these results,
it can be concluded that an E1cB elimination including a catalytic water molecule can
take place.
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Abbildung 7.12: a) Reaction pathway resulting from the combination of several PES (PM3
as QM method) with single point calculations (B3LYP/aug-cc-pVDZ and
SCS-MP2/aug-cc-pVDZ as QM methods). W12 TS′ is the structure of the
deprotonated inhibitor containing an isolated oxonium ion.
b) NEB reaction path (B3LYP/cc-pVDZ as QM method) of the reaction from
W1 wat to W2 wat and from W2 wat to W3 wat. NEB profiles from W1 wat
to W2 wat and from W2 wat to W3 wat were combined in one reaction
coordinate, the x-axis therefore contains equidistant marks, one for each
frame of the calculation. More detailed information about the respective
structures is given in Figure 7.47 (see Chapter 7.3.4).
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Abbildung 7.13: Possible reaction mechanisms for cathepsin B with a carbamate warhead.
All structures are optimized using SCS-MP2/aug-cc-pVDZ including impli-
cit solvation (COSMO;  = 78.93). Energies are given in kcal/mol; n.c.: not
converged. The examined mechanism is indicated in bold.
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Step Two: Carbamylation - QM Calculations on a Model System
The subsequent reaction step of the inhibition (carbamylation) was investigated based
on the aforementioned gained results. It includes a nucleophilic attack of Cys29
at the isocyanate carbon and a protonation at the nitrogen N1 trough His199 (see
Figure 7.14). In a first attempt, the small model system described above with an addi-
tional acetate buffer was used for DFT calculations. The calculations showed that an
“anti“orientation of the deprotonated nucleophilic sulfur and the protonating H-atom
of the buffer relative to the C-N double bond results in a barrier-free reaction.
Abbildung 7.14: Lewis structures of W3, W4 and W5.
Step Two: Carbamylation - Orientation of the Isocyanate
For further investigations using QM/MM methodologies, the acetate buffer and phe-
nol were deleted from structure W3 wat (see Figure 7.11a). The remaining inhibitor
(isocyanate) was in an unfavourable position for a reaction with the active site amino
acids Cys29 and His199. In order to examine whether a reorientation of the warhead
is possible, a MD simulation was performed. Throughout the simulation, the inhi-
bitor left the active site several times but always diffused back inside in a different
orientation. Therefore a rearrangement of the inhibitor does therefore not seem to be
problematic.
Step Two: Carbamylation - Generation of a Suitable Starting Structure
In order to gain suitable structures for NEB calculations, several PES (PM3 as QM
method) were calcua with the starting structure in order to gain a more favourable
position of the inhibitor near Cys29. The resulting structure was used for the
generation of W4 and W5 (see Figure 7.14) via several PES (PM3 as QM method).
None of the three structures, W3, W4 or W5, reached convergence within QM/MM
geometry optimizations on a higher level of theory (B3LYP/cc-pVDZ as QM method).
A closer examination of the adjacent amino acids and water shell lead to the need
for additional MD simulations with the structures W3 and W5 in order to obtain
geometries including a relaxed environment which can stabilize the systems. The
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simulation of W3 did not lead to further results. For W5, a water molecule diffused
in a favourable position for a water-bridged proton transfer. Based on this structure,
the reaction was calculated backwards via PES (PM3 as QM method) in order to gain
converged structures of W4 and W3. The structures converged for unconstrained
geometry optimized with B3LYP/cc-pVDZ as QM method.
Step Two: Carbamylation - Nudged Elastic Band Calculations
The converged structures of W3, W4 and W5 were taken for NEB calculations of the
whole reaction (W3 to W5) and the single reaction steps (W3 to W4 and W4 to W5).
Due to the amount of structural changes during the reaction, the NEB calculation
from W3 to W5 did not converge, in contrast to the other two computations. The final
reaction path, gained through the combination of the two calculations, is shown in
Figure 7.15.
Abbildung 7.15: NEB path (B3LYP/cc-pVDZ as QM method) of the carbamylation of Cys29
through the isocyanate intermediate. NEB profiles from W3 to W4 and from
W4 to W5 were combined in one reaction coordinate, the x-axis therefore
contains equidistant marks, one for each frame of the calculation.
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The x-axis contains equidistant marks, one for each frame of the calculation. The
calculations predict a reaction barrier of 5.1 kcal/mol for the nucleophilic attack of
sulfur and a nearly barrier-free water-bridged proton transfer between His199 and
the inhibitor. The high exothermicity of the reaction could be traced back to the product
W5′, a structure that emerged throughout the NEB calculation from W4 to W5 and
entails strong hydrogen bonds between the reaction partners (see Figure 7.15).
Conclusions
Finally, the reaction mechanism of a carbamate-based inhibitor and cathepsin B was
successfully investigated with help of MD simulations and different approaches on the
QM and QM/MM level. The calculations showed that the water shell surrounding the
active site has a significant impact on the mechanism. Several reaction steps would not
take place without a catalytic water molecule partaking in the reaction. An energetic
connection between the elimination reaction (first step) and the carbamylation (second
step) could not be quantified, as the second step required a rearrangement of the
participating reactants.
7.3 Step One: E1cB Elimination
There are several possibilities for the computational analysis of a mechanism, inclu-
ding reaction profiles, potential energy surfaces and NEB calculations. Within reaction
profiles, the influence of one structural parameter on the reaction can be examined.
Potential energy surfaces cover the mutual influence of two parameters while NEB
calculations include the variation of an arbitrary number of parameters. The compu-
tational effort of these calculations rises with the number of varied parameters. The
iterative scheme of NEB calculations hardly converge in difficult cases, depending
on the amount of structural change during the mechanism. Thus, a combination of
all three methods was utilized for the investigations in this work, depending on the
respective task. As mentioned above, the investigated mechanism contains the two
steps shown in Figure 7.17. Due to the complexity of the reaction path, the steps were
investigated separately.
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Abbildung 7.16: Possible reaction mechanisms for cathepsin B with a carbamate warhead.
All structures are optimized using SCS-MP2/aug-cc-pVDZ including impli-
cit solvation (COSMO;  = 78.93). Energies are given in kcal/mol; n.c.: not
converged. The examined mechanism is indicated in bold.
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Abbildung 7.17: Proposed mechanism for the reaction of carbamate-based inhibitors in ca-
thepsin B.
7.3.1 Reaction Path
In a first attempt, the initiating E1cB elimination is computed with the help of a
potential energy surface, using the QM/MM method. The reaction corresponds to the
path A→ B2→ C1 of Figure 7.8 and 7.16. As QM method, the semi empirical PM3
approach is used. The reaction coordinates are defined as the distance between S and
H1 in order to describe the deprotonation and between C1 and O1 to simulate the
dissociation of the inhibitor (see Figure 7.18).
Abbildung 7.18: Reaction scheme of an E1cB elimination of the inhibitor inside the active site
of cathepsin B.
The surface indicates, that the deprotonation of the inhibitor is the initiating step of the
mechanism with the subsequent dissociation corresponding to an E1cB elimination
reaction. The barrier of the resulting reaction path (grey line on surface in Figure 7.19)
is high (40.8 kcal/mol), as is the reaction enthalpy of 34.7 kcal/mol. As semi empiri-
cal methods are mostly suitable for the qualitative assessment of a reaction, single
point calculations on a higher level of theory for the QM area (B3LYP/aug-cc-pVDZ)
were performed on the geometries of the reaction path, extracted from the surface
(see Figure 7.20). Through the utilization of the diffuse basis set, the properties of
the sulfur anion were supposed to be described more properly. The reaction barrier
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decreases by 10.4 kcal/mol, compared to the semi empirical results. Moreover, there
are abrupt changes in the energy (up to 8.0 kcal/mol), that can not be explained by the
structurally small deviation of the respecting molecules. The results indicate, that the
semi empirical PM3 method neglects fundamental effects of the reaction.
Abbildung 7.19: Potential energy surface calculated with the QM/MM method (PM3 as QM
method) of the deprotonation and dissociation of the inhibitor. Structures
PM3 W1 and PM3 W2 correspond to A and C1 in Figure 7.16.
Several consequences are drawn from the results. Concerning the computational me-
thods, PM3 can only be used for pre-optimizations. In order to save calculation time,
all further QM/MM calculations will be pre-optimized with PM3 and subsequent-
ly re-optimized with B3LYP/cc-pVDZ as QM method. The choice of a non-diffuse
basis set was based on the fact that geometry optimizations, including diffuse ba-
sis functions, are hard to converge. The augmented basis was therefore included in
subsequent single point calculations. As the mechanism seems to be rather complex,
73
7.3. STEP ONE: E1CB ELIMINATION
several following calculations were performed on a QM level of theory within a small
model system in order to gain detailed insights. Based on the obtained conclusions
from the model system, further QM/MM calculations with the original system could
subsequently be performed more efficiently. However, before further calculations on
the reaction mechanism were performed, the focus was directed to the phenolate ion
that is formed by dissociation of the inhibitor.
Abbildung 7.20: Energy profile of the deptrotonation and dissociation of the inhibitor. Levels
of theory are single point QM/MM calculations (B3LYP/aug-cc-pVDZ as QM
method; red) on optimized structures (PM3 as QM method; black).
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7.3.2 Stabilization of Phenolate
Abbildung 7.21: Possible reaction mechanisms for cathepsin B with a carbamate warhead.
All structures are optimized using SCS-MP2/aug-cc-pVDZ including impli-
cit solvation (COSMO;  = 78.93). Energies are given in kcal/mol; n.c.: not
converged. The examined mechanism is indicated in bold.
75
7.3. STEP ONE: E1CB ELIMINATION
Based on the idea that a stabilization of the phenolate anion, formed after the
dissociation (C1 in Figure 7.21) could decrease the reaction barrier different reali-
zations thereof were analyzed. Potential non-covalent interactions of the oxygen
atom with either adjacent amino acids or water molecules were investigated. For this
purpose, MD simulations with a structure of the dissociated inhibitor (PM3 TS in
Figure 7.19) were performed. In a second step, an actual protonation of the alcoholate
ion through cysteine was included in the reaction mechanism. As the inclusion of a
third coordinate requires additional computational effort, the system was reduced
to a model system, containing the warhead of the inhibitor and a methanethiol as a
cysteine representative.
Non-Covalent Interactions
The environment around the phenolate anion was investigated in order to determine
potential hydrogen bonding partners. Concerning adjacent amino acids, all relevant
compounds inside a radius of 5 Å around the oxygen atom are shown in Figure 7.22.
Abbildung 7.22: Dissociated inhibitor (ball and stick) with all adjacent amino acids in a radius
of 5 Å around the negatively charged oxygen atom.
The structure taken for the investigations originates from the potential energy surface
(PM3 TS Figure 7.19). It was subsequently optimized with B3LYP/cc-pVDZ as QM
method. The smallest distance of a potential proton donor to the phenolate oxygen
amounts to 3 Å and emerges with the backbone amino group of Gly71. Even though
the position of the amino acids were altered during a MD simulation, their orienta-
tion relative to the inhibitor anion is not favourable for the formation of stabilizing
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interactions. Additionally, the phenolate will presumably diffuse out of the active site,
which makes a permanent stabilization of the phenolate by the amino acids unlikely.
Similar to the adjacent amino acids, there are no water molecules near enough for a
stabilization of the anion in the observed structure. As the small water molecules are
more flexible in contrast to the amino acids, the possibility of a solvation of the anion
was investigated with help of a MD simulation. Figure 7.23 shows the dissociated
inhibitor inside the active site of the enzyme. The blue area marks a region with an
increased number of water molecules.
Abbildung 7.23: Dissociated inhibitor inside the active site of cathepsin B. The water-rich
region is marked in blue.
In order to investigate the movement of the environment relative to a fixed inhibitor
position, the following approach was applied: The QM area (containing Cys29 and
the inhibitor) is described through an electrostatic potential (ESP), calculated with
the semi empirical method AM1. As the calculation corresponds to a single structure,
the QM area remains frozen throughout the MD simulation. The water molecules and
enzymatic environment in contrast can freely move around the inhibitor. A simulation
over a time of 2 ns was performed with the purpose of obtaining a relaxation of
the environment around the dissociated inhibitor. The amino acid side chains and
backbones remain in a stable position (with the exception of Trp30), whereas the
water molecules migrate towards the phenolate anion. Different water molecules
repeatedly stabilize the phenolate over time periods of at least 50 ps. Figure 7.24 shows
the distance r between several water molecules (defined by the respectively closer
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hydrogen atom) and the anion oxygen. One water molecule (Wat540 in Figure 7.25)
even diffuses inside the active site and stays near the negative charge of the alcoholate,
while Trp30 provides additional space by rotation of the side chain.
Abbildung 7.24: Distances between several water molecules (with regard to the closer hydro-
gen atom) and the phenolate oxygen. All distances are given in Å and the
simulation time amounts to 213 ps in total.
The calculations show that a stabilization of the phenolate anion can be provided
through non-covalent interactions with surrounding water molecules. The quanti-
fication of the stabilization is however a challenging task, as even small changes
in a number of environmental compounds (water molecules and amino acids) can
lead to an extreme difference in the energy of the system. In an attempt to do so,
the left structure shown in Figure 7.25 was taken as a reference system. The water
molecule Wat540 was positioned inside the active site, similar to the right structure
in Figure 7.25. For both systems (Wat540 inside and Wat540 outside the active site),
single point calculations were performed using B3LYP/aug-cc-pVDZ as QM method.
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Abbildung 7.25: Snapshot of the MD simulation after 0.0 (left) and 9.8 (right) ps for the
simulation of a relaxing environment with a frozen QM area (inhibitor after
the dissociation).
The calculations show a destabilization of 10.8 kcal/mol for the system in which the
water molecule sits inside the active site. However, this result has to be interpreted
with caution, as the water was positioned manually and the structures were not
optimized to avoid a big number of small structural changes in the environment.
In conclusion, it can be stated that the negative charge of the phenolate molecule
can be stabilized through adjacent water molecules. The promising structure with
an additional water molecule inside the active site will be further studied in a later
Chapter of this work (see Chapter 7.3.4).
Protonation of Phenolate on a Model System
As the proposed mechanism involves an actual protonation of the phenolate, the re-
action is now extended to an additional step. Therefore, the system was reduced to
a smaller model, containing the inhibitor warhead and a methanethiol as a represen-
tative for the active site amino acid Cys29 (see Figure 7.27). The reduced size allows
for QM calculations at the B3LYP/aug-cc-pVDZ level of theory in cooperation with
the implicit solvation model COSMO (=78.93). Initially, a potential energy surface,
describing the dissociation of the inhibitor and protonation of phenolate through
methanethiol, was calculated.
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Abbildung 7.26: Possible reaction mechanisms for cathepsin B with a carbamate warhead.
All structures are optimized using SCS-MP2/aug-cc-pVDZ including impli-
cit solvation (COSMO;  = 78.93). Energies are given in kcal/mol; n.c.: not
converged. The examined mechanism is indicated in bold.
80
7.3. STEP ONE: E1CB ELIMINATION
The starting point of the computations was a manually built structure of the depro-
tonated inhibitor (see Figure 7.27). In a subsequent calculation, the deprotonation of
the inhibitor was calculated backwards, using the same starting structure.
Abbildung 7.27: Structure of the deprotonated inhibitor and methanethiol, the starting point
for the calculations of the PES. The structures INT 1 and INT 2 correspond
to B2 and C11 in Figure 7.26. Distances are given in Å.
Abbildung 7.28: PES (B3LYP/aug-cc-pVDZ with COSMO) describing the dissociation of the
inhibitor and the protonation osf phenolate through cysteine.
The PES shows a significantly lower reaction barrier for the dissociation of the inhibitor
(12.0 kcal/mol) and indicates a concerted protonation of the alcoholate anion. As the
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starting structure of the surface (deprotonated inhibitor; INT1 in Figure 7.27 ≡ B2
in Figure 7.26) was originally not the start of the reaction, its energy, relative to the
protonated and undissociated inhibitor, is calculated with the help of the reaction
profile mentioned above.
Abbildung 7.29: Energetic profile (B3LYP/aug-cc-pVDZ with COSMO) describing the depro-
tonation of the inhibitor.
The profile depicted in Figure 7.29 shows that the deprotonated form of the inhibitor
is not a local minimum of the reaction mechanism, which is in agreement with
the potential energy surface of the deprotonation and dissociation of the inhibitor
(see Figure 7.19). The reaction barrier of 16.8 kcal/mol increases the barrier of
the complete reaction to 28.8 kcal/mol, which is again unfavourable. The energe-
tic difference of nearly 3 kcal/mol between the penultimate and last structure can
be attributed to the change of the frozen reaction coordinates during the optimizations.
Abbildung 7.30: Reaction coordinates for the investigation of the concerted mechanism.
82
7.3. STEP ONE: E1CB ELIMINATION
To this point, the deprotonation of the inhibitor was presumed to be the first step of
the mechanism. In the following, a completely concerted reaction course, containing
the deprotonation of the inhibitor (A→ B2 in Figure 7.26), its dissociation (B2→ C1
in Figure 7.26) and the protonation of the phenolate (C1 → C11 in Figure 7.26) was
examined. For this purpose, the three reaction coordinates shown in Figure 7.30 were
introduced.
Abbildung 7.31: Potential energy surfaces (B3LYP/aug-cc-pVDZ) scanning three reaction
coordinates by freezing one coordinate per PES and varying the other two.
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As a potential energy surface only covers two reaction coordinates, several surfaces
were calculated to describe the reaction. One of the coordinates (distance between C
and O) was kept fixed throughout the calculation of one PES and was parametrically
changed for each surface. Three surfaces were calculated with r(C-O) = 1.4 Å , 1.6 Å
and 2.0 Å (see Figure 7.31). The resulting reaction path is shown in Figure 7.32.
The path still shows a barrier of 32.9 kcal/mol. It also predicts the deprotonation to
be the first step of the reaction mechanism. From that it could be concluded that
the reaction would not take place under the present conditions. However, there are
further parameters that have not been considered until now.
Abbildung 7.32: Reaction pathway (QM) for the concerted mechanism, resulting from the
three PES (B3LYP/aug-cc-pVDZ) shown in Figure 7.31.
7.3.3 Nudged Elastic Band Calculations
The reaction under consideration seems to depend on a number of parameters.
In order to include all relevant degrees of freedom into the reaction mechanism,
Nudged Elastic Band (NEB) calculations were performed. For this purpose, the
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system was enlarged to its original size and examined using QM/MM hybrid
methods. The procedure entails an optimization of the desired start and end structure
of the reaction, which were taken as input structures of the NEB calculation. The
probability of an iterative NEB calculation to converge depends on the amount that
the system changes during the reaction. Thus, not only the start and end structure of
the mechanism, but also intermediate products were optimized (see Figure 7.33).
Geometry Optimizations
The key structures of the mechanism W1, W2, W3′ and W3 (see Figure 7.33) were
optimized on QM/MM level using B3LYP/cc-pVDZ as the QM method. The calcula-
tions of the structure of the deprotonated inhibitor (W2 ≡ B2 in Figure 7.16) did not
converge, but instead changed back to the reactant structure. The resulting structure
will be called W1′. This result is in agreement with the previously described calcu-
lations, indicating that W2 is not an intermediate partaking in the mechanism. As a
consequence, only the NEB path of solely the deprotonation could not be calculated.
Instead, the reaction path betweenW1 and W3 and from W1 to W3′ were computed.
Abbildung 7.33: NEB reaction pathways for the system under consideration. All structures
were optimized at the QM/MM level of theory with B3LYP/cc-pVDZ as QM
method. W1, W2, W3′ and W3≡A, B2, C1 and C11 respectively in Figure 7.16;
n.c. = not converged.
Single point calculations with B3LYP/aug-cc-pVDZ and SCS-MP2/aug-cc-pVDZ as
QM methods were subsequently performed for selected structures. The results are
listed in Table 7.1. The comparison of the MM energy contributions reveal energy
differences of 40 - 50 kcal/mol between W1 and the remaining structures.
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Tabelle 7.1: Energy differences between structures W1, W1′, W3 and W3′. Sin-
gle Point QM/MM energies (QM methods: B3LYP/aug-cc-pVDZ and
SCS-MP2/aug-cc-pVDZ (bold)) on optimized geometries (B3LYP/cc-pVDZ as QM
method). Energies are given in kcal/mol.
W1 - W1′ W1 - W3′ W1 - W3 W1′ - W3 W1′ -W3′ W3′ - W3
QM 1.9 / 2.2 14.3 / 11.7 23.8 / 22.1 17.7 / 15.5 27.2 / 25.8 9.5 / 10.3
MM -46.5/ -46.5 -44.7 / -44.7 -40.9 / -40.9 3.3 / 3.3 7.1 / 7.1 3.8 / 3.8
QM/MM -48.4 / -48.7 -30.4 / -32.9 -17.1 / -18.8 20.9 / 18.7 32.9 / 32.9 13.3 / 14.1
In order to determine the origin of this phenomenon, the two structures of W1 and W1′
were examined more closely, as they are structurally close, but still show an energetic
difference of nearly 50 kcal/mol. Since this examination includes an enlargement of the
QM area, a small benchmark was performed, in order to see if a computationally less
demanding method than SCS-MP2/aug-cc-pVDZ is sufficient for these calculations.
In Table 7.2, the difference of the single point QM/MM energies between W1 and W1′
are compared for different QM methods.
Tabelle 7.2: Energy differences between structure W1 and W1′. Single Point QM/MM energies
on optimized geometry (B3LYP/cc-pVDZ as QM method). Energies are given in
kcal/mol.
PM3 B3LYP/cc-pVDZ B3LYP/aug-cc-pVDZ SCS-MP2/aug-cc-pVDZ
QM -3.9 -2.3 -3.4 -3.7
MM -47.9 -47.9 -47.9 -47.9
QM/MM -51.9 -50.3 -51.3 -51.7
The results show that PM3 is sufficiently by accuracy for the usage in further inves-
tigations. The QM energy contribution only differs by 0.2 kcal/mol, compared to the
SCS-MP2/aug-cc-pVDZ energy. As the same force field is used for all calculations, the
MM contributions are identical. The QM area is now enlarged to radii of +3 Å, +5 Å
and +7 Å, relative to the original QM area (QMnorm: inhibitor, Cys29 and His162).
Additionally, a calculation excluding the water molecules from the MM area was per-
formed. The results are summarized in Table 7.3. The enlargement of the QM area does
not lead to significant changes in the energies. The neglect of the water molecules,
in contrast, diminishes all differences in the MM energy contributions. The energy
differences thus originate from the water shell. The structures of W1 and W1′ were
aligned in order compare the arrangement of the water molecules for both systems
(see Figure 7.34).
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Tabelle 7.3: Energy differences between structure W1 and W1′. Single Point QM/MM energies
(PM3 as QM method) with different QM areas. Energies are given in kcal/mol.
QMnorm QMnorm +3 Å QMnorm +5 Å QMnorm +7 Å QMnorm no water
QM -3.9 -0.4 -0.5 -1.2 0.2
MM -47.9 -49.2 -48.6 -48.4 0.0
QM/MM -51.9 -48.8 -49.1 -49.6 0.2
The alignment shows that a large number of water molecules slightly differ in their
respective position. Each deviation only contributes a small amount to the total energy.
Nevertheless, the sum of all contributions can result in a significant energy difference.
For a verification of this assumption, the two structures W1 and W1′ are compared
to W3′ (see Figure 7.35). As shown in Table 7.1, the MM energy contributions of W3′
and W1′ only have a small difference of 3.3 kcal/mol, whereas those of W3′ and W1
differ by 44.7 kcal/mol. If the assumption that the position of the water molecules
is responsible for the MM energy difference is correct, the water shells of W1′ and
W3′ should be nearly identical. At the same time W1 and W3′ should show the same
deviations as the ones of W1 and W1′, depicted in Figure 7.34.
Abbildung 7.34: Structures W1 and W1′ with surrounding water molecules. The respectively
identical water molecules of the systems have the same colour. Molecules
with slightly different orientations are highlighted by circles.
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Abbildung 7.35: Comparison of the structures W1, W3′ (left) and W1′, W3′ (right). The re-
spectively identical water molecules of the systems have the same colour.
Molecules with slightly different orientations are highlighted by circles.
The comparison of the structures supports the assumption that the large energy
differences between W1′ and the remaining structures originate from the position
of the water molecules. As a consequence, the structure W1′ was from now on
used as the reactant structure for further investigations. The single point energies
(B3LYP/aug-cc-pVDZ and SCS-MP2/aug-cc-pVDZ) of W1′, W3′ and W3 are summa-
rized in Table 7.4.
Tabelle 7.4: Energy differences between the structures W1′, W3 and W3′. Single Point QM/MM
energies (B3LYP/aug-cc-pVDZ and SCS-MP2/aug-cc-pVDZ in bold) as QM me-
thods on optimized geometries (B3LYP/cc-pVDZ as QM methods). Results from
the thermodynamic QM calculations with the model system from Chapter 7.2 are
given for comparison. Energies are given in kcal/mol.
W1′ - W3 W1′ - W3′ W3′ - W3
QM 17.7 / 15.5 27.2 / 25.8 9.5 / 10.3
MM 3.3 / 3.3 7.1 / 7.1 3.8 / 3.8
QM/MM 20.9 / 18.7 32.9 / 32.9 13.3 / 14.1
Model System 16.8 21.5 4.7
The Table additionally shows the reaction enthalpies (SCS-MP2/aug-cc-pDVZ)
obtained from the thermodynamic calculations within the model system (see
Chapter 7.2). Concerning the the energy difference between W1′ and W3, the results
are in a relatively good agreement between the QM contribution of the QM/MM
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calculation (SCS-MP2) and the QM calculation of the model system (SCS-MP2)
(∼ 2 kcal/mol). The remaining results indicate that W3′, the intermediate structure
with the deprotonated phenolate anion, is less stabilized within the QM/MM
calculations. With a shift of around 10 kcal/mol, the negative phenolate anion is
energetically more favoured inside the model system. This could be due to the fact
that, in contrast to the protein environment, the implicit solvation contribution of
COSMO is self-consistently optimized for each system. A possible stabilization of
the phenolate through non-covalent interactions, as discussed in Chapter 7.3.2, could
however lower the energy of W3′.
Nudged Elastic Band Calculations
Based on the introduced structures W1′, W3′ and W3, NEB calculations were per-
formed at the QM/MM level of theory with B3LYP/cc-pVDZ as QM method. The
two resulting reaction pathways from W1′ to W3′ (A → C1 in Figure 7.26) and to
W3 (A→ C11 in Figure 7.26) will be discussed in the following. The reaction path
between W1′ and W3′ is depicted in Figure 7.36.
Abbildung 7.36: NEB path (B3LYP/cc-pVDZ as QM method) of the reaction from W1′ to W3′.
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The reaction has no local minimum at the structure of W3′. The reaction barrier is
40.1 kcal/mol, which indicates that the reaction will not take place in this setting.
Figure 7.36 illustrates the progression of the relevant distances throughout the reac-
tion. The deprotonation and dissociation of the inhibitor begin simultaneously at 0.4 on
the reaction coordinate. However, the deprotonation is finished at 0.5 (r(H1-S) = 1.4 Å),
while the C-O bond is still at 1.5 Å, which means it is not dissociated completely at this
point. The actual dissociation of the inhibitor occurs at 0.7 on the reaction coordinate.
Abbildung 7.37: Changes of relevant distances during the reaction path from W1′ to W3′.
Figure 7.38 shows the NEB reaction path between W1′ and W3. In contrast to the pre-
vious reaction, the product structure is now a local minimum of the PES. The reaction
barrier of 43.8 kcal/mol is in a similar range as the barrier between W1′ and W3′. In
accordance with the comparable energy barriers, the structure W TS2 in Figure 7.36
(highest point) practically corresponds to W3′. The progression of the relevant para-
meters throughout the reac-tion is shown in Figure 7.39. The deprotonation (r(H1-N))
and dissociation (r(C-O2)) are completely concerted and occur between 0.4 and 0.6
on the reaction coordinate. The protonation of the phenolate oxygen (r(H1-O2)) takes
place subsequently.
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Abbildung 7.38: NEB path (B3LYP/cc-pVDZ as QM method) of the reaction from W1′ to W3.
Abbildung 7.39: Changes of relevant distances during the reaction path from W1′ to W3.
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In conclusion, none of the applied approaches lead to an energy barrier of the reaction
below 30 kcal/mol. An E1cB elimination of carbamate-based inhibitors would thus
not take place in cathepsin B. However, further considerations based on a recent pu-
blication of the group of Prof. Engels in Wu¨rzburg lead to the idea of a water-bridged
proton transfer. [34] The following Chapter concentrates on the implementation of this
idea.
7.3.4 Water-Mediated Proton Transfer
During the simulation described in Chapter 7.3.2, a water molecule moved inside
the active site of the enzyme. The position of the water molecules would allow for a
water-mediated proton transfer between Cys29 and the inhibitor (see Figure 7.40).
Abbildung 7.40: Orientation of the water molecule that moved into the active site during the
MD simulation.
The reaction mechanism now entails a water molecule, that mediates both the depro-
tonation of the inhibitor and the protonation of phenolate, as shown in Figure 7.41. As
this mechanism introduces further reaction coordinates, several potential energy sur-
faces were calculated (QM/MM level with PM3 as QM method) with different degrees
of freedom that were kept fixed in order to obtain an overview of potential intermedia-
te structures for the NEB calculations. The surfaces with the lowest reaction barriers
are discussed in the following (the remaining surfaces are found in the appendix of
this work). The PES of the water-mediated deprotonation of the inhibitor is shown
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in Figure 7.42. With a barrier of 18.2 kcal/mol, the reaction is in a more favourable
energetic area compared to the previous results without a participating water mole-
cule. The calculations predict an intermediate structure with an isolated oxonium ion
and the protonation of Cys29 in a separated second step. The surface contains three
significant structures that may be utilized as starting points for the calculation of the
inhibitor dissociation. Those structures are the transition state W12 wat TS, the in-
termediate W12 wat INT with an isolated hydronium ion and the structure W2 wat
of the deprotonated inhibitor (see Figure 7.42). W2 wat will not be used as starting
structure for further investigations, as the next reaction step includes a deprotonation
of Cys29 and the reaction would thus proceed back to structure W12 wat INT. For
W12 wat TS and W12 wat INT the cysteine sulfur already interacts with HA1 but did
not form a covalent bond that would have to be broken for the next reaction step.
Abbildung 7.41: Reaction scheme of a water-mediated proton transfer between the inhibitor
and Cys29.
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Abbildung 7.42: PES of the water bridged proton transfer (PM3 as QM method). W1 wat and
W2 wat ≡ A and B2 in Figure 7.26.
For the investigation of the following step (the dissociation of the inhibitor and the
protonation of phenolate), three potential energy surfaces were calculated. Addi-
tionally to these evaluations, starting from W12 wat TS and W12 wat INT, a surface
with W1 wat as starting structure is performed in order to investigate the possibility
that Cys29 is not included in the mechanism at all. In this case, H1 would be abstracted
by the water molecule and subsequently be transferred to O1 (phenolate oxygen)
during the dissociation. Figure 7.43 shows the potential energy surface of this reaction.
A second PES of this variant with another set of reaction variables was calculated that
had an even higher barrier of 64.0 kcal/mol (see appendix of this work).
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Abbildung 7.43: PES of the water bridged dissociation of the inhibitor with the simultaneous
protonation of phenolate (PM3 as QM method) without the participation of
Cys29.
The surface shows that the participation of Cys29 seems to be crucial for the reac-
tion, as the surface excluding Cys29 as a reactive component has a reaction barrier
of 45.6 kcal/mol. It is important to note that all calculations were performed with the
semi empirical method PM3 and only give a qualitative assessment. The herein dis-
cussed mechanism without Cys29 is nevertheless energetically the most unfavourable
one compared to the others and additionally excludes the key amino acid of the en-
zyme. Therefore it will not be further considered in this work. In comparison of the
remaining two surfaces, the path with starting structure W12 wat TS shows a lower
reaction barrier and was therefore exclusively considered for further investigations.
Figure 7.44 depicts the potential energy surface of the dissociation and protonation
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of the inhibitor starting from structure W12 wat TS′ with an energy of 10.6 kcal/mol
(gray values in Figure 7.44), relative to the reactant structure W1 wat. The structure
W12 wat TS′ results from a constrained optimization of W12 wat TS with the new
reaction coordinates for the dissociation and protonation of the inhibitor.
Abbildung 7.44: PES of the water bridged dissociation of the inhibitor with the simulta-
neous protonation of phenolate (PM3 as QM method) with starting structure
W TS′. Grey values are the energies of the respective structures relative to
structure W1 wat in Figure 7.42.
The calculations predict the dissociation to be the initial step of the reaction with
subsequent protonation of the phenolate. The reaction barrier is 33.5 kcal/mol (with
PM3 as QM method) relative to the reactant structure W1 wat (gray values in Fig-
ure 7.44). A combination of the two surfaces depicted in Figure 7.42 and 7.44 gives a
reaction profile of the water-mediated deprotonation and dissociation of the inhibitor
with subsequent protonation of the phenolate anion. Figure 7.45 shows the relative
energies of the key structures. The geometries calculated with PM3 as QM method
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were used for QM/MM single point calculations with higher quantum mechanical
levels for the QM area (B3LYP/aug-cc-pVDZ and SCS-MP2/aug-cc-pVDZ).
Abbildung 7.45: Reaction profile of the deprotonation and dissociation of the inhibitor.
QM/MM optimizations were performed with PM3 as QM method. QM/MM
single point calculations were performed with B3LYP and SCS-MP2 as QM
method.
The highest reaction barrier of the profile is 21.0 kcal/mol (SCS-MP2/aug-cc-pVDZ as
QM method), which is again in a more favourable energetic range compared to the
calculated reaction pathways without a mediating water. In the following, different
attempts were applied in order to find a path with an even lower reaction barrier.
Several potential energy surfaces with different reaction coordinates, including the
angles shown in Figure 7.45 in combination with a number of bonds were calculated.
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The PES thereof are depicted in the appendix of this work. The approaches did not
reveal new results. Comparable to the system without an additional water molecule,
two reaction coordinates do not seem to be sufficient for an accurate description of
the reaction. Therefore, NEB calculations were performed for the system.
Nuged Elastic Band Calculations
Similar to the procedure described in Chapter 7.3.3, three NEB calculations were
performed for the system (see Figure 7.46). The calculation describing the whole E1cB
elimination including the protonation of the phenolate (NEB12 wat) did not converge,
as the structural changes during the reaction are too drastic. The two calculations
NEB1 wat and NEB2 wat did however converge. Figure 7.47 depicts the resulting
reaction path in one normalized coordinate with equidistant marks (one for each
frame of the calculation).
Abbildung 7.46: Reaction scheme of the performed NEB calculations with a water-mediated
proton transfer.
The reaction barrier of the deprotonation (15.3 kcal/mol) is similar to the respective
barrier calculated from the potential energy surfaces (see Figure 7.45). The barrier
for the dissociation of the inhibitor is now significantly lower at 9.8 kcal/mol and the
reaction path does not include an isolated hydronium ion. The small barriers at 0.2
and 0.7 on the reaction coordinate occur from a reorientation of the water molecule.
Figure 7.48 shows the progression of all relevant distances during the reaction. The
water-mediated proton transfer between the inhibitor and Cys29 occurs as a concerted
reaction. The abstraction of the proton (r(OA-H1)) changes simultaneously to the
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protonation of Cys29 (r(S-HA1)). After cysteine is in its protonated form, His199 rotates
away from the sulfur atom towards the recognition unit of the inhibitor (r(S-His)
in Figure 7.47). At 0.7-0.9 of the reaction coordinate, the protonation of phenolate
(r(O1-HA2)) takes place simultaneously to the dissociation of the inhibitor (r(C1-O1)).
Abbildung 7.47: NEB path (B3LYP/cc-pVDZ as QM method) of the reaction from W1 wat to
W3 wat. NEB profiles from W1 wat to W2 wat and from W2 wat to W3 wat
were combined in one reaction coordinate, the x-axis therefore contains equi-
distant marks, one for each frame of the calculation.
The results of the NEB calculations show that the reaction depends on a number of
different coordinates and is partially concerted. The inclusion of a water molecule in
the active site leads to a significant reduction of the reaction barriers and results in an
exothermic reaction with a barrier of only 15.3 kcal/mol. An inhibition of cathepsin B
with a carbamate-based inhibitor, initiated by an E1cB mechanism, could thus take
place.
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Abbildung 7.48: Changes of relevant distances during the NEB reaction path from W1 wat to
W3 wat.
Proton Transfer via Two Water Molecules
As the reaction barrier was significantly reduced by the inclusion of a water molecule,
the need to analyze the effect of a second water molecule inside the active site arose.
The corresponding reaction scheme is depicted in Figure 7.49.
Abbildung 7.49: Inhibition scheme for carbamate-based inhibitors inside cathepsin B with
two water molecules inside the active site.
The modified system was prepared by the manual insertion of a second water mole-
cule inside the active site. Both the protonated and deprotonated inhibitor structures
were used for this procedure. Several attempts were needed, as the second water
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molecule repeatedly diffused outside the reactive center of the enzyme during geo-
metry optimizations. With help of several constrained force field optimizations and
subsequent unconstrained optimization at the QM/MM level of theory, both water
molecules could be brought in a stable position between the deprotonated inhibitor
and Cys29 (marked red in Figure 7.50). Unfortunately, the orientation of the molecules
is unsuitable for the reaction mechanism. Therefore, they were rotated in the correct
position (marked green in Figure 7.50) via a potential energy surface (PM3 as QM
method). However, the two water molecules did not stay in their new orientation
during an unconstrained optimization of the system. The conclusion is drawn that
the active site of the enzyme does not appear to have enough space for two water
molecules. The effect of two water molecules inside the active site on the mechanism
was therefore not investigated any further.
Abbildung 7.50: Deprotonated inhibitor inside the active site of cathepsin B with two different
orientations of the water molecules (Inhibitor not shown).
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7.4 Step Two: Carbamylation
Abbildung 7.51: Possible reaction mechanisms for cathepsin B with a carbamate warhead.
All structures are optimized using SCS-MP2/aug-cc-pVDZ including impli-
cit solvation (COSMO;  = 78.93). Energies are given in kcal/mol; n.c.: not
converged. The examined mechanism is indicated in bold.
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On the basis of the gained results, the carbamylation of Cys29 (see emphasized path
in Figure 7.51 will be investigated in the following. Figure 7.52 illustrates the reaction
mechanism between the compounds. The reaction includes two steps, the nucleophilic
attack of the deprotonated Cys29 at the isocyanate carbon and the protonation of the
nitrogen atom through His199 (see Figure 7.52).
Abbildung 7.52: Reaction scheme of the carbamylation of Cys29 with an isocyanate and
His199. W3, W4 and W5 ≡ C11, E2 and F1 in figure 7.51.
7.4.1 QM Calculations on a Model System
The influence of the protonation state of Cys29 on the reaction was investigated
within a model system using a DFT approach. These investigations occur from an
earlier attempt, where the protonation of the phenolate anion through Cys29 was not
discussed yet. For an attack of the protonated cysteine, a syn orientation would occur.
A deprotonated cysteine in contrast needs an external proton donor, that could be in
an anti orientation relative to Cys29. These two possibilities were compared with help
of potential energy surfaces.
Abbildung 7.53: Scheme of the two reaction mechanisms for a carbamylation within a model
system. Left: protonated Cys29 with a syn protonation; right: deprotonated
Cys29 with an anti protonation.
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Abbildung 7.54: Potential energy surface (B3LYP/aug-cc-pVDZ with COSMO; =78.39) of the
carbamylation of a protonated methanethiol.
Abbildung 7.55: Potential energy surface (B3LYP/aug-cc-pVDZ with COSMO; =78.39) of the
carbamylation of a deprotonated methanethiol with acetic acid as external
proton donor.
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The surfaces (see Figure 7.54 and 7.55) show a significant difference in the reaction
barriers. While the reaction with a protonated thiol and a syn attack has a barrier of
29.2 kcal/mol, the deployment of a proton donor in anti orientation to the nucleophilic
attack is barrier-free. This indicates that the reaction in the enzymatic environment
would probably also be favoured if Cys29 attacks in a deprotonated form, while the
protonation occurs anti to the nucleophilic attack from a proton donor. This is in
accordance with previous results, which indicate a deprotonation of Cys29 before the
carbamylation takes place.
7.4.2 Orientation of the Isocyanate
The structure arising from the calculations of the E1cB mechanism (W3 wat in Fig-
ure 7.47) was taken for the simulation of the final reaction steps on QM/MM level.
Therefore, the phenolate was removed from the system, as it is assumed to diffuse out
of the pocket and otherwise would provide sterical hindrance to the reaction. In the
resulting structure, the distance between the isocyanate carbon and Cys29 exceeds
5 Å and the functional group faces in the opposite direction of the active site amino
acid. This does thus not provide a good starting point for the reaction. Members
of the group of Prof. Guetschow previously docked the structure of the isocyanate
intermediate inside the active site of cathepsin B (crystal structure 1HUC [1,26]). This
structure was used to investigate if the inhibitor maintains a stable position inside the
active site or if a reorientation is possible. For this purpose, a MD simulation of the
docked structure was performed. The simulation ran over 10 ns with time steps of 1 fs.
Figure 7.56 illustrates the RMSD values of different parts inside the system relative
to the first frame. Both amino acids of the catalytic dyade stay in a stable position
during the simulation. Also, the entire enzymatic backbone does not show significant
conformational changes (see Figure 7.56; protein backbone). The inhibitor, in contrast,
changes its position and moves relatively free. It repeatedly leaves the active site, but
always diffuses back inside, each time with a different orientation. From this it can be
assumed that a reorientation of the inhibitor into a more favourable position for the
reaction is possible.
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Abbildung 7.56: RMDS values from the MD simulation (10 ns) of the isocyanate intermediate
inside the active site of Cathespin B.
7.4.3 Generation of a Staring Structure
Starting from structure W3 wat (see Figure 7.46), structure W3 (see Figure 7.52) was
formed though the removal of phenole from the system and the exclusion of the
water molecule from the active site. The isocyanate was rotated and placed closer
to the active site with the help of several PES (PM3 as QM method). However, the
inhibitor moved back into a unfavourable position for unconstrained optimizations.
In order to create the structures W4 and W5 (≡ E2 and F1 in Figure 7.51), shown in
Figure 7.52, further PES were performed with the QM/MM approach, using PM3 as
QM method. The negatively charged intermediate structure W4 did not converge in
an unconstrained optimization, but instead ran back to structure W3 (see Figure 7.52).
However, the structure remained in a stable position if the sulfur carbon distance is
fixed (at 1.9 Å) during the optimization. The resulting structure is shown in Figure 7.57.
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Abbildung 7.57: Structure of W4 (see Figure 7.52) with two adjacent water molecules.
Two adjacent water molecules are in a favourable position for a water-bridged proton
transfer from His199 to the inhibitor‘s nitrogen. The protonation was calculated by
manual repositioning of the hydrogen atoms with subsequent optimizations using
QM/MM (B3LYP/cc-pVDZ as QM method). Starting from this newly generated struc-
ture W5, a surface of the backwards reaction was calculated as a new attempt to create
a converged structure W4. W4 did not converge, but instead transformed back to
structure W3. An energetic comparison of W3 and W5, resulting from single point
calculations with B3LYP/aug-cc-pVDZ as QM method, showed a destabilization of
the product W5 by 8.4 kcal/mol compared to the intermediate W3. The fact that the
product structure lies energetically higher than the reactant is indicating that the en-
zymatic environment has an impact on the stabilization of the respective structures.
A closer investigation of the adjacent compounds reveals that there are no poten-
tial interaction partners near the inhibitor to stabilize the warhead. Especially for
the negatively charged adduct of structure W4, this could have a significant impact
on the mechanism. A possible relaxation of the environment to the structures was
therefore investigated via MD simulations with the isocyanate structure W3 (resulting
from the backwards reaction of W5) and the product structure W5. Before the simula-
tion was started, several water molecules were added near the active site to support
the formation of stabilizing interactions. Several frames from the simulation of the
newly relaxed system W3 are taken as starting points for QM/MM unconstrained
optimizations (PM3 as QM method). None of the calculations converged in a station-
ary geometry. The structures taken from the simulations of W5 in contrast, resulted
in a converged product structure within a relaxed environment (see Figure 7.58;
pre-optimized with PM3 as QM method, optimized using B3LYP/cc-pVDZ as QM
method). Additionally, a water molecule diffused into the active site in a favourable
position for a water-bridged proton transfer.
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Abbildung 7.58: Product structure W5 within a relaxed environment, including a water mo-
lecule in the active site. The distances are given in Å.
Starting from this structure, QM/MM potential energy surfaces (PM3 as QM method)
of the backwards reaction were calculated in order to generate the structures W3 and
W4 with the additional water molecule inside the active site. All structures converged
in a subsequent unconstrained QM/MM optimization with B3LYP/cc-pVDZ as QM
method. Figure 7.59 illustrates the structures that are in a following step taken for
NEB calculations.
Abbildung 7.59: Converged structures W3, W4 and W5 with a water molecule in the active
site.
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7.4.4 Nudged Elastic Band Calculations and Potential Energy
Surfaces
Three NEB calculations were performed at the QM/MM level of theory in order to
investigate the carbamylation of Cys29 trough the isocyanate-based intermediate.
One computation included the whole mechanism, starting from structure W3 with
structure W5 as the reaction product. The calculation did, as some previous NEB cal-
culations, not converge. As the tendency of a NEB calculation to converge is indirectly
proportional to the amount of structural changes during the reaction, two calculations
describing the reaction steps from W3 to W4 and from W4 to W5 were performed.
Both calculations (B3LYP/cc-pVDZ as QM method) converged. The reaction path be-
tween W4 and W5 shows an interesting behaviour, as the structure W5 is not predicted
to be a local minimum. Suitable to the energies of the geometry optimizations (see
Figure 7.59), W5 lies 5.2 kcal/mol below W4 in the NEB path. However, a structure
similar to W5 (His199 deprotonated, inhibitor protonated) emerges with an energy of
-14.7 kcal/mol relative to W4. This structure will be called W5′.
Abbildung 7.60: Structures of W5 and W5′, the two product structures emerging from the
NEB calculation from W4 to W5.
A comparison of W5 and W5′ reveals a strong hydrogen bonding network between
His199, the water and the amino group of the inhibitor (see Figure 7.60) for structure
W5′. For W5, the respective compounds do also interact, but with increased distan-
ces. Additionally, small changes in a number of adjacent molecules contribute to the
significant energy difference between the two structures of around 10 kcal/mol. Based
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on these results, a second NEB calculation was performed, going from W4 to W5′. The
resulting reaction pathways (W3 to W4 and W4 to W5′) were again combined in one
normalized axis (see Figure 7.61) with equidistant marks (one per frame). The nucleo-
philic attack of sulfur at the isocyanate carbon has a reaction barrier of 5.1 kcal/mol.
During this step, the water molecule already starts approaching to His199 (see struc-
ture one and two in Figure 7.61). The reaction has an enthalpy of -13.0 kcal/mol and
segues nearly barrier-free into the next step, a water-bridged proton transfer. The de-
protonation of His199 and the protonation of the inhibitor through a water molecule
occurs simultaneously and results in the product structure W5′.
Abbildung 7.61: QM/MM NEB path (B3LYP/cc-pVDZ as QM method) of the carbamylation of
Cys29 through the isocyanate intermediate. NEB profiles from W3 to W4 and
from W4 to W5 (see Figure 7.52) were combined in one reaction coordinate.
The x-axis therefore contains equidistant marks, one for each frame of the
calculation.
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The reaction enthalpy for the whole reaction is -34.4 kcal/mol. The calculations thus
predict an irreversible inhibition. The significant decrease of the enthalpy for this
calculation compared to the thermodynamic calculations of the model system seems
to be mainly correlated to the adjacent water molecules. Beneath the stabilizing envi-
ronmental water molecules around the reaction center, the water inside the active site
stabilizes all reactants simultaneously.
In conclusion, the theoretical investigations showed that the inhibition mechanism of
cathepsin B with carbamate-based inhibitors is a complex procedure. The protonation
of the phenolate anion seems to be a crucial aspect, as well as several water-mediated
proton transfer reactions. The environmental water shell and adjacent amino acids
stabilize the reactive center of the system, especially concerning the carbamylation
reaction. Based on the results, the examined mechanism could take place.
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8 Nitroalkenes as Rhodesain
Inhibitors
8.1 Background and Previous Experimental Results
This chapter focuses on nitroalkenes as potential covalent reversible inhibitors for
rhodesain and provides a detailed overview of possible influencing factors on the
inhibition. The following sections are structured similarly to chapter 7. A summary
is placed directly after a short introduction to the topic. A detailed discussion of
the investigations is given subsequently. Additionally to the Nudged Elastic Band
calculations performed for the computation of certain mechanism steps, potential
energy surfaces and reaction profiles were computed. This is due to the fact that while
NEB calculations can provide reliable results concerning the mechanistic process,
they are computationally extremely demanding and do not converge in many cases.
In order to gain a detailed insight in the mechanism, both calculation types were
performed.
The irreversibly binding vinylsulfone K11777 [28] (Figure 8.1a) was taken as a basis for
the development of an inhibitor class with a similar structure but higher binding affi-
nities. Peptidyl nitroalkenes are potential compounds for this task, which was shown
in a recent publication, testing a number of dipeptidyl nitroalkenes with rhodesain,
cruzain and the cathepsins B and L. [2] The results showed that this molecule class
is able to reversibly bind to proteases with high binding affinities. The structures of
K11777 and a nitroalkene inhibitor are depicted in Figure 8.1a. The essential difference
between the inhibitors lies in the electronic properties of the warheads. The inhibition
mechanism for both compounds (Figure 8.1b) is initiated by a nucleophilic attack
of the sulfur anion from deprotonated cysteine, creating a carbanion intermediate.
Due to the pKa values of the corresponding acids (nitroalkanes: 17.2 pKa; sulfones:
29 pKa in DMSO), [170] the nitroalkene carbanion has a lower basicity than the one
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from the vinylsulfones. [2] This could result in a less exothermic second reaction step
for nitroalkenes, and might explain a reversible inhibition.
Abbildung 8.1: a) Structures of inhibitor K11777 and a dipeptidyl nitroalkene.
b) Inhibition mechanism of vinylsulfones and nitroalkenes in cysteine pro-
teases; RA = vinylsulfone, RB = nitroalkene
In a collaboration with the groups of Prof. Schirmeister in Mainz [3] and Prof. Gonza´lez
in Castello´ (Spain), [179] several nitroalkene derivatives were synthesized and investi-
gated experimentally. The compounds are shown in Figure 8.2 and 8.3 together with
excerpts from recently published experimental data listed in Table 8.2. [2] The investi-
gated compounds were compared to the irreversibly binding inhibtor K11777. Besides
variations within the recognition unit of the inhibitors, the warhead was altered at
the R2 residue (see Figure 8.2). The data contains unaltered nitroalkenes (R2 = H)
methylated nitroalkenes (R2 = CH3) and fluorinated nitroalkenes (R2 = F; see Fig-
ure 8.3). Dilution essays proved the reversibility of the inhibition for all compounds
with the exception of K11777, which was already known to be a covalent irreversible
inhibitor.
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Abbildung 8.2: Dipeptidyl nitroalkenes that were tested as rhodesain inhibitors by the group
of Prof. Schirmeister. [2]
Abbildung 8.3: Structures of synthesized fluorinated nitroalkenes in the group of Prof.
Gonza´lez. [179]
For components 11-20, the inhibitors showed a large range in their inhibition poten-
tial. The Ki values differ significantly, depending on the peptidyl residues and the
respective protease. The inhibition of the two parasitic cysteine proteases rhodesain
and cruzain was more effective for all tested agents compared to the human cathepsin
B and L. Nitroalkenes could therefore present an interesting molecule class for tro-
pical diseases and parasitic infections. Compounds 15 and 20 both show very weak
inhibition potentials for all proteases compared to the remaining nitroalkenes. Both
components have a methyl group at the α position of the double bond. This pheno-
menon is even more interesting in inhibitor 11 and 15, which only differ in this methyl
residue (Figure 8.4) but showed drastic differences in their inhibition potential. While
inhibitor 11 continuously has the lowest Ki values, inhibitor 15 shows poor values for
the tested enzymes.
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Tabelle 8.1: Ki values in [nM] for the evaluated nitroalkenes 11 to 20, the vinylsulfone K11777
and for the fluorinated nitroalkenes FGA123, FGA124 and FGA125 (K∗i /Ki).
[180]
Inhibitor Rhodesain Cruzain Cathepsin B Cathepsin L
11 0.49 0.44 8 11
12 6. 16 68 30
13 29 130 310 110
14 4.2 11 34 19.6
15 50 N.D. 6300 280
16 30 130 310 200
17 18.4 25 210 46
18 18 28 710 49
19 14 17 72 27
20 544 N.D. 3200 2020
K11777 20 N.D. 390 80
FGA123 4.1* /16.3 - - -
FGA124 2.9*/23.7 - - -
FGA125 0.5*/4.9 - - -
N.D. = not determined; *: K∗i value of the fluorinated nitroalkenes corresponds to Ki value
of the unfluorinated compounds. Ki value of the fluorinated compounds is connected to a
“sub-stepo¨f the reaction, measured in the experiments.
Abbildung 8.4: Structures of the dipeptidyl nitroalkene inhibitors 11 and 15.
Concerning the fluorinated nitroalkenes, there are different kinds of Ki-values listed
in Table 8.2, which can be explained by a peculiar aspect of the respective inhibition
behaviour that was revealed through the experiments. For all unfluorinated nitroal-
kenes, one Ki value could be measured for each inhibitor. The information included
in this parameter contains the formation of a non-covalent enzyme-inhibitor complex
(E...I, see Figure 8.5) as well as the reaction to the covalent product E I (if it is formed;
see Figure 8.5). Depending on the respective mechanism of the bond formation, this
step can contain a number of reaction steps itself. In the case of the unfluorinated
nitroalkenes, the whole reaction occurs so fast that only one Ki value was measured,
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which represents the inhibition. This case will be referred to as an “one-step“ mech-
anism. In case of the fluorinated nitroalkenes, two separate values Ki and K∗i were
measured. This case will be referred to as a “two-step“ mechanism, assigning the Ki
value to the first measured step, and the K∗i to the whole reaction. Therefore, the Ki
value of the unfluorinated nitroalkenes corresponds to the K∗i value of the fluorinated
alkenes. A “two-step“ mechanism contains an element that slows down the reaction
at some point. This element can be a longer residence time of the inhibitor in the active
site of the enzyme in the non-covalent inhibitor-enzyme complex. In a more complex
reaction mechanism where the second step (formation of the covalent product E I)
itself consists of several steps, each of these “substeps”can cause the slowdown. This
means that the Ki value of the fluorinated compounds is not necessarily assigned to
the first step (shown in Figure 8.5). The respective inhibitors are called slow-binders.
The K∗i values of the fluorinated nitroalkenes are in a range between 0.5 to 4.1 nM,
which is similar to the Ki values of the most effective unfluorinated compounds 11
and 14 (0.49 nM and 4.2 nM). The respective Ki value of the fluorianted nitroalkenes
are in a higher range (4.9-23.7 nM).
Abbildung 8.5: Scheme of a “two-step”mechanism for a covalent reversible inhibition.
The experimental data discussed above raised questions concerning the different in-
hibition potentials and different behaviour of the compounds. Therefore, a computa-
tional study was performed in this work. In chapter 8.2, the unfluorinated nitroalkene
11 (see Figure 8.2) was compared to a fluorinated derivative in rhodesain in order
to explain the connection between the slow-binding mechanism and the fluor sub-
stituent. The calculations focus on the mechanistic procedure of both compounds in
order to find the element that slows down the reaction with the fluor-derivatives. This
would thus define the part of the reaction that can be assigned to the Ki value of the
“two-step“ mechanism. In chapter 8.3 the inhibition potentials of the two inhibitors
11 and 15 were investigated in order to explain the quantitative difference in their
inhibition behaviour.
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8.2 Fluorinated Nitroalkenes
This chapter addresses the question why fluorinated nitroalkenes bind in a “two-step“
mechanism to rhodesain, while unfluorinated compounds (represented by inhibitor
11, see Figure 8.7) show an “one-step“ mechanism. As mentioned, the term “one-step“
mechanism includes a rapid reaction between enzyme and inhibitor. This entails the
formation of the complex E...I, as well as the possible reaction between the compounds
to the product E I. In the case of this mechanism, the second step consists of two stages
it self. First, the sulfur of Cys25 binds in a nucleophilic attack to the β carbon of the
warhead. The second step is the protonation at the α carbon through His197.
Abbildung 8.6: Inhibition mechanism of fluorinated nitroalkenes with cysteine proteases after
the formation of the complex E...I.
In case of the unfluorinated nitroalkene 11, all steps occur rapidly and can not be
measured as separate processes. However, the measured Ki value could also only
include the formation of the non-covalent complex if the entire reaction stops at
this point. In contrast, the mechanism of FGA123, FGA124 and FGA125 contains
an element that slows the inhibition down. Thus, a “two-step”mechanism can be
measured. In order to find this element, a computational study has been performed.
The starting point of the theoretical investigations was a docking study of inhibitor
11 in rhodesain, performed by the group of Prof. Schirmeister. This situation refers to
the formation of the non-covalent complex enzyme-inhibitor complex E...I. The fluor
atom was subsequently added into the system by hand. Hence, the two inhibitors
shown in Figure 8.7 are the focus of the computations. FGA124 and FGA124′ differ
in the functional group at the end of the recognition unit. These structural differences
are not assumed to have a crucial impact on the behaviour of the compounds.
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Abbildung 8.7: Comparison of the unfluorinated inhibitor 11 and the fluorinated inhibitor
FGA124’.
8.2.1 Summary
As mentioned in the beginning of this Chapter, a summary of all relevant results is
given, followed a detailed discussion of the respective topics.
Thermodynamics
In a first approach, thermodynamic calculations for several small model systems con-
taining the warhead structures shown in Figure 8.8 as well as a methanethiol as a
representative for cysteine were performed. In order to gain insight in a systematic
influence of the warhead or substituent on the reaction enthalpy the investigated sys-
tems include vinylsulfones and nitroalkenes along with fluorinated and unfluorinated
derivatives .
Abbildung 8.8: Structures of the investigated warheads used for thermodynamic calculations.
The calculations were performed on the SCS-MP2/aug-cc-pVDZ level of theory with
the implicit solvent model COSMO ( = 78.93). The comparison of the component
classes showed the following order in reaction enthalpies, beginning with the most
exothermic reaction:
f luorinated nitroalkenes < nitroalkenes ∼ f luorinated vinylsul f ones < vinylsul f ones
The fluorination of the compounds leads to lower reaction enthalpies by 1 to
4 kcal/mol, depending on the respective warhead structure. In addition, the positi-
on of the formed thioester group was computed for both the α and the β position of
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the double bond. The products, resulting from a nucleophilic attack at the β position,
were approximately 1 to 5 kcal/mol lower in energy compared to their α derivati-
ves. Based on the results of a bachelor thesis performed by Alexander Geis in the
group of Prof. Engels, the idea of the mechanism ending after the nucleophilic at-
tack was included in the calculations. [181] The stabilization of the resulting negatively
charged adduct via hydrogen bonding was simulated through the protonation of the
electron withdrawing group. The respective reaction enthalpies proved to be less
exothermic (8 to 15 kcal/mol) compared to the other mechanisms. Although syste-
matic differences in the reaction enthalpies, depending on the choice of the electron
withdrawing group and substituent position could be revealed, there was no indica-
tion for a “two-step”mechanism within the fluorinated compounds compared to the
unfluorinated systems.
Abbildung 8.9: Reaction scheme for the investigation of the barriers and the performance of
MD simulations.
Molecular Dynamic Simulations - Reactants
The behaviour of both compounds in the enzyme-inhibitor complex E...I was investi-
gated with help of MD simulations. The simulations in the reactant environment did
not reveal a different behavior of the two inhibitors 11 and FGA124′. Both inhibitors
stayed in a similar position inside the active site of the environment.
Reaction Profiles - Reactants
Based on the MD simulations, reaction profiles for compound 11 were compu-
ted on a QM/MM level with different QM methods. The most promising proce-
dure showed to be geometry optimizations with B3LYP/cc-pVDZ and subsequent
SCS-MP2/aug-cc-pVDZ single point energies, which is used for all further investi-
gations. From the structures of 11, 11 Int and 11 P in the active site gained from
the reaction profiles, the respective analogues FGA124′, FGA124′ Int and FGA124′ P
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were built by the manual substitution of a the α hydrogen atom with fluor. NEB
calculations of step one and two were performed for both systems in the relaxed envi-
ronment of the reactant structures. The results showed a similar energy progression,
with only approximately 1 kcal/mol deviation within the systems. The first barrier
is around 9 - 10 kcal/mol and the second barrier is 6 - 7 kcal/mol. The energy of the
fluorinated intermediate was 3 - 4 kcal/mol lower compared to 11 Int. The results did
not show a significant difference between the systems. Based on the idea that the inter-
mediate structures could have a different residence time due to a better stabilization,
MD simulations were performed for the intermediate systems.
Molecular Dynamic Simulations - Intermediates
For each system 11 Int and FGA124′ Int, MD simulations were performed. The simu-
lations revealed a different behavior of the inhibitors in the active site of the enzyme.
The unfluorinated compound showed to be in a stabilized position during the simula-
tion without significant changes. For FGA124′ Int in contrast, the active site′s His162,
which normally stabilizes the nitro compound of the warhead and is responsible for
the protonation of the double bond, rotated away from the inhibitor and the active
site Cys25. In this orientation, the protonation of the double bond through histidine is
sterically hindered. The reason for the rotation could be linked to the reduced electron
density in the warhead, caused by the fluorination. The rotation could imply a longer
residence time inside the active site for the fluorinated intermediate, as either histidine
has to rotate back or the protonation would have to take place from the unfavourable
orientation. This behaviour is able to explain the “two-step”mechanism of the fluori-
nated inhibitor, as it is caused by a longer residence time of the intermediate inside
the active site.
Reaction Profiles - Intermediates
In order to quantize the energetic differences of the herein gained results, reaction
profiles and NEB calculation were performed on a QM/MM level. As the starting point
for the calculations are the intermediate structures, step A of the mechanism had to
be calculated backwards. The profiles were computed with PM3 as QM method to
obtained structures 11, FGA124′, 11 P and FGA124′ P. The structures were optimized
with B3LYP/cc-pVDZ as QM method in order to perform NEB calculations. The NEB
reaction path of compound 11 in both environments (reactant and intermediate) was
compared. Logically, the intermediate structure 11 Int was stabilized better in the
intermediate environment. Additionally, the first reaction barrier is 4.3 kcal/mol lower
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within the intermediate environment. As the NEB calculations for the fluorinated
systems did not converge, reaction profiles were computed for both orientations of
histidine with relaxed scans. For the sterically hindered system, the reaction barrier
of the protonation (step B) exceeds 30 kcal/mol and would therefore not take place.
The other orientation shows a barrier of 6.8 kcal/mol for the protonation, which is
comparable to the unfluorinated system. In most cases during the simulations, His162
coordinated to the nitro group of the warhead.
Conclusions
The results explain the significantly different behaviour of the fluorinated intermediate
system compared to 11 Int. Due to the decreased electron density in FGA124′ Int, the
non-covalent interactions of the warhead with the surrounding amino acids lead to
a less fixed orientation of His162. The “two-step”mechanism of FGA124′ can thus
occur from longer residence time of the intermediate inside the active site, as the
histidine ring has to rotate back in its original position before the protonation can take
place. The NEB calculations together with the low Ki value of inhibitor 11 indicate
that the inhibition reaction for this component includes both, the formation of the
non-covalent enzyme-inhibitor complex and the formation of the reaction product.
8.2.2 Thermodynamics
The general influence of the fluor substituent on the electronic structure of the system
was investigated by means of thermodynamic calculations. In order to use a more
reliable and more computationally demanding QM method, the systems were scaled
down. The inhibitors were reduced to their warhead and cysteine was represented by
methanethiol. The computations did not only include fluorinated and unfluorinated
nitroalkenes, but also vinylsulfones with and without a fluor substituent. A compa-
rison of the different systems can give rise to systematical effects of the warheads
and substituents. Five inhibitor warheads (shown in Figure 8.10) were included in the
calculations.
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Abbildung 8.10: Structures of the investigated warheads, used for thermodynamic calculati-
ons.
Based on results of Alexander Geis and Bernd Engels [181], the idea of an altered
mechanism arose. Therein, the protonation in the second step would not take place.
Instead, the electron density of the negatively charged intermediate, resulting from
the nucleophilic attack, is stabilized through the mesomeric effect of the electron
withdrawing group of the warhead and hydrogen bonding with adjacent amino
acids and water molecules (see Figure 8.11). To simulate this mechanism within the
framework of thermodynamic calculations, a proton was added to the NO2-group
(see Figure 8.12).
Abbildung 8.11: Structure of inhibitor FGA124’ in rhodesain (crystal structure 2P7U [28]), taken
from QM/MM calculations of Alexander Geis. [181]
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Abbildung 8.12: Reactant and product structures of the thermodynamic calculations within a
model system, containing the warhead and methanethiole for a) the nucleo-
philic attack at the α carbon, b) the nucleophilic attack at the β carbon and c)
the protonation at the nitro group of the warhead.
Tabelle 8.2: Reaction enthalpies of the model systems for the fluorinated and unfluorina-
ted warheads. Calculations were performed on the SCS-MP2/aug-cc-pVDZ level,
including an implicit solvent model to account for polarizable solvent effects;
energies are given in kcal/mol.
system (reactants) 11 A 11 B 11 C 15 A 15 B 15 C
reaction enthalpy -12.1 -15.1 -2.2 -10.4 15.0 -5.9
system (reactants) FGA124’ A FGA124’ B FGA124’ C VS A VS B VS F A VS F B
reaction enthalpy -16.3 -19.9 -2.2 -9.7 -10.1 -11.7 -10.6
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The protonation of the electron withdrawing group is energetically not favoured
compared to the protonation of the double bond. The respective reaction enthalpies
are approximately 10 kcal/mol higher compared to the respective enthalpies of the
structures without a protonated electron withdrawing group. From a chemical point
of view, this outcome is unsurprising. Additionally, the proposed mechanism does not
include an actual protonation of the electron withdrawing group. The systems with
the protonation at α position are in all cases higher in energy (about 1 - 5 kcal/mol)
than the β protonated systems. The fluorination of the warheads of inhibitor 11 and
15 lowers the reaction enthalpy approximately by 6.0 kcal/mol, except for the reaction
pathways with 11 C and 15 C. For the vinylsulfones, the stabilization of the products
by a fluorination is only around 1 kcal/mol. Compared to the respective nitroalkene
systems, the vinylsulfones also have systematically higher reaction enthalpies.
Based on these thermodynamic results, the measured “two-stepmechanism of the
fluor-substituted systems cannot be immediately explained. The fact that a fluor sub-
stituent lowers the reaction enthalpies would instead indicate a faster reaction due
to a higher thermodynamic driving force. The concept of the negative charged inter-
mediate being stabilized through hydrogen bonding could, however, entail a longer
residence time of the covalent intermediate before the reaction continues. If the fluo-
rinated and unfluorinated intermediates show a different behaviour in the active site
of the enzyme, this could imply a difference in the inhibition and possibly explain
the slow-binding mechanism of FGA123, FGA124 and FGA125. To address this is-
sue, the systems have subsequently been enlarged and investigated in an enzymatic
environment.
8.2.3 Molecular Dynamic Simulations - Reactants
The orientation and behaviour of the inhibitors 11 and FGA124′ were investigated
using MD simulations. The starting structure of inhibitor 11 was taken from docking
studies from the group of Prof. Schirmeister in Mainz. [3] The structure of FGA124′
was obtained by manual substitution of the α hydrogen with a fluor atom. Both
structures were relaxed and prepared for the simulations as described in chapter 6.
The simulations run over a time of 10 ns with time steps of 1 fs. A number of structural
aspects including dihedral angels and distances, were compared for both inhibitors
in order to investigate the orientation throughout the simulation. Neither revealed
any differences of the compounds in the active site. As a representative example, the
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distance between the Cys25 sulfur and the β carbon of the double bond is depicted in
Figure 8.13.
Abbildung 8.13: Distance between the active site sulfur S and the β carbon of the warheads
throughout the MD simulations for inhibitor 11 and FGA124′ in rhodesain.
As the simulations did not give a final answer to the question of the different behavior
of the fluorinated and unfluorinated compound, the energetic progress of the reaction
pathway is investigated as the next step.
8.2.4 Reaction Profiles - Reactants
In order to get insight into the energetic barriers of the reaction, the mechanisms
were computed via relaxed scans and Nudged Elastic Band calculations. For the for-
mer, constrained optimizations were performed, which implies that selected degrees
of freedom are to be frozen and varied for a defined set of values during the op-
timization. Depending on the chosen variables, different desired mechanisms can
be simulated. NEB calculations automatically compute a reaction path between two
structures. In order to perform this type of calculation, converged reactant and product
structures are required. All calculations are performed using the QM/MM approach
with different AMBER force fields. For more detailed information see chapter 6.
In the following, the procedure for the calculation of the reaction profiles and NEB
calculations will be elucidated briefly. The investigation starts from a structure of com-
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pound 11, selected from MD simulations. This structure was taken for the computation
of the reaction pathways of step A and B (see Figure 8.15) with different QM/MM me-
thods in order to find the most promising method for further calculations. Based on
the structures of inhibitor 11, the intermediate 11 Int and the product 11 P (achieved
from the relaxed scan calculations, the fluorinated analogues FGA124′, FGA124′ Int
and FGA124′ P) were constructed by the manual substitution of the respective hydro-
gen atom with fluor. Unconstrained geometry optimizations were performed for all
six systems in preparation of the NEB calculations. The final step is the performance
of NEB calculations of step A and B for both systems. Although NEB calculations
provide detailed information about the reaction mechanism of a system, the probabi-
lity of convergence strongly depends on the amount of structural changes during the
reaction. Therefore, both, reaction profiles and NEB calculations were performed and
evaluated in this work.
Abbildung 8.14: Reaction scheme of the mechanistic steps used for the calculations of energy
profile and NEB calculations.
Reaction Profiles
Reaction profiles of the unfluorinated inhibitor 11 in rhodesain were computed. The
starting structure was obtained from docking studies (performed by the group of
Prof. Schirmeister). Subsequent MD Simulations were used to relax the system′s envi-
ronment. The structure which was selected from the simulations was optimized and
subsequently varied with respect to the distance between the sulfur of Cys25 and the
β carbon of the inhibitor (step A in Figure 8.14). The acquired structure of the interme-
diate, 11 Int, was taken as a starting point for the simulation of the second mechanistic
step. To this end, the distance between the α carbon of the double bond and the His162
hydrogen was used as reaction coordinate (step B in Figure 8.14). The resulting reac-
tion profile combines both reaction coordinates in one axis. The QM/MM calculations
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were performed using B3LYP/cc-pVDZ as QM method. QM/MM single point calcu-
lations were subsequently performed on the geometries using B3LYP/aug-cc-pVDZ
and SCS-MP2/aug-cc-pDVZ as QM methods. The results are shown in Figure 8.15.
Abbildung 8.15: Reaction profile (relaxed scan) of the inhibition of rhodesaine by compound
11. QM/MM calculations were performed with B3LYP/cc-pVDZ (optimiza-
tion), B3LYP/aug-cc-pVDZ (single point) and SCS-MP2/aug-cc-pVDZ (singe
point) as QM methods.
The nitro compound of the warhead continuously interacts with two water molecules
as well as Gln19. The histidine ring rotates during the reaction. In the beginning, it
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faces cysteine with a distance of 2.1 Å between hydrogen and sulfur (see Figure 8.15).
After the nucleophilic attack at the double bond, the positively charged histidine
turns towards the increased electron density at the NO2 compound and stabilizes the
negative charge along with glutamine and water. In step B of the reaction, the five-
membered ring rotates back towards the double bond, where the protonation takes
place. At the end of the reaction (reaction coordinate is 1.0), histidine has a orientation
similar to the one in the beginning (reaction coordinate is 0.0).
The profiles shown in Figure 8.15 display differences in energies and barrier heights
within the applied methods. With SCS-MP2/aug-cc-pVDZ assumed to be the most ac-
curate method, the first reaction barrier ∆∆E1 is underestimated by around 4 kcal/mol
within the B3LYP/aug-cc-pVDZ calculations. The second barrier only varies around
2 - 3 kcal/mol between the methods, whereas B3LYP/cc-pVDZ predicts the highest
barrier. A more significant difference lies in the stabilization of the intermediate
11 Int, where the energies of B3LYP with the non-diffuse basis set lie 5 - 6 kcal/mol
above the other methods. The resulting reaction energies are in a broad range between
-4.6 kcal/mol and -13.5 kcal/mol, which nevertheless allows for a covalent reversible
inhibition in all cases. As the qualitative pathway of the profiles are in accordance, all
further calculations follow the same pattern, where B3LYP/cc-pVDZ is taken for geo-
metry optimizations, while the energies are calculated with SCS-MP2/aug-cc-pVDZ
single point energies (B3LYP/cc-pVDZ//SCS-MP2/aug-cc-pVDZ).
NEB Calculations
Abbildung 8.16: Reaction scheme
As mentioned above, the structures of inhibitor 11, the intermediate 11 Int and
product 11 P were used as a reference to construct the respective fluorinated sys-
tems FGA124′, FGA124′ Int and FGA124′ P. The reactant, intermediate and pro-
duct structures of all systems were relaxed with unconstrained optimizations using
B3LYP/cc-pVDZ as the QM method. The resulting structures were used as a starting
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and end point for carrying out NEB calculations. Three calculations were performed
for both systems. The first reaction step is calculated using 11 / FGA124′ as starting
and 11 Int / FGA124′ Int as final structures. For the second step, the reaction starts
with the intermediate structures and ends with the products 11 P and FGA124′ P.
Furthermore, NEB calculations of the entire reaction with the reactants as starting and
products as end point were performed. The latter did non converge, as the structural
changes inside the systems are too significant. The results of the individual reaction
steps were combined in one normed reaction coordinate with one dot per frame for
each system. They are depicted in Figure 8.17.
Abbildung 8.17: Resulting reaction path from NEB calculations of reaction step 1 and 2 for
inhibitor 11 and FGA124′. The NEB calculations (QM/MM) were performed
with B3LYP/cc-pVDZ as QM method. Subsequent single point calculati-
ons(QM/MM) were performed with SCS-MP2/aug-cc-pVDZ as QM method.
The results show that the fluorination of the system does not have a significant impact
on the reaction barriers. They only differ by 0.7 - 0.9 kcal/mol. The intermediate
structure of FGA124′ is about 3 kcal/mol lower in energy compared to 11 Int. The
reaction enthalpies are in a similar range around -14 kcal/mol. In contrast to the
computed relaxed scans (Figure 8.15), the first reaction barrier is lower than the second
one (around 2 kcal/mol). The geometrical changes during the reaction are similar for
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both systems. The comparison showed no significant differences. Figure 8.18 displays
selected structures from the NEB calculation of inhibitor 11. Besides the change of
the coordinates involved in the reaction, the histidine ring performs a rotational
movement, as already detected within the relaxed scan calculations. In the beginning,
the positively charged NH group coordinates to Cys25. During the nucleophilic attack,
it turns to the nitro compound of the warhead, indicating a strong interaction due to
a hydrogen-oxygen distance of only 1.5 Å for structure 15. The movement of the five-
membered ring of His162 continues towards the opposite direction, back to Cys25,
while a protonation of the double bond takes place. The electron withdrawing NO2
compound is again stabilized by two water molecules and the amino acid Gln19.
Abbildung 8.18: NEB path (QM/MM) of inhibitor 11 with exemplary structures. Calculations
were performed with B3LYP/cc-pVDZ as QM method and the subsequent
single point calculations with SCS-MP2/aug-cc-pVDZ as QM method.
As the structural progressions and energies are similar for both systems, the calcula-
tions do not indicate a significant difference between the inhibition potentials. Next,
MD simulations of the intermediate systems 11 Int and FGA124′ Int were performed.
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Due to the fact that the calculation of an NEB pathway is based on one start and one
final structure, a possible reorientation of the environment is neglected. In some cases,
the influence of the environment can have a significant impact on the reaction energies
and barriers. Based on this consideration, additional MD simulations were performed
in order to relax the environment around the structures of 11 Int and FGA124′ Int. In
the aforementioned environment (reactant environment), the intermediates differ by
up to 3.0 kcal/mol. The influence of the enzymatic environment and water molecules
could enlarge this deviation or reveal a different behavior of the systems throughout
the simulation.
8.2.5 Molecular Dynamic Simulations - Intermediates
MD simulations were performed with the intermediate structures inside the active
site of rhodesain. The simulation time was 8 ns for each system with time steps of
1 fs. Several parameters were compared, out of which the distance between His162
and the α carbon and the dihedral between the five-membered ring and the double
bond showed a significantly different behaviour between the systems. During the
simulation of the fluorinated compound, His162 rotates out the active site and away
from the double bond and Cys25. In this orientation, the function as a proton donor
is sterically hindered.
Abbildung 8.19: Dihedral angle Φ and distance r of the intermediates 11 Int and FGA124′ Int
during MD simulations.
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Before the rotation, the inhibitors have a similar orientation in the active site of the
enzyme. The distance between the α carbon and the histidine δ proton fluctuates
around 2 Å for both systems. The same holds for the dihedral angle Φ between the
ring and the double bond, which fluctuates by approximately 75◦. The rotation of the
histidine residue drastically changes these parameters for the fluorinated system.
In order to investigate the origin of this behavior, the active sites of both systems were
compared, focusing on the arrangement and interactions of histidine (Figure 8.20).
Within cysteine proteases, the active site′s histidine is normally stabilized by the in-
teraction with the active site cysteine and an asparagine residue via hydrogen bonding
(see chapter 3.1.2 and Figure 8.20). As cysteine is covalently bound to the warhead,
the former interaction does not take place within the intermediate structures. For
11 Int, two major interactions contribute to the stabilization of histidine. The first one
is between the  amino group of histidine and asparagine. Additionally, the δ amino
group of the positively charged histidine ring faces towards the nitro compound of
the warhead creating another stabilizing interaction. In case of FGA124′ inside, the δ
hydrogen of histidine does in contrast face towards the α atom of the double bond. As
shown in Figure 8.19, the distance to theα carbon is, however, similar for both systems.
The interaction with asparagine only takes place before the ring rotates. The induc-
tive effect of the halogen substituent decreases the electron density of the warhead,
including the NO2 compound. As a result, the non-covalent interactions between the
δ amino group of the histidine ring and the warhead are weaker compared to the
unfluorinated system. This phenomenon could cause a rotation of the less stabilized
ring. Concerning the experimental data, the two separately measured steps are the
formation of the non-covalent enzyme-inhibitor complex together with the forma-
tion of the sulfur-carbon bond between Cys29 and the nitroalkene. The subsequent
reorientation of the inhibitor causes the slowdown of the reaction.
Abbildung 8.20: Exemplary structures of the orientations of intermediate 11 Int and
FGA124′ Int during the MD simulation. Distances are given in in Å.
132
8.2. FLUORINATED NITROALKENES
8.2.6 Reaction Profiles - Intermediates
The effect on the reaction path by structural changes in the active site and the enzymatic
environment was investigated with relaxed scans and NEB calculations in the relaxed
environment of the intermediates. The starting structures for these investigations were
taken from MD simulations as described in chapter 8.2.5. Within the simulations,
containing the intermediate structures of the systems, the environment could adapt
to the structural changes of the QM area (compared to the structural arrangement of
the reactants). The following investigations are all based on the system containing
this newly adapted environment. The starting structures are shown in Figure 8.20,
whereas for the fluorinated system, two structures were investigated. In one structure,
the histidine ring is in the orientation it had before the rotation and the other structure
contains the ring after the rotation.
The unfluorinated system was investigated via NEB calculations in the newly adapted
environment. Starting from the intermediate structure 11 Int (depicted in Figure 8.20)
two relaxed scans were performed on QM/MM level with PM3 as QM method. The
goal thereof was to obtain the reactant and product structures of the reaction in
this environment. The first reaction step (nucleophilic attack) had to be calculated
backwards, as the computation started with an intermediate structure. The resulting
structures of reactant 11, intermediate 11 Int and product 11 P were subsequently
optimized (QM/MM) with B3LYP/cc-pVDZ as the QM method to yield the starting
and end structures for the subsequent NEB calculations. Two calculations were per-
formed (one for each reaction step) and afterwards combined in one normed reaction
coordinate with equidistant marks, one per frame. In Figure 8.21, the NEB pathways
for inhibitor 11 inside the two relaxed environments are depicted. Compared to the
reaction pathway of inhibitor 11 in the reactant environment, the reaction enthalpy
is now 2.4 kcal/mol lower in energy. Better stabilization of the intermediate structure
(4.3 kcal/mol) is an expected consequence of the MD simulation and the therefore
relaxed environment around the intermediate structures. The second reaction barrier
is similar for both environments, as is the barrier of the reaction from the intermediate
to the reactant structure (backwards). The first barrier of the reaction in the interme-
diate environment is by 4.3 kcal/mol lower compared to its analogue in the reactant
environment.
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Abbildung 8.21: NEB path (QM/MM) of inhibitor 11 in two different environments adapted to
the reactant structure (reactant environment) and to the intermediate struc-
ture (intermediate environment). Geometry optimizations were performed
with B3LYP/cc-pVDZ as the QM method and the subsequent single point
calculations utilized SCS-MP2/aug-cc-pVDZ as QM methods.
As the NEB calculations did not converge for the fluorinated system in the in-
termediate environment, relaxed scans of the second reaction step (protonation)
were performed in order to quantize the influence of the histidine rotation on
the reaction barrier. One calculation started with the histidine before the rotation
(FGA124′ Int inside; Figure 8.20) and one after the rotation (FGA124′ Int outside;
Figure 8.20).
The profile, shown in Figure 8.22, has a reaction barrier of 6.8 kcal/mol. This barrier is
comparable to the one of the unfluorinated systems.
The reaction barrier for the system including a histidine which is twisted out of the
active site, shown in Figure 8.23, is 32.1 kcal/mol high in energy. Due to the orientation
of the ring, a protonation of the double bond is very unlikely, with regard to the sterical
and energetic barriers. This result implies that it is necessary for the histidine to rotate
back into its original orientation before the reaction can progress.
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Abbildung 8.22: Reaction profile of the warhead protonation by histidine before its rotation
out of the active side. Relaxed scan calculations (QM/MM) were performed
with B3LYP/cc-pVDZ with subsequent SCS-MP2/aug-cc-pVDZ single point
calcualtions as QM method. Distances are given in Å.
Abbildung 8.23: Reaction profile of the warhead protonation by histidine after its rotation
out of the active side. Relaxed scan calculations (QM/MM) were performed
with B3LYP/cc-pVDZ with subsequent SCS-MP2/aug-cc-pVDZ single point
calculations as QM methods. Distances are given in Å.
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Conclusion
The herein discussed results concerning fluorinated and unfluorinated nitroalkenes
indicate a weaker interaction between His162 and the warhead for FGA124’ in gene-
ral, most likely caused by the reduced electron density in the halogenated warhead.
This is especially the case for the intermediate structure FGA124’ Int, as the diffuse
negative charge of Cys25 does not contribute to the stabilization of His162. This lower
interaction can cause the five-membered histidine ring to rotate into a more distant
orientation to the double bond and thus cause an extremely high energy barrier for the
protonation. The slow binding behavior of fluorinated nitroalkenes can be explained
by the necessity of the histidine ring to rotate back before the inhibition can proceed.
This entails an extension of the residence time of the fluorinated intermediate struc-
ture. The comparable barrier heights of the fluorinated system, where the histidine is
in a favourable position compared to the unfluorinated system, is able to explain the
similar inhibition potentials, measured by the group of Prof. Schirmeister. [3]
8.2.7 Beta Fluorinated Nitroalkenes
As an additional aspect, the inhibition reaction of nitroalkenes in rhodesain was
investigated with an inhibitor that was fluorinated at the β carbon of the nitroalkene
double bond (see Figure 8.24).
Abbildung 8.24: Structures of inhibitor FGA124′ and FGA124’ beta.
The structure of the new inhibitor was obtained by the manual preparation of inhibi-
tor 11 inside the active site of rhodesain. The system was optimized on QM/MM
level using B3LYP/cc-pVDZ as QM method. The obtained relaxed structure was
taken for the performance of relaxed scan calculations to create the intermediate
and product structure of the system. Based on those structures, QM/MM NEB cal-
culations were performed using B3LYP/cc-pVDZ as QM method, with subsequent
SCS-MP2/aug-cc-pVDZ singe point calculations. Two NEB calculations were per-
formed, one for the nucleophilic attack of Cys25 at the β carbon and one for the
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protonation of the double bond at α position. Figure 8.25 shows the resulting NEB
path, combining the two calculations in one normed reaction coordinate.
Abbildung 8.25: NEB path (QM/MM) of the α and β fluorinated inhibitors FGA124′ and
FGA124′ beta in rhodesain. The calculations were performed with B3LYP/cc-
pVDZ and subsequent single point calculations with SCS-MP2/aug-cc-pVDZ
as QM methods.
The first reaction barrier of the β fluorinated compound is nearly 0.0 kcal/mol. This
result is expected, as fluor decreases the electron density at the β carbon, making
it a stronger electrophile. The second barrier (8.4 kcal/mol) is in the same energetic
range as the respective barriers of the unfluorinated and α fluorinated systems. In
collaboration with the group of Prof. Schirmeister, the compounds are planned to be
synthesized in the future.
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8.3 Theoretical Studies on Inhibitor 11 and 15
8.3.1 Summary
As mentioned in the beginning of this chapter, a summary of all relevant results is
given, followed by a detailed discussion of the respective topics.
The objective of the following considerations is to determine the origin of the dif-
ferent behaviour of the two inhibitors 11 and 15, shown in Figure 8.26. With the
help of a model system containing only the warhead and a cysteine representative
(methanethiol), thermodynamic calculations were performed using DFT approaches
(B3LYP/aug-cc-pVDZ). The computed reaction showed a slight energetic favour for
the inhibition of compound 11.
Abbildung 8.26: Structures of the dipeptidyl nitroalkene inhibitors 11 and 15.
In a second approach, potential energy surfaces were calculated with the above men-
tioned model systems at the QM level of theory (B3LYP/aug-cc-pVDZ). The possibility
of a histidine-independent mechanism was investigated. The nucleophilic attack and
protonation were thus both assisted by the methanethiol in this mechanism. Both
reaction barriers exceed 40 kcal/mol. The reactions would thus not take place under
the given conditions. As the comparison of the electronic properties of the warheads
did not yield sufficient answers to the question of the different inhibition behavior of
the components, the orientation of the inhibitors inside the active site of rhodesain
were compared in a second step. The group of Prof. Schirmeister from Mainz per-
formed covalent and non-covalent docking for both inhibitors in rhodesain (crystal
structure 2P7U [28]). All investigated docking poses had the same orientation of the
inhibitors, with the warhead being placed near the active site′s dyade. In most cases,
the warhead is stabilized by hydrogen bonding with the two adjacent amino acids
Trp184 and Gln19. The peptidyl backbones of all inhibitors lie in the active site cleft,
also stabilized via hydrogen bonds through amino acids Asp161 and Gly66. Although
slight differences appeared within the studies and inhibitor 11 is again favoured in the
orientation and interaction contributions, no significant connection could be drawn to
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the methyl group at the α position of inhibitor 15. In a third attempt, MD simulations
were performed for both systems in order to compare the behaviour and stabilization
of the inhibitors over a certain period of time. Ten simulations are performed for each
system, with a simulation time of 8 ns each and time steps of 1 fs. These trajectories
showed significant differences between the inhibitors. The distance between the β
carbon of the warhead and the sulfur of the active site′s cysteine was compared for all
MD runs and both systems. While for compound 11 this parameter stays in a range
smaller than 5Å for seven of the ten simulations, compound 15 exceeds this range in
seven of ten runs. The origin of this behaviour of compound 15 is assumed to result
from the steric arrangement of the methyl group at the α carbon relative to the second
methyl residue of the inhibitor. In the beginning of the simulations, the two residues
face in the same direction (similar to a “syn” orientation). This orientation is sterically
not favoured. A comparison of the dihedral angle between the residues and the di-
stances between Cys25 and the double bond clearly showed that if the methyl groups
rotate towards an “anti”position, the warhead is twisted out of the active site. As this
steric aspect does not hold for component 11, this explains the difference between
compound 11 and 15.
8.3.2 Thermodynamics
In a first attempt, the electronic properties of the warheads from both inhibitors were
compared within a model system. The system consists of the respective warhead
and double bond (see Figure 8.27), as well as methanethiol as a model representing
cysteine. Thermodynamic QM calculations with B3LYP/aug-cc-pVDZ were performed
in order to quantify the differences between the attack of the sulfur atom at both
carbon atoms of the double bond and the following protonation. The continuous
solvation model COSMO (=78.39) was additionally included in order to include
possible polarization effects of the environment. The usage of a diffuse basis set
is needed to describe the involved sulfur atom satisfactorily. The results of these
calculations are depicted in Figure 8.28.
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Abbildung 8.27: Inhibition reaction of the model system representing the reaction of two
nitroalkene inhibitors with the active site′s cysteine of rhodesain.
Abbildung 8.28: Results for the thermodynamic calculations of the reaction between the war-
heads 11′ and 15′ and the cysteine representative methanethiol. The calcu-
lations were performed with B3LYP/aug-cc-pVDZ and COSMO ( = 78.39).
Energies are given in kcal/mol.
The nucleophilic attack at the β carbon atom is more favourable for both compounds
compared to the corresponding reaction at the α carbon (2.1 kcal/mol for 11′ and
2.2 kcal/mol for 15′). Additionally, the reaction enthalpies for compound 11 are ener-
getically favoured. However, the electronic properties of the warheads do not seem
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to be the origin of the different performance of the inhibitors, at least when they are
computed in an isolated, non-enzymatic environment.
8.3.3 Potential Energy Surfaces of an Alternative Pathway
The thermodynamic results of the model systems did not reveal significant diffe-
rences between the two inhibitors. In order to get insight into the reaction barriers,
potential energy surfaces (PES) of the model systems were performed using DFT
(B3LYP/aug-cc-pVDZ) with an implicit solvation model (COSMO; = 78.39). The idea
of a histidine independent mechanism was investigated by including only a methanet-
hiol as representative for the protonated cysteine residue and the inhibitor warheads
(structure 11′ and 15′ in Figure 8.27). In this mechanism, the nucleophilic attack and
protonation are both performed by the methanethiol.
The barriers for this mechanism are 31.6 kcal/mol for 11′ and 30.6 kcal/mol for 15′. This
result clearly shows that a syn-addition of a protonated cysteine residue will not take
place. Additionally, the two systems show a very similar behaviour. As the pKa value
of the thiol group can be influenced by the enzymatic environment, the barriers could
decrease, if the whole system is included in the calculations. However, the cysteine side
chain is a weak acid and the energies of the barriers are in an energetic area, implying
the enlargement of the system to not be promising. The participation of histidine
as a proton donor seems to be a crucial part of the mechanism. For both systems,
an intermediate (Int 11 and Int 15 in Figure 8.29 and 8.30) was formed during the
reaction through the protonation of the NO2 group. In the enzymatic environment, this
electron withdrawing group is stabilized via hydrogen bonding and this intermediate
is unlikely to play a crucial role in the inhibition mechanism. Regarding the small
influence of the methyl group on the electronic structure of inhibitor 15, however,
a more detailed investigation of the energetic barriers are not in the scope of this
work. Instead, steric effects and the interaction of the inhibitors with the enzymatic
environment are compared for both inhibitors.
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Abbildung 8.29: Potential energy surface of the model system with methanethiol as nucleo-
phile and proton donor for inhibitor 11′.
Abbildung 8.30: Potential energy surface of the model system with methanethiol as nucleo-
phile and proton donor for inhibitor 15′.
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8.3.4 Docking Studies
The similar electronic properties of the warheads are not unusual, keeping their small
structural difference in mind. The different behaviour of the compounds could instead
result from a different orientation inside the active site of the enzyme. Therefore,
docking studies, performed by the group of Prof. Schirmeister in Mainz, need to
be evaluated and compared. [3] Compound 11 and 15 were docked covalently and
non-covalently against rhodesain (crystal structure 2P7U [28]). The three structures
with the highest ratings of each docking study were analyzed. Figure 8.31 shows a
superimposition of the best non-covalent docking structures of 11 and 15 in the active
site of rhodesain.
Abbildung 8.31: Results from the non-covalent docking of inhibitor 11 (left) and 15 (right) in
rhodesain (crystal structure 2P7U [28]).
The enzymatic environment around the inhibitor (within a radius of 5 Å) is plotted
as a surface. The red color represents residues, which form polar non-covalent in-
teractions with the inhibitor, the green shaped surface are non-polar residues. Both
inhibitors have the same orientation in all docking poses. The warhead and the re-
cognition unit of the inhibitors lie inside the active site cleft and are stabilized by
polar interactions. In Figure 8.32, the respective interacting amino acids are explicitly
shown. The aromatic ring from the benzyl carbamate at the back end of the inhibitors
is not positioned rigidly in the hydrophilic pocket. Its orientation differs within the
different docking structures. However, this does not have an impact on the settled
orientation of the inhibitor backbone and the position of the warhead. In Table 8.4, the
polar non-covalent interactions of both inhibitors of the non-covalent docking study
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are summarized and compared to those of K11777. The contributions are separated
into polar interactions between enzyme and warhead (1 - 3) and polar interactions
with the inhibitor backbone (4 - 6). All interactions are identical within the investiga-
ted inhibitors, with the exception of a hydrogen bond between the amino group of
the backbone of Cys25 and the NO2 group of inhibitor 11 and 15, that only occurs in
three of the docked structures.
Abbildung 8.32: Scheme of possible non-covalent polar interactions between the inhibitors
(11: R = H; 15: R = Me) and the active site of rhodesain.
These structures, namely 11 1, 15 1 and 15 2 show slight rotations of the warhead
towards the cysteine backbone (see Figure 8.32). Through the rotation, the double
bond of the warhead is pushed away from the active site Cys25. This orientation is
unfavourable for the attack of the sulfur at the double bond. However, the resulting
difference in the sulfur-β carbon distance of the two orientations is only about 1 Å. Fur-
thermore, there are docking structures for both inhibitors, showing more favourable
orientations. Thus, this issue could have only a small impact on the inhibition.
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Tabelle 8.3: Contributing non-covalent polar interactions for non-covalent docking poses. As-
signment of the interaction is referring to Figure 8.32.
1 2 3 4 5 6
K11777 x x x x x
11 1 x x x x x x
11 2 x x x x x
11 3 x x x x x
15 1 x x x x x x
15 2 x x x x x x
15 3 x x x x x
Another interesting aspect to be investigated is the orientation of both inhibitors,
after the inhibition has taken place. For this purpose, covalent docking structures of
compound 11 and 15 in rhodesain are analyzed. Through the covalent bond between
Cys25 and the double bond, the inhibitors were closer to the active site, and steric
effects gain impact on the orientation. Figure 8.33 shows the overlaid covalent docking
structures of both inhibitors.
Abbildung 8.33: Results from the covalent docking of inhibitor 11 (right) and 15 (left) in
rhodesain (crystal structure 2P7U [28]).
The general orientation of all inhibitors was similar. The recognition unit lies inside
a network of polar interactions with the enzyme and the warhead is faced in the
same direction. Still, in the covalently docked structures, more differences between
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11 and 15 are found than within the non-covalently docked structures. The back end
of the compounds is twisted in some cases, resulting in interchanging positions of
the aromatic rings. The concerned structures lack interaction 6 (see Table 8.4), which
is the interaction of the hydrogen bond between the amino group of the inhibitor
backbone with Gly66 (see Figure 8.33). This orientation interchange does, however,
take place for both inhibitors and seems to be independent of the methyl group at the
α position of the double bond. On one of the structures of inhibitor 15 (15 3), the whole
backbone of the molecule is rotated in a way that renders any polar interaction with
the enzyme unfeasible. Regarding the warhead, three different orientations emerge.
The first equals the orientation of the warhead from K11777, forming hydrogen bonds
with the amino acids Gln19 and Trp184. This orientation is close to the non-covalently
docked results and holds for the structures 11 2, 15 2 and 15 3 (see Table 8.4). The
second orientation includes an additional hydrogen bond between the warhead and
the backbone of the active site Cys25. This orientation occurs in structure 11 1 and
is known from the non-covalent docking poses. In this case, the double bond of the
warhead is slightly inclined away from the active site. The third orientation is the
most unfavourable one, as the warhead and double bond are twisted out of the active
site, and thus no stabilization can take place. Again, this orientation occurs for both
inhibitors (11 3 and 15 1) and thus the methyl group of compound 15 at the α position
has no influence on it.
Tabelle 8.4: Contributing covalent polar interactions for non-covalent docking poses. Assi-
gnment of the interaction is referring to Figure 8.32.
1 2 3 4 5 6
K11777 x x x x x
11 1 x x x x x x
11 2 x x x x
11 3 x x
15 1 x x x
15 2 x x x x
15 3 x x
Although inhibitor 11 shows statistically slightly better results in all aspects discussed
above, no significant differences can be observed within the docking structures of the
compounds. The orientation of the inhibitors inside the active site does hence not seem
to have an influence on the different inhibition potentials. The focus was therefore set
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on another aspect, namely the residence time of the inhibitors in the active site. This
behaviour was investigated via MD simulations.
8.3.5 Molecular Dynamic Simulations
For each inhibitor, ten simulations were computed, each running over a time of 8 ns
with time steps of 1 fs. The starting structure of the simulations was taken from the
docking study of the non-covalently docked inhibitors. The systems were prepared
as described in chapter 6. As a first descriptor, the distance between the active site
cysteine sulfur and the β-carbon C2 of the double bond was compared for all MD runs.
The simulations (see Figure 8.34) revealed a differing behaviour of the inhibitors. For
compound 11, the distance between S and C2 increases to several Å(>> 5Å) in three
of the ten simulations. Therefore, the warhead is placed outside of the reaction range
of the active site amino acid. For compound 15, this behaviour is found in seven out
of ten times. To get a more detailed insight into this phenomenon, further descriptors
have been investigated. The polar interactions between the inhibitor and the active
site amino acids (see Figure 8.32), were compared for all simulations.
Abbildung 8.34: Distance between the active site sulfur S and the β carbon C2 of the warhead
throughout all MD simulations for both inhibitors.
The results do not reveal the origin of the different behaviour of the inhibitors, but
show that they never completely leave the active site cleft. The rear part of the
inhibitor′s backbone stays inside the active site, while in some cases the frontal part,
including the warhead, rotates out. A closer investigation of the warhead orienta-
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tions leads to the observation of a peculiar behaviour of inhibitor 15 throughout all
simulations.
Abbildung 8.35: a) Orientation of the methyl groups of inhibitor 15 for the three best non-
covalent docking poses; b) Two different orientations of the methyl groups
of inhibitors 15, occurring throughout the MD simulations.
In the non-covalent docking poses of 15, the orientation of the methyl group of the
inhibitor backbone relative to the methyl group at the α position matched for all
poses (see Figure 8.35a). The two residues point in the same direction. This orien-
tation will be called syn-orientation and is sterically not favoured. In each of the
simulations, in which the warhead leaves the active side cleft (r(S-C2) > 5Å), the two
methyl groups rotate apart from each other. This results in a sterically more favour-
able “antiorientation, which entails a twist of the warhead out of the active site. In
order to validate this finding, two variables were examined for all MD runs. The
first one is the distance between the β carbon of the double bond and the sulfur of
the active site Cys (r(S-C2)). The second descriptor is the dihedral angle Φ between
the two methyl groups. The results show a clear dependence of the descriptors for
component 15. Figure 8.36 illustrates the values for two MD simulations, with both
variables of inhibitor 15 staying below 5 Å . The corresponding dihedral angles stay
in a steady range around 60◦. Figure 8.37, on the other hand, contains all data for
the simulations, in which the inhibitor rotates out the active site. For the first ns, the
inhibitor stays very close the active site Cys25 (r(S-C2) < 4.0 Å). During this period,
the angle Φ is again in a range around 60◦. As soon as the distance increases, the
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two methyl groups rotate away from each other. In some simulations, the dihedral
settles at a value around -70◦, in other cases it takes values around 180◦. The effect of
the rotation always entails a drastic increase of the intermolecular distance between
the warhead and Cys25. The question whether the rotation of the methyl residues
initiates the increase of the distance or vice versa, is difficult to answer. The change in
both variables happens nearly at the same time. A plausible assumption could be that
the small fluctuations of the intermolecular distance at some point give enough space
to initiate the rotation, which then increases the distance, once again.
Abbildung 8.36: The two variables r(S-C2) and Φ (defined in Figure 8.35) during several MD
simulations, in which the warhead of compound 15 moved out of the active
site of rhodesain.
Abbildung 8.37: The two variables r(S-C2) and Φ (defined in Figure 8.35) during several MD
simulations, in which the warhead of compound 15 stayed inside the active
site of rhodesain.
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For inhibitor 11, no steric hindrance is provided as its hydrogen atom at the β position
is significantly smaller than a methyl group. Hence, the above observed dependen-
cy between the distance r(S-C2) and Φ does not occur during the respective MD
simulations. Figure 8.38 shows exemplary simulations of inhibitor 11, in which the
warhead rotates out the active site. The dihedral angel Φ is clearly independent to the
intermolecular distance between sulfur and the double bond.
Abbildung 8.38: The two variables r(S-C2) and Φ (defined in Figure 8.35) during all performed
MD simulations of compound 11 in rhodesain.
Conclusion
The inhibition potential of the two nitroalkenes 11 and 15 in rhodesain were inves-
tigated via different theoretical approaches. MD simulations of the two inhibitors in
rhodesain showed that the warhead of inhibitor 15 is twisted out of the active site
due to sterical hinderance of two adjacent methyl groups of the inhibitor. The war-
head of inhibitor 11, in contrast, stays in a stable position inside the active site during
the simulation. For this inhibitor, no sterical hinderance was found, as it differs from
inhibitor 15 by a hydrogen atom (instead of a methyl group). The analysis of the MD
simulations provided an explanation for the experimental results, which showed a
higher inhibition potential for inhibitor 11, compared to inhibitor 15. [3]
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9 Appendix
Experimental Data of the Group of Prof. Guetschow[1]
Tabelle 9.1: Experimental data concerning the inhibition efficiency of the four carbamate-
based inhibitors in Cathepsin B shown in Figure 9.1 (from the working group of
Prof. Guetschow). Measured data is given for an inhibitor concentration of [I] =
20 µM. The term kinac/Ki is a measure for the overall inhibition efficiency, based
on the scheme in Figure 9.2.
[H] Inhibitor enzyme activity kinac/Ki [M−1s−1]
1 2% 745
2 4% 711
3 85% -
4 98% -
Abbildung 9.1: Investigated compounds from the working group of Prof. Guetschow.
Abbildung 9.2: Scheme of a irreversible inhibition reaction with E: enzyme, I: inhibitor, Ki =
inhibitor concentration of half maximal rate of covalent bond formation.
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Further Results of chapter 7.3.4 - Water-Mediated
Proton Transfer of Carbamate-Based Inhibitors in
Cathepsin B
Abbildung 9.3: Definition of the geometric parameters of the system.
Abbildung 9.4: PES (QM/MM) of the water-bridged proton transfer from the inhibitor to the
Cys29 (QM method PM3) with an alternative set of coordinates compared to
the one described in chapter 7.3.4.
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Abbildung 9.5: PES of the water-bridged dissociation of the inhibitor with the simultaneous
protonation of the phenolate (PM3 as QM method) with starting structure
W INT’ from Figure 7.26 in chapter 7.3.4. Gray values give the energies relative
to the reactant structure of the mechanism.
153
Abbildung 9.6: PES of the water bridged dissotiation of the inhibitor with the simultanious
protonation of phenolat (PM3 as QM method) without the participation of
Cys29 with an alternative set of coordinates compared to the one described in
chapter 7.3.4. Gray values give the energies relative to the reactant structure
of the mechanism.
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Abbildung 9.7: PES (PM3 as QM method) of the reaction from starting structure W TS’ from
Figure 7.45 in chapter 7.3.4 for the modification of the two angles φ1 and
φ2. Gray values give the energies relative to the reactant structure of the
mechanism.
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Abbildung 9.8: PES (PM3 as QM method) of the reaction from starting structure W TS’ from
Figure 7.45 in chapter 7.3.4 for the modification the angle φ1 and the C-O2
bond. Gray values give the energies relative to the reactant structure of the
mechanism.
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Abbildung 9.9: QM/MM PES (Single Point calculations with B3LYP/aug-cc-pVDZ (upper gra-
phic) and SCS-MP2/aug-cc-pVDZ (lower graphic) as QM methods on the
structures, optimized with PM3 es QM method) of the reaction from starting
structure W TS’ from Figure 7.45 in chapter 7.3.4 for the modification of the
angle φ1 and the C-O2 bond. Gray values give the energies relative to the
reactant structure of the mechanism.
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10 Abbreviations
ACh Acetylcholine
AChE Acetylcholine esterase
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
Cys Cysteine
DFT Density functional theory
FF Force field
GAFF Generalized AMBER force field
GGA Generalized gradient approximation
Gln Glutamine
Glu Glutamic acid
Gly Glycine
HAT Human African Trypanosomiasis
HF Hartree Fock
His Histidine
Ile Isoleucine
LDA Local density approximation
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Leu Leucine
Lys Lysine
MD Molecular dynamics
Met Methionine
MM Molecular mechanics
MP2 Second order Møller-Plesset Perturbation Theory
NEB Nugded Elastic Band
Phe Phenylalanine
Pro Proline
QM Quantum Mechanics
RMSD Root mean square deviation
SCS Spin component scaling
Ser Serine
T.b. Trypanosoma brucei
Thr Threonine
Trp Tryptophan
Tyr Tyrosine
Val Valine
WHO World Health Organization
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